<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Autoinflation for otitis media with effusion (OME) in children - Webster, KE - 2023 | Cochrane Library</title> <meta content="Autoinflation for otitis media with effusion (OME) in children - Webster, KE - 2023 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015253.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Autoinflation for otitis media with effusion (OME) in children - Webster, KE - 2023 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015253.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD015253.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Autoinflation for otitis media with effusion (OME) in children" name="citation_title"/> <meta content="Katie E Webster" name="citation_author"/> <meta content="Nuffield Department of Surgical Sciences, University of Oxford" name="citation_author_institution"/> <meta content="Caroline A Mulvaney" name="citation_author"/> <meta content="Nuffield Department of Surgical Sciences, University of Oxford" name="citation_author_institution"/> <meta content="Kevin Galbraith" name="citation_author"/> <meta content="Nuffield Department of Surgical Sciences, University of Oxford" name="citation_author_institution"/> <meta content="Mridul Rana" name="citation_author"/> <meta content="Frimley Health NHS Foundation Trust" name="citation_author_institution"/> <meta content="Tal Marom" name="citation_author"/> <meta content="Samson Assuta Ashdod University Hospital, Ben Gurion University Faculty of Health Sciences" name="citation_author_institution"/> <meta content="Mat Daniel" name="citation_author"/> <meta content="Nottingham Children's Hospital" name="citation_author_institution"/> <meta content="Roderick P Venekamp" name="citation_author"/> <meta content="University Medical Center Utrecht, Utrecht University" name="citation_author_institution"/> <meta content="Anne GM Schilder" name="citation_author"/> <meta content="Samuel MacKeith" name="citation_author"/> <meta content="Oxford University Hospitals NHS Foundation Trust" name="citation_author_institution"/> <meta content="samuel.mackeith@ouh.nhs.uk" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="9" name="citation_issue"/> <meta content="10.1002/14651858.CD015253.pub2" name="citation_doi"/> <meta content="2023" name="citation_date"/> <meta content="2023/09/26" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015253.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015253.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015253.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Cognition; *Drug-Related Side Effects and Adverse Reactions; Epistaxis; *Otitis Media with Effusion [therapy]; Pain" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015253.pub2&amp;doi=10.1002/14651858.CD015253.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015253.pub2&amp;doi=10.1002/14651858.CD015253.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015253.pub2&amp;doi=10.1002/14651858.CD015253.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015253.pub2&amp;doi=10.1002/14651858.CD015253.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015253.pub2&amp;doi=10.1002/14651858.CD015253.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015253.pub2&amp;doi=10.1002/14651858.CD015253.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015253.pub2&amp;doi=10.1002/14651858.CD015253.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015253.pub2&amp;doi=10.1002/14651858.CD015253.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015253.pub2&amp;doi=10.1002/14651858.CD015253.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015253.pub2&amp;doi=10.1002/14651858.CD015253.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015253.pub2&amp;doi=10.1002/14651858.CD015253.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015253.pub2&amp;doi=10.1002/14651858.CD015253.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015253.pub2&amp;doi=10.1002/14651858.CD015253.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015253.pub2&amp;doi=10.1002/14651858.CD015253.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015253.pub2&amp;doi=10.1002/14651858.CD015253.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015253.pub2&amp;doi=10.1002/14651858.CD015253.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015253.pub2&amp;doi=10.1002/14651858.CD015253.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015253.pub2&amp;doi=10.1002/14651858.CD015253.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015253.pub2&amp;doi=10.1002/14651858.CD015253.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015253.pub2&amp;doi=10.1002/14651858.CD015253.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015253.pub2&amp;doi=10.1002/14651858.CD015253.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015253.pub2&amp;doi=10.1002/14651858.CD015253.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD015253.pub2&amp;doi=10.1002/14651858.CD015253.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="xNbeAU8n";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD015253\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD015253\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD015253\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD015253\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANS","zh_HANT","pt","ms","hr","fa","id","fr","pl","hu"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD015253.pub2",title:"Autoinflation for otitis media with effusion (OME) in children",firstPublishedDate:"Sep 26, 2023 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane ENT Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=xNbeAU8n&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD015253.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD015253.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD015253.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD015253.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD015253.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD015253.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;hu&quot;,&quot;title&quot;:&quot;Összefoglalás közérthető nyelven&quot;},{&quot;language&quot;:&quot;id&quot;,&quot;title&quot;:&quot;Saripati tinjauan sistematik&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD015253.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD015253.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD015253.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD015253.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>1712 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD015253.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015253.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015253.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015253.pub2/full#CD015253-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015253.pub2/full#CD015253-sec-0097"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015253.pub2/full#CD015253-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015253.pub2/full#CD015253-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015253.pub2/full#CD015253-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015253.pub2/full#CD015253-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015253.pub2/full#CD015253-sec-0044"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015253.pub2/full#CD015253-sec-0091"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015253.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015253.pub2/appendices#CD015253-sec-0103"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015253.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015253.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/supinfo/CD015253-dataPackage.zip?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/supinfo/CD015253-dataPackage.zip?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015253.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015253.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD015253.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD015253.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD015253.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD015253.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2023 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Autoinflation for otitis media with effusion (OME) in children</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD015253.pub2/information#CD015253-cr-0004">Katie E Webster</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD015253.pub2/information#CD015253-cr-0005">Caroline A Mulvaney</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD015253.pub2/information#CD015253-cr-0006">Kevin Galbraith</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD015253.pub2/information#CD015253-cr-0007">Mridul Rana</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD015253.pub2/information#CD015253-cr-0008">Tal Marom</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD015253.pub2/information#CD015253-cr-0009">Mat Daniel</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD015253.pub2/information#CD015253-cr-0010">Roderick P Venekamp</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD015253.pub2/information#CD015253-cr-0011">Anne GM Schilder</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD015253.pub2/information#CD015253-cr-0012"><i class="icon corresponding-author fa fa-envelope"></i>Samuel MacKeith</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/information/en#CD015253-sec-0108">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 26 September 2023 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD015253.pub2">https://doi.org/10.1002/14651858.CD015253.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD015253-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD015253-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD015253-abs-0017">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD015253-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD015253-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD015253-abs-0004">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD015253-abs-0001" lang="en"> <section id="CD015253-sec-0001"> <h3 class="title" id="CD015253-sec-0001">Background</h3> <p>Otitis media with effusion (OME) is an accumulation of fluid in the middle ear cavity, common amongst young children. The fluid may cause hearing loss. When persistent, it may lead to behavioural problems and a delay in expressive language skills. Management of OME includes watchful waiting, medical, surgical and mechanical treatment. Autoinflation is a self‐administered technique, which aims to ventilate the middle ear and encourage middle ear fluid clearance by providing a positive pressure of air in the nose and nasopharynx (using a nasal balloon or other handheld device). This positive pressure (sometimes combined with simultaneous swallow) encourages opening of the Eustachian tube and may help ventilate the middle ear. </p> </section> <section id="CD015253-sec-0002"> <h3 class="title" id="CD015253-sec-0002">Objectives</h3> <p>To assess the efficacy (benefits and harms) of autoinflation for the treatment of otitis media with effusion in children. </p> </section> <section id="CD015253-sec-0003"> <h3 class="title" id="CD015253-sec-0003">Search methods</h3> <p>The Cochrane ENT Information Specialist searched the Cochrane ENT Register; Central Register of Controlled Trials (CENTRAL); Ovid MEDLINE; Ovid Embase; Web of Science; ClinicalTrials.gov; ICTRP and additional sources for published and unpublished trials. The date of the search was 20 January 2023. </p> </section> <section id="CD015253-sec-0004"> <h3 class="title" id="CD015253-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) and quasi‐randomised trials in children aged 6 months to 12 years with unilateral or bilateral OME. We included studies that compared autoinflation with either watchful waiting (no treatment), non‐surgical treatment or ventilation tubes<i>.</i> </p> </section> <section id="CD015253-sec-0005"> <h3 class="title" id="CD015253-sec-0005">Data collection and analysis</h3> <p>We used standard Cochrane methods. Our primary outcomes were determined following a multi‐stakeholder prioritisation exercise and were: 1) hearing, 2) OME‐specific quality of life and 3) pain and distress. Secondary outcomes were: 1) persistence of OME, 2) other adverse effects (including eardrum perforation), 3) compliance or adherence to treatment, 4) receptive language skills, 5) speech development, 6) cognitive development, 7) psychosocial skills, 8) listening skills, 9) generic health‐related quality of life, 10) parental stress, 11) vestibular function and 12) episodes of acute otitis media. We used GRADE to assess the certainty of evidence for each outcome. </p> <p>Although we included all measures of hearing assessment, the proportion of children who returned to normal hearing was our preferred method to assess hearing, due to challenges in interpreting the results of mean hearing thresholds. </p> </section> <section id="CD015253-sec-0006"> <h3 class="title" id="CD015253-sec-0006">Main results</h3> <p>We identified 11 completed studies that met our inclusion criteria (1036 participants). The majority of studies included children aged between 3 and 11 years. Most were carried out in Europe or North America, and they were conducted in both hospital and community settings. All compared autoinflation (using a variety of different methods and devices) to no treatment. Most studies required children to carry out autoinflation two to three times per day, for between 2 and 12 weeks. The outcomes were predominantly assessed just after the treatment phase had been completed. Here we report the effects at the longest follow‐up for our main outcome measures. </p> <p><b>Return to normal hearing</b> </p> <p>The evidence was very uncertain regarding the effect of autoinflation on the return to normal hearing. The longest duration of follow‐up was 11 weeks. At this time point, the risk ratio was 2.67 in favour of autoinflation (95% confidence interval (CI) 1.73 to 4.12; 85% versus 32%; number needed to treat to benefit (NNTB) 2; 1 study, 94 participants), but the certainty of the evidence was very low. </p> <p><b>Disease‐specific quality of life</b> </p> <p>Autoinflation may result in a moderate improvement in quality of life (related to otitis media) after short‐term follow‐up. One study assessed quality of life using the Otitis Media Questionnaire‐14 (OMQ‐14) at three months of follow‐up. Results were reported as the number of standard deviations above or below zero difference, with a range from ‐3 (better) to +3 (worse). The mean difference was ‐0.42 lower (better) for those who received autoinflation (95% CI ‐0.62 to ‐0.22; 1 study, 247 participants; low‐certainty evidence; the authors report a change of 0.3 as clinically meaningful). </p> <p><b>Pain and distress caused by the procedure</b> </p> <p>Autoinflation may result in an increased risk of ear pain, but the evidence was very uncertain. One study assessed this outcome, and identified a risk ratio of 3.50 for otalgia in those who received autoinflation, although the overall occurrence of pain was low (95% CI 0.74 to 16.59; 4.4% versus 1.3%; number needed to treat to harm (NNTH) 32; 1 study, 320 participants; very low‐certainty evidence). </p> <p><b>Persistence of OME</b> </p> <p>The evidence suggests that autoinflation may slightly reduce the persistence of OME at three months. Four studies were included, and the risk ratio for persistence of OME was 0.88 for those receiving autoinflation (95% CI 0.80 to 0.97; 4 studies, 483 participants; absolute reduction of 89 people per 1000 with persistent OME; NNTB 12; low‐certainty evidence). </p> </section> <section id="CD015253-sec-0007"> <h3 class="title" id="CD015253-sec-0007">Authors' conclusions</h3> <p>All the evidence we identified was of low or very low certainty, meaning that we have little confidence in the estimated effects. However, the data suggest that autoinflation may have a beneficial effect on OME‐specific quality of life and persistence of OME in the short term, but the effect is uncertain for return to normal hearing and adverse effects. The potential benefits should be weighed against the inconvenience of regularly carrying out autoinflation, and the possible risk of ear pain. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD015253-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD015253-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD015253-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD015253-abs-0018">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD015253-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD015253-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD015253-abs-0009">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/hu#CD015253-abs-0016">Magyar</a> </li> <li class="section-language"> <a class="" href="full/id#CD015253-abs-0012">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="full/ms#CD015253-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD015253-abs-0015">Polski</a> </li> <li class="section-language"> <a class="" href="full/pt#CD015253-abs-0007">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD015253-abs-0005">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD015253-abs-0006">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD015253-abs-0002" lang="en"> <h3>Autoinflation for otitis media with effusion (OME or 'glue ear') in children</h3> <p><b>Key messages</b> </p> <p>Due to a lack of robust evidence, we are uncertain whether autoinflation has any effect on hearing. Using autoinflation two to three times per day may slightly reduce the number of children with OME after three months follow‐up. Scores on a questionnaire that looked at quality of life for people with OME were also better for children who carried out autoinflation. However, some children may experience pain when using autoinflation. </p> <p><b>What is OME?</b> </p> <p>Otitis media with effusion (OME, sometimes called 'glue ear') is a common condition affecting young children. Fluid collects in the middle ear, causing hearing impairment. As a result of their poor hearing, children may have behavioural difficulties and delays in their speech development. </p> <p><b>How is OME treated?</b> </p> <p>Most of the time, OME does not need any treatment and the symptoms will get better with time. In children with persistent OME, different treatments have been explored, including medications or surgery. Autoinflation is a technique where children blow air out of their nose against a pressure device (such as a balloon). This forces air back through the Eustachian tube, which connects the back of the nose to the middle ear. Opening of this tube may allow the middle ear fluid to drain away. </p> <p><b>What did we want to find out?</b> </p> <p>We wanted to identify whether autoinflation was better than no treatment, medical treatment or surgical treatment for children with OME. </p> <p>We also wanted to see if there were any unwanted effects associated with autoinflation.</p> <p><b>What did we do?</b> </p> <p>We searched for studies that compared autoinflation with no treatment or other treatments in children with OME. We compared and summarised the study results, and rated our confidence in the evidence, based on factors such as study methods and sizes. </p> <p><b>What did we find?</b> </p> <p>We found 11 studies that involved 1036 children with OME. Most of the studies were in children aged over three years old, and only lasted for up to three months. They compared autoinflation (carried out two to three times per day) with no treatment. </p> <p>We are uncertain whether autoinflation has any effect on hearing, as there was very little evidence about this. </p> <p>Autoinflation may slightly reduce the number of children who still have OME after three months of follow‐up, and may result in an improvement in quality of life. </p> <p>Children who use autoinflation may experience more ear pain than those who do not receive any treatment, but only one study assessed this, and the number of children with pain was small (4.4% compared to 1.3% in those who did not have treatment). </p> <p><b>What are the limitations of the evidence?</b> </p> <p>We have very little information about the longer‐term effects of autoinflation. A variety of different techniques and devices are available for autoinflation, and we do not know if some of these are more effective than others. </p> <p><b>How up‐to‐date is this evidence?</b> </p> <p>The evidence is up‐to‐date to January 2023.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD015253-sec-0097" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD015253-sec-0097"></div> <h3 class="title" id="CD015253-sec-0098">Implications for practice</h3> <section id="CD015253-sec-0098"> <p>There may be some small benefit from the use of autoinflation for otitis media with effusion (OME) with regard to persistence of OME and quality of life, although whether this benefit persists in the long term is unclear. The evidence is uncertain regarding return to normal hearing and adverse events. We are also unable to identify whether one type of autoinflation device is more effective than another. </p> <p>We did not look for evidence regarding the need for additional treatment in children with OME, and the data on longer‐term follow‐up were sparse. Therefore, we do not know whether the use of autoinflation has any impact on the requirement for medical treatment (such as antibiotics or steroids), or any effect on the number of children who require surgery for OME. </p> </section> <h3 class="title" id="CD015253-sec-0099">Implications for research</h3> <section id="CD015253-sec-0099"> <p>We identified a number of trials in this area, including a total of 1036 participants. Nonetheless, the evidence available for this intervention remains low‐ or very low‐certainty. Further consideration should be given to which children may be most likely to benefit from this intervention before embarking on large‐scale trials. This review forms part of a suite of five reviews, which consider interventions for OME (<a href="./references#CD015253-bbs2-0103" title="GalbraithK , MulvaneyCA , MacKeithS , MaromT , DanielM , VenekampRP , et al. Autoinflation for otitis media with effusion (OME) in children. Cochrane Database of Systematic Reviews2022, Issue 4. Art. No: CD015253. [DOI: 10.1002/14651858.CD015253]">Galbraith 2022</a>; <a href="./references#CD015253-bbs2-0068" title="MacKeithS , MulvaneyCA , GalbraithK , MaromT , DanielM , VenekampRP , et al. Ventilation tubes (grommets) for otitis media with effusion (OME) in children. Cochrane Database of Systematic Reviews2022, Issue 3. Art. No: CD015215. [DOI: 10.1002/14651858.CD015215]">MacKeith 2022a</a>; <a href="./references#CD015253-bbs2-0069" title="MacKeithS , MulvaneyCA , GalbraithK , MaromT , DanielM , VenekampRP , et al. Adenoidectomy for otitis media with effusion (OME) in children. Cochrane Database of Systematic Reviews2022, Issue 4. Art. No: CD015252. [DOI: 10.1002/14651858.CD015252]">MacKeith 2022b</a>; <a href="./references#CD015253-bbs2-0075" title="MulvaneyCA , GalbraithK , MacKeithS , MaromT , DanielM , VenekampRP , et al. Antibiotics for otitis media with effusion (OME) in children. Cochrane Database of Systematic Reviews2022, Issue 4. Art. No: CD015254. [DOI: 10.1002/14651858.CD015254]">Mulvaney 2022a</a>; <a href="./references#CD015253-bbs2-0076" title="MulvaneyCA , GalbraithK , MacKeithS , MaromT , DanielM , VenekampRP , et al. Topical and oral steroids for otitis media with effusion (OME) in children. Cochrane Database of Systematic Reviews2022, Issue 4. Art. No: CD015255. [DOI: 10.1002/14651858.CD015255]">Mulvaney 2022b</a>). Here we present implications for research in this field, which are shared across the suite of reviews: </p> <p> <ul id="CD015253-list-0042"> <li> <p>As OME is a fluctuating condition with high rates of resolution and recurrence, and a highly variable impact on children, clinical trials (and, in particular, randomised controlled trials) may not be the research design of choice. Instead, evidence may be better obtained from surgical or clinical registries (for example, see <a href="./references#CD015253-bbs2-0093" title="SchmalbachCE , BreretonJ , BowmanC , DennenyJC . American Academy of Otolaryngology–Head and Neck Surgery/Foundation Reg-ent Registry: Purpose, Properties, and Priorities. Otolaryngology – Head and Neck Surgery2021;164(5):964-71.">Schmalbach 2021</a>) or prospective cohort studies, with the use of 'big data'. These data sets may also be used to help identify subgroups of children who are at greater risk of persistent disease or long‐term consequences of OME. A clearer understanding of possible subgroups of children is needed to better target interventions to those who need them most, whilst avoiding over‐treatment for those in whom spontaneous resolution is anticipated. </p> </li> <li> <p>Adverse effects of interventions are important, and should always be assessed. However, randomised controlled trials are also not the best method to consider these ‐ especially when events are rare. Observational studies with longer follow‐up and larger numbers of participants are needed to provide more robust evidence on the frequency of side effects. It is important to note that the protocol, inclusion criteria and search strategy used for this review would have excluded these types of studies. It is therefore possible that evidence of this type may exist. With this in mind, we would advocate a review of observational data, to assess whether evidence regarding longer‐term outcomes and adverse events is already available. This may be particularly important when assessing harms from serious but rare adverse events. </p> </li> <li> <p>It is encouraging that a core outcome set has been developed in this field (<a href="./references#CD015253-bbs2-0047" title="BruceI , HarmanN , WilliamsonP , TierneyS , CalleryP , MohiuddinS , et al. The management of Otitis Media with Effusion in children with cleft palate (mOMEnt): a feasibility study and economic evaluation. Health Technology Assessment2015;19(68):1-374. [DOI: 10.3310/hta19680]">Bruce 2015</a>; <a href="./references#CD015253-bbs2-0067" title="LiuPZ , Ismail-KochH , StephensonK , DonneAJ , FergieN , DerryJ , et al. A core outcome set for research on the management of otitis media with effusion in otherwise-healthy children. International Journal of Pediatric Otorhinolaryngology2020;134:110029. [DOI: 10.1016/j.ijporl.2020]">Liu 2020</a>). Guidance on <i>how</i> to measure the different outcomes would also be helpful for future research. </p> </li> <li> <p>Comparison of mean hearing thresholds is widely used in research to assess the impact of different interventions on hearing. However, this outcome measure risks underestimating the potential impact of interventions on hearing. Small changes in mean hearing thresholds may be consistent with a substantial improvement in the number of children whose hearing returns to normal ‐ particularly in a condition with a high spontaneous resolution rate. We would encourage researchers to assess hearing with the proportion of children in whom hearing returns to normal, in preference to mean hearing thresholds. </p> </li> </ul> </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD015253-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD015253-sec-0008"></div> <div class="table" id="CD015253-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Autoinflation compared to no treatment for otitis media with effusion (OME) in children</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="bottom"> <p><b>Autoinflation compared to no treatment for otitis media with effusion (OME) in children</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="bottom"> <p><b>Patient or population:</b> otitis media with effusion (OME) in children aged 6 months to 12 years<br/><b>Setting:</b> outpatient<br/><b>Intervention:</b> autoinflation <br/><b>Comparison:</b> no treatment </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell table-tint" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>What happens</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Without autoinflation</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With autoinflation</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Difference</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children whose hearing is normal</p> <p>Follow‐up: up to 3 months</p> <p>№ of participants: 94<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>RR 2.67 (1.73 to 4.12)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>31.9%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85.2%<br/>(55.2 to 100) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53.3% more<br/>(23.3 more to 68.1more) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>1,2,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of autoinflation on return to normal hearing at 3 months. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Disease‐specific quality of life</p> <p>Mean difference in standardised OMQ‐14 scores (lower score is favourable)</p> <p>Follow‐up: 3 months (short‐term)</p> <p>№ of participants: 247<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.42 lower<br/>(0.62 lower to 0.22 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>1,4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that autoinflation may improve disease‐specific quality of life at 3 months. The study authors reported a change of 0.3 as clinically meaningful. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain and distress related to the procedure: otalgia</p> <p>Follow‐up: 3 months (short‐term)</p> <p>№ of participants: 320<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>RR 3.50 (0.74 to 16.59)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.4%</p> <p>(1 to 22.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.1% more (0.3% fewer to 19.5% more)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>1,5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Autoinflation may slightly increase the risk of ear pain (otalgia), but the evidence is very uncertain. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Persistence of OME</p> <p>Follow‐up: 3 months (short‐term)</p> <p>№ of participants: 483<br/>(4 RCTs) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>RR 0.88<br/>(0.80 to 0.97) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>74.1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65.2%<br/>(59.3 to 71.9) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.9% fewer<br/>(14.8 fewer to 2.2 fewer) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>1,6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that autoinflation may slightly reduce persistence of OME at 3 months. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br/><br/><b>CI:</b> confidence interval; <b>OME:</b> otitis media with effusion; <b>OMQ‐14:</b> Otitis Media Questionnaire‐14; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by one level for a risk of performance bias. </p> <p><sup>2</sup>Downgraded by one level for indirectness, as no description of 'normal hearing' was provided. </p> <p><sup>3</sup>Downgraded by one level for imprecision, as the optimal information size (OIS) was not reached (&lt; 300 events). </p> <p><sup>4</sup>Downgraded by one level for imprecision, as the OIS was not reached (&lt; 400 participants). </p> <p><sup>5</sup>Downgraded by two levels for imprecision, as the OIS was not reached (&lt; 300 events) and the confidence interval crosses two decision thresholds (RR 0.8 and 1.25). </p> <p><sup>6</sup>Downgraded by one level for a risk of detection bias. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD015253-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD015253-sec-0009"></div> <section id="CD015253-sec-0010"> <h3 class="title" id="CD015253-sec-0010">Description of the condition</h3> <p>Otitis media with effusion (OME) is a common condition in early childhood. The condition, also known as 'glue ear' and serous otitis media, is defined as "the presence of fluid in the middle ear without signs or symptoms of acute infection" (<a href="./references#CD015253-bbs2-0089" title="RosenfeldRM , ShinJJ , SchwartzSR , CogginsR , GagnonL , HackellJM , et al. Clinical practice guideline: otitis media with effusion (update). Otolaryngology - Head &amp; Neck Surgery2016;154:S1-S41. [DOI: 10.1177/0194599815623467]">Rosenfeld 2016</a>). </p> <p>A key clinical feature of OME is hearing loss, due to decreased mobility of the tympanic membrane and consequent loss of sound conduction (<a href="./references#CD015253-bbs2-0089" title="RosenfeldRM , ShinJJ , SchwartzSR , CogginsR , GagnonL , HackellJM , et al. Clinical practice guideline: otitis media with effusion (update). Otolaryngology - Head &amp; Neck Surgery2016;154:S1-S41. [DOI: 10.1177/0194599815623467]">Rosenfeld 2016</a>). When hearing loss persists, this may affect speech and language development, and lead to behavioural problems in some children (<a href="./references#CD015253-bbs2-0077" title="NICE. Otitis media with effusion in under 12s: Otitis media with effusion in under 12s: surgery (CG60). Available at: https://www.nice.org.uk/guidance/cg60 2008 (accessed 3 November 2021).">NICE 2008</a>). Other symptoms that may be attributable to OME include balance (vestibular) problems and ear discomfort (<a href="./references#CD015253-bbs2-0089" title="RosenfeldRM , ShinJJ , SchwartzSR , CogginsR , GagnonL , HackellJM , et al. Clinical practice guideline: otitis media with effusion (update). Otolaryngology - Head &amp; Neck Surgery2016;154:S1-S41. [DOI: 10.1177/0194599815623467]">Rosenfeld 2016</a>). When symptoms persist, they may lead to poor school performance and affect a child's daily activities, social interactions and emotions, possibly leading to a poorer quality of life for the child (<a href="./references#CD015253-bbs2-0087" title="RosenfeldRM , BhayaMH , BowerCM , BrookhouserPE , CasselbrantML , ChanKH , et al. Impact of tympanostomy tubes on child quality of life. Archives of Otolaryngology - Head &amp; Neck Surgery2000;126:585-92. [DOI: 10.1001/archotol.126.5.585]">Rosenfeld 2000</a>). </p> <p>It is thought that up to 80% of children have had OME by the age of four years, but a decline in prevalence is observed for children beyond six years of age (<a href="./references#CD015253-bbs2-0099" title="WilliamsonI . Otitis media with effusion in children. BMJ Clinical Evidence2011;2011:0502. [PMID: 19454116]">Williamson 2011</a>). Most episodes of OME in children resolve spontaneously within three months, however approximately 35% of children will have more than one episode of OME and, furthermore, 5% to 10% of episodes will last for more than a year (<a href="./references#CD015253-bbs2-0089" title="RosenfeldRM , ShinJJ , SchwartzSR , CogginsR , GagnonL , HackellJM , et al. Clinical practice guideline: otitis media with effusion (update). Otolaryngology - Head &amp; Neck Surgery2016;154:S1-S41. [DOI: 10.1177/0194599815623467]">Rosenfeld 2016</a>). Children with OME following an episode of untreated acute otitis media have a 59% rate of resolution by one month rising to 74% by three months, while children with newly diagnosed OME of unknown duration demonstrate a resolution rate of 28% by three months and up to 42% by six months (<a href="./references#CD015253-bbs2-0088" title="RosenfeldRM , KayD . Natural history of untreated otitis media. Laryngoscope2003;113:1645-57.">Rosenfeld 2003</a>). The condition is more prevalent in children with craniofacial syndromes, such as Down syndrome or cleft palate (Flynn 2009 [https://revman.cochrane.org/#/767321080313575379/dashboard/htmlView/current?revertEnabled=false&amp;versionWithProductionChanges=false#REF‐Flynn‐2009]; Maris 2014 [https://revman.cochrane.org/#/767321080313575379/dashboard/htmlView/current?revertEnabled=false&amp;versionWithProductionChanges=false#REF‐Maris‐2014]). Atopy has been considered a potential risk factor for OME in children (<a href="./references#CD015253-bbs2-0063" title="Kreiner-MøllerE , ChawesBL , Caye-ThomasenP , BønnelykkeK , BisgaardH . Allergic rhinitis is associated with otitis media with effusion: a birth cohort study. Clinical and Experimental Allergy2012;42(11):1615-20. [DOI: 10.1111/j.1365-2222.2012.04038.x]">Kreiner‐Møller 2012</a>; <a href="./references#CD015253-bbs2-0070" title="MarsegliaGL , PagellaF , CaimmiD , CaimmiS , CastellazziAM , PoddigheD , et al. Increased risk of otitis media with effusion in allergic children presenting with adenoiditis. Otolaryngology – Head and Neck Surgery2008;138(5):572-5. [DOI: 10.1016/j.otohns.2008.01.020]">Marseglia 2008</a>; <a href="./references#CD015253-bbs2-0101" title="ZernottiME , PawankarR , AnsoteguiI , BadellinoH , CroceJS , HossnyE , et al. Otitis media with effusion and atopy: is there a causal relationship?World Allergy Organization Journal2017;10(1):37. [DOI: 10.1186/s40413-017-0168-x]">Zernotti 2017</a>), as have parental smoking, attendance at day care and low socioeconomic status (<a href="./references#CD015253-bbs2-0049" title="DeweyC , MidgeleyE , MawR . The relationship between otitis media with effusion and contact with other children in a british cohort studied from 8 months to 3 1/2 years. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. International Journal of Pediatric Otorhinolaryngology2000;55(1):33-45.">Dewey 2000</a>; <a href="./references#CD015253-bbs2-0072" title="MarxJ , OsguthorpeJD , ParsonsG . Day care and the incidence of otitis media in young children. Otolaryngology Head and Neck Surgery1995;112(6):695-9.">Marx 1995</a>; <a href="./references#CD015253-bbs2-0090" title="RoversMM , deKokIM , SchilderAG . Risk factors for otitis media: an international perspective. International Journal of Pediatric Otorhinolaryngology2006;70(7):1251-6.">Rovers 2006</a>). </p> <p>Diagnosis of OME is typically by clinical examination including (pneumatic) otoscopy and/or tympanometry in primary care. Following diagnosis, there will often be a period of active observation for at least three months. During the observation period the care provider may offer a non‐surgical intervention such as hearing aids or autoinflation. The National Institute for Health and Care Excellence (NICE) and the American Academy of Otolaryngology–Head and Neck Surgery (AAO‐HNS) do not currently recommend the use of antibiotics, antihistamines, decongestants or corticosteroids for OME as there is insufficient evidence to suggest they are effective treatments (<a href="./references#CD015253-bbs2-0077" title="NICE. Otitis media with effusion in under 12s: Otitis media with effusion in under 12s: surgery (CG60). Available at: https://www.nice.org.uk/guidance/cg60 2008 (accessed 3 November 2021).">NICE 2008</a>; <a href="./references#CD015253-bbs2-0089" title="RosenfeldRM , ShinJJ , SchwartzSR , CogginsR , GagnonL , HackellJM , et al. Clinical practice guideline: otitis media with effusion (update). Otolaryngology - Head &amp; Neck Surgery2016;154:S1-S41. [DOI: 10.1177/0194599815623467]">Rosenfeld 2016</a>). If OME has not resolved within the three‐month observation period, the child may be referred for further management/active intervention. This may include hearing aid provision or review by an ENT surgeon for consideration for myringotomy, ventilation tubes insertion and/or adenoidectomy. The choice of active intervention varies considerably. Earlier active intervention may be considered for children at increased risk of developmental difficulties (see <a href="./references#CD015253-bbs2-0089" title="RosenfeldRM , ShinJJ , SchwartzSR , CogginsR , GagnonL , HackellJM , et al. Clinical practice guideline: otitis media with effusion (update). Otolaryngology - Head &amp; Neck Surgery2016;154:S1-S41. [DOI: 10.1177/0194599815623467]">Rosenfeld 2016</a> for a list of 'at‐risk' factors). </p> <p>This Cochrane Review focusses on autoinflation as a treatment for OME in children. This review forms part of a suite of five reviews of OME treatment, which will address those interventions identified in a prioritisation exercise as being most important and in need of up‐to‐date Cochrane Reviews, namely myringotomy and insertion of ventilation tubes, adenoidectomy with or without ventilation tubes, topical and oral steroids, autoinflation and antibiotics (<a href="./references#CD015253-bbs2-0048" title="CochraneENT . Otitis media with effusion: a project to prioritise Cochrane systematic reviews. https://ent.cochrane.org/otitis-media-effusion-ome-glue-ear 2020 (accessed 3 November 2021).">Cochrane ENT 2020</a>). </p> </section> <section id="CD015253-sec-0011"> <h3 class="title" id="CD015253-sec-0011">Description of the intervention</h3> <p>Autoinflation is a technique that forces the Eustachian tube to open by raising intranasal pressure. Its main goal is to aerate the middle ear cavity and equalise pressures in both sides of the tympanic membrane. Autoinflation can be achieved in a number of ways: forced exhalation with mouth and nose closed, for example the Valsalva manoeuvre; blowing up of a balloon through each nostril (demonstrated <a href="https://www.youtube.com/watch?v=Bwh5IyN26Fk" target="_blank">here</a>); or use of a device that utilises Politzeration, which involves blowing air up the nose while the patient swallows. There are commercial devices available, such as the Otovent nasal balloon device, and the air‐pump EarPopper device (<a href="./references#CD015253-bbs2-0083" title="The Royal Australian College of General Practitioners. Autoinflation: glue ear. https://www.racgp.org.au/getattachment/14295770-1083-475d-b7ae-8d43d7ecfb69/Autoinflation-for-glue-ear-in-children.aspx 2016 (accessed 3 November 2021).">RACGP 2016</a>). Given the manipulation required for successful autoinflation, it is considered suitable for children aged four years and over (<a href="./references#CD015253-bbs2-0100" title="WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , KellyS , et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. Canadian Medical Association Journal2015;187(13):961-9. [DOI: 10.1503/ cmaj.141608]">Williamson 2015</a>). It is a low‐cost intervention that can be used during an active observation period post‐diagnosis and may avoid the need for a surgical intervention (<a href="./references#CD015253-bbs2-0078" title="National Institute for Health and Care Excellence. Otovent nasal balloon for otitis media with effusion. https://www.nice.org.uk/advice/mib59/resources/otovent-nasal-balloon-for-otitis-media-with-effusion-pdf-63499234925509 2016 (accessed 3 November 2021).">NICE 2016</a>). </p> </section> <section id="CD015253-sec-0012"> <h3 class="title" id="CD015253-sec-0012">How the intervention might work</h3> <p>The aim of autoinflation is to introduce air into the middle ear, via the Eustachian tube, thus equalising the pressures either side of the tympanic membrane, and promoting drainage of fluid (<a href="./references#CD015253-bbs2-0081" title="PereraR , GlasziouP , HeneghanCJ , McLellanJ , WilliamsonI . Autoinflation for hearing loss associated with otitis media with effusion. Cochrane Database of Systematic Reviews2013, Issue 5. Art. No: CD006285. [DOI: 10.1002/14651858.CD006285.pub2]">Perera 2013</a>). Each time the procedure is repeated, it promotes aeration of the middle ear, thereby mitigating any abnormal Eustachian tube function until normal functioning returns (<a href="./references#CD015253-bbs2-0046" title="BerkmanND , WallaceIF , SteinerMJ , HarrisonM , GreenblattAM , LohrKN , et al. Otitis media with effusion: comparative effectiveness of treatments [Internet]. Report No.: 13-EHC091-EF edition. Vol. 1. Rockville (MD): Agency for Healthcare Research and Quality (US), 2013.">Berkman 2013</a>). </p> </section> <section id="CD015253-sec-0013"> <h3 class="title" id="CD015253-sec-0013">Why it is important to do this review</h3> <p>A Cochrane Review assessing the effects of autoinflation on OME for adults and children was published in 2013 (<a href="./references#CD015253-bbs2-0081" title="PereraR , GlasziouP , HeneghanCJ , McLellanJ , WilliamsonI . Autoinflation for hearing loss associated with otitis media with effusion. Cochrane Database of Systematic Reviews2013, Issue 5. Art. No: CD006285. [DOI: 10.1002/14651858.CD006285.pub2]">Perera 2013</a>), updating a review originally published in 2006. Searches were run to 2013 and the review included eight studies. The studies were small and had a short follow‐up. The review authors concluded that "it is reasonable to consider autoinflation whilst awaiting natural resolution of otitis media with effusion". </p> <p>A scoping search undertaken in 2020 identified seven abstracts published since 2013, including five publications assessing the EarPopper device and two publications relating to nasal balloon autoinflation with the Otovent device. Searches also identified two clinical trial registrations relating to a Swedish study of the Otovent device (<a href="./references#CD015253-bbs2-0052" title="EjnellH . A comparison of surgical and a new non-surgical treatment methods for secretory otitis media in children- hearing and socioeconomic aspects. https://clinicaltrials.gov/show/nct02546518 (first received 11 September 2015).">Ejnell 2015a</a>; <a href="./references#CD015253-bbs2-0053" title="EjnellH . The effect of early non-surgical treatment of children with middle ear effusion on the hearing level and the health economics. https://clinicaltrials.gov/show/nct02549612 (first received 15 September 2015).">Ejnell 2015b</a>). A prioritisation exercise undertaken in 2020 identified a review of autoinflation for OME as a top priority (<a href="./references#CD015253-bbs2-0048" title="CochraneENT . Otitis media with effusion: a project to prioritise Cochrane systematic reviews. https://ent.cochrane.org/otitis-media-effusion-ome-glue-ear 2020 (accessed 3 November 2021).">Cochrane ENT 2020</a>). Given the number of relevant studies published in recent years, it is timely to update the evidence. </p> <p>This review has been produced as part of a suite of reviews, which also inform a NICE guideline on the management of OME in children (<a href="./references#CD015253-bbs2-0079" title="National Institute for Health and Care Excellence. Otitis media with effusion in under 12s. NICE guideline [NG233]; August 2023. https://www.nice.org.uk/guidance/ng233.">NICE 2023</a>). The population of interest was therefore confined to children for consistency across the suite of reviews, and to align with the NICE guideline update. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD015253-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD015253-sec-0014"></div> <p>To assess the effects (benefits and harms) of autoinflation for otitis media with effusion (OME) in children. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD015253-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD015253-sec-0015"></div> <section id="CD015253-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD015253-sec-0017"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials (RCTs) and quasi‐randomised trials (where studies were designed as RCTs, but the sequence generation for allocation of treatment used methods such as alternative allocation, birth dates and alphabetical order). </p> </section> <section id="CD015253-sec-0018"> <h4 class="title">Types of participants</h4> <p>The population of interest was children aged 6 months to 12 years with unilateral or bilateral otitis media with effusion (OME). If a study included children aged younger than 6 months and older than 12 years, we planned to only include the study if the majority of children fit our inclusion criteria, or if the study authors presented outcome data according to age group. We included all children regardless of any comorbidity such as Down syndrome or cleft palate. Clinical diagnosis of OME was confirmed by oto(micro)scopy or tympanometry, or both. </p> </section> <section id="CD015253-sec-0019"> <h4 class="title">Types of interventions</h4> <section id="CD015253-sec-0020"> <h5 class="title">Intervention</h5> <p>Autoinflation by any method.</p> </section> <section id="CD015253-sec-0021"> <h5 class="title">Comparator</h5> <p>We planned to assess the following comparisons:</p> <p> <ul id="CD015253-list-0001"> <li> <p>autoinflation versus watchful waiting;</p> </li> <li> <p>autoinflation versus non‐surgical treatment;</p> </li> <li> <p>autoinflation versus ventilation tubes.</p> </li> </ul> </p> <p>If study participants had received other treatments (for example, intranasal steroids, oral steroids, antibiotics, mucolytics or decongestants), we included the study if both arms received identical treatments. </p> </section> </section> <section id="CD015253-sec-0022"> <h4 class="title">Types of outcome measures</h4> <p>We analysed the following outcomes in the review, but we did not use them as a basis for including or excluding studies. We assessed all outcomes at very short term (&lt; 6 weeks), short term (&gt; 6 weeks to ≤ 3 months), medium term (&gt; 3 months to ≤ 1 year) and long term &gt; 1 year. </p> <section id="CD015253-sec-0023"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD015253-list-0002"> <li> <p>Hearing:</p> <ul id="CD015253-list-0003"> <li> <p>Proportion of children whose hearing has returned to normal, with normal hearing defined as 20 dB HL or less (assessed using age‐appropriate tests). </p> </li> <li> <p>Hearing threshold.</p> </li> </ul> </li> </ul> </p> <p>It was anticipated that study data for these outcomes may be derived from a variety of assessment methods. To avoid loss of important evidence, we extracted all such data for analysis. However, we gave consideration to the appropriateness of pooling different types of data in meta‐analysis. Our selection of primary outcomes is based principally upon clinical importance, but also permits applicability across a variety of age‐appropriate assessment methods and considers the types of outcome data that are most likely to be available. Accordingly, we regard the proportion of participants whose hearing has returned to normal as the most important measure of hearing impact. We consider medium‐ and long‐term outcome data as the most clinically important. </p> <p> <ul id="CD015253-list-0004"> <li> <p>Disease‐specific quality of life measured using a validated instrument, for example:</p> <ul id="CD015253-list-0005"> <li> <p>OM8‐30 (<a href="./references#CD015253-bbs2-0058" title="HaggardMP , SmithSC , NichollsEE . Quality of life and child behaviour. In: RosenfeldRM , BluestoneCD , editors(s). Evidence-based Otitis Media. 2nd edition. Hamilton, Ontario: BC Decker Inc, 2003:401-29. [https://researchonline.lshtm.ac.uk/id/eprint/15108]">Haggard 2003</a>); </p> </li> <li> <p>Otitis Media‐6 (<a href="./references#CD015253-bbs2-0086" title="RosenfeldRM , GoldsmithAJ , TetlusL , BalzanoA . Quality of life for children with otitis media. Archives of Otolaryngology - Head &amp; Neck surgery1997;123:1049-54. [DOI: 10.1001/archotol.1997.01900100019002]">Rosenfeld 1997</a>). </p> </li> </ul> </li> <li> <p>Adverse events ‐ pain and distress caused by the procedure, including otalgia.</p> </li> </ul> </p> </section> <section id="CD015253-sec-0024"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD015253-list-0006"> <li> <p>Presence/persistence of OME.</p> </li> <li> <p>Adverse events ‐ measured by the number of participants affected:</p> <ul id="CD015253-list-0007"> <li> <p>eardrum perforation.</p> </li> </ul> </li> <li> <p>Compliance.</p> </li> <li> <p>Receptive language skills, measured using a validated scale, for example:</p> <ul id="CD015253-list-0008"> <li> <p>Peabody Picture Vocabulary Test ‐ Revised (<a href="./references#CD015253-bbs2-0050" title="DunnLM , DunnDM . Peabody Picture Vocabulary Test, Fourth Edition (PPVT™-4). Pearson Education, 2007.">Dunn 2007</a>); </p> </li> <li> <p>Reynell Developmental Language Scales (relevant domains) (<a href="./references#CD015253-bbs2-0085" title="ReynellJH . Reynell Development Language Scales Manual. 2nd edition. Windsor, UK: NFER-Nelson, 1985.">Reynell 1985</a>); </p> </li> <li> <p>Preschool Language Scale (PLS) (relevant domains) (<a href="./references#CD015253-bbs2-0102" title="ZimmermanIL , SteinerVG , PondRE . Preschool Language Scale-3. San Antonio, TX: The Psychological Corporation, 1992.">Zimmerman 1992</a>); </p> </li> <li> <p>Sequenced Inventory of Communication (SCID) (relevant domains) (<a href="./references#CD015253-bbs2-0060" title="HedrickDL , PratherEM , TobinAR . Sequenced Inventory of Communication Development. Seattle, WA: University of Washington Press, 1984.">Hedrick 1984</a>). </p> </li> </ul> </li> <li> <p>Speech development, or expressive language skills, measured using a validated scale, for example: </p> <ul id="CD015253-list-0009"> <li> <p>Schlichting test (<a href="./references#CD015253-bbs2-0092" title="SchlichtingJEPT , Lutje SpelbergHC . Schlichting Test for Language Comprehension; Instruction manual. Wooden: Bohn Stafleu van Loghum, 2010.">Schlichting 2010</a>); </p> </li> <li> <p>Lexi list (<a href="./references#CD015253-bbs2-0091" title="SchlichtingJEPT , Lutje SpelbergHC . Lexilijst Begrip: An instrument to investigate language comprehension in children aged 15-25 months in the context of early identification. Amsterdam: Pearson Assessment &amp; Information BV, 2007.">Schlichting 2007</a>); </p> </li> <li> <p>Reynell Developmental Language Scales (relevant domains) (<a href="./references#CD015253-bbs2-0085" title="ReynellJH . Reynell Development Language Scales Manual. 2nd edition. Windsor, UK: NFER-Nelson, 1985.">Reynell 1985</a>); </p> </li> <li> <p>PLS (relevant domains) (<a href="./references#CD015253-bbs2-0102" title="ZimmermanIL , SteinerVG , PondRE . Preschool Language Scale-3. San Antonio, TX: The Psychological Corporation, 1992.">Zimmerman 1992</a>); </p> </li> <li> <p>SCID (relevant domains) (<a href="./references#CD015253-bbs2-0060" title="HedrickDL , PratherEM , TobinAR . Sequenced Inventory of Communication Development. Seattle, WA: University of Washington Press, 1984.">Hedrick 1984</a>). </p> </li> </ul> </li> <li> <p>Cognitive development, measured using a validated scale, for example:</p> <ul id="CD015253-list-0010"> <li> <p>Griffiths Mental Development Scales (<a href="./references#CD015253-bbs2-0057" title="GriffithsR . The Griffiths Mental Development Scales from Birth to Two Years, manual, the 1996 revision. Henley: Association for Research in Infant and Child Development, Test Agency, 1996.">Griffiths 1996</a>); </p> </li> <li> <p>McCarthy General Cognitive Index (<a href="./references#CD015253-bbs2-0073" title="McCarthyD . Manual for the McCarthy Scales of Children's Abilities. New York: Psychological Corp, 1972.">McCarthy 1972</a>); </p> </li> <li> <p>Bayley Scales of Infant and Toddler Development (<a href="./references#CD015253-bbs2-0045" title="BayleyN . Bayley Scales of Infant and Toddler Development. 3rd edition. San Antonio, TX: Harcourt Assessment, Inc, 2006.">Bayley 2006</a>). </p> </li> </ul> </li> <li> <p>Psychosocial outcomes, measured using a validated scale, for example:</p> <ul id="CD015253-list-0011"> <li> <p>Social Skills Scale of the Social Skills Rating System (<a href="./references#CD015253-bbs2-0056" title="GreshamFM , ElliottSN . Social Skills Rating System. Circle Pines, MN: American Guidance Service, 1990.">Gresham 1990</a>); </p> </li> <li> <p>Child Behaviour Checklist (<a href="./references#CD015253-bbs2-0044" title="AchenbachTM . Child Behavior Checklist. In: KreutzerJS , DeLucaJ , CaplanB , editors(s). Encyclopedia of Clinical Neuropsychology. New York, NY: Springer, 2011. [DOI: 10.1007/978-0-387-79948-3_1529]">Achenbach 2011</a>); </p> </li> <li> <p>Strengths and Difficulties Questionnaire (<a href="./references#CD015253-bbs2-0055" title="GoodmanR . The Strengths and Difficulties Questionnaire: a research note. Journal of Child Psychology and Psychiatry1997;38:581-6. [DOI: 10.1111/j.1469-7610.1997.tb01545.x]">Goodman 1997</a>); </p> </li> <li> <p>Pediatric Symptom Checklist (<a href="./references#CD015253-bbs2-0062" title="JellinekMS , MurphyJM , RobinsonJ , FeinsA , LambS , FentonT . Pediatric Symptom Checklist: screening school-age children for psychosocial dysfunction. Journal of Pediatrics1988;112(2):201-9. [DOI: 10.1016/s0022-3476(88)80056-8]">Jellinek 1988</a>). </p> </li> </ul> </li> <li> <p>Listening skills, for example listening to stories and instructions effectively. Given that there are few validated scales to assess listening skills in children with OME, we included any methods used by trialists. </p> </li> <li> <p>Generic health‐related quality of life assessed using a validated instrument, for example: </p> <ul id="CD015253-list-0012"> <li> <p>EQ‐5D (<a href="./references#CD015253-bbs2-0082" title="RabinR , deCharroF . EQ-5D: a measure of health status from the EuroQol Group. Annals of Medicine2001;33(5):337-43. [DOI: 10.3109/07853890109002087]">Rabin 2001</a>); </p> </li> <li> <p>TNO AZL Children’s QoL (TACQOL) (<a href="./references#CD015253-bbs2-0096" title="VerripsGH , VogelsAGC , Verloove-VanhorickSP , FekkesM , KoopmanHM , KamphuisRP , et al. Health-related quality of life measure for children - the TACQOL. Journal of Applied Therapeutics1998;1(4):357-60.">Verrips 1998</a>); </p> </li> <li> <p>TNO AZL Pre‐school children QoL (TAPQOL) (<a href="./references#CD015253-bbs2-0054" title="FekkesM , TheunissenNC , BrugmanE , VeenS , VerripsEG , KoopmanHM , et al. Development and psychometric evaluation of the TAPQOL: a health-related quality of life instrument for 1–5-year-old children. Quality of Life Research2000;9:961-72. [DOI: 10.1023/a:1008981603178]">Fekkes 2000</a>); </p> </li> <li> <p>TNO AZL Infant Quality of Life (TAIQOL) (<a href="./references#CD015253-bbs2-0095" title="TNO—Prevention and Health/LUMC. TAIQOL—Questionnaire for parents of children aged 1—5 years. Leiden, The Netherlands: Leiden University Medical Center, 1997.">TNO 1997</a>); </p> </li> <li> <p>Infant Toddler Quality of Life Questionnaire (ITQOL) (<a href="./references#CD015253-bbs2-0064" title="LandgrafJM . The Infant/Toddler Child Health Questionnaire: conceptual framework, logic content, and preliminary psychometric results. Boston: Health Act, 1994.">Landgraf 1994</a>); </p> </li> <li> <p>Child Health Questionnaire (CHQ) (<a href="./references#CD015253-bbs2-0065" title="LandgrafJL , AbetzL , WareJE . The CHQ User’s Manual. Boston: The Health Institute, New England Medical Center, 1996.">Landgraf 1996</a>). </p> </li> </ul> </li> <li> <p>Parental stress, measured using a validated scale, for example: Parenting Stress Index (<a href="./references#CD015253-bbs2-0043" title="AbidinRR . Parenting Stress Index: Professional Manual. Third edition. Odessa, FL: Psychological Assessment Resources, 1995.">Abidin 1995</a>). </p> </li> <li> <p>Vestibular function:</p> <ul id="CD015253-list-0013"> <li> <p>balance;</p> </li> <li> <p>co‐ordination.</p> </li> </ul> </li> <li> <p>Number of doctor‐diagnosed acute otitis media (AOM) episodes within a specified time frame. </p> </li> </ul> </p> <p>These outcomes were identified as the most important in two studies that aimed to develop a core outcome set for children with OME (<a href="./references#CD015253-bbs2-0047" title="BruceI , HarmanN , WilliamsonP , TierneyS , CalleryP , MohiuddinS , et al. The management of Otitis Media with Effusion in children with cleft palate (mOMEnt): a feasibility study and economic evaluation. Health Technology Assessment2015;19(68):1-374. [DOI: 10.3310/hta19680]">Bruce 2015</a>; <a href="./references#CD015253-bbs2-0067" title="LiuPZ , Ismail-KochH , StephensonK , DonneAJ , FergieN , DerryJ , et al. A core outcome set for research on the management of otitis media with effusion in otherwise-healthy children. International Journal of Pediatric Otorhinolaryngology2020;134:110029. [DOI: 10.1016/j.ijporl.2020]">Liu 2020</a>). As this review forms part of a suite of reviews of interventions for OME, not all outcomes will be relevant for all reviews. </p> </section> </section> </section> <section id="CD015253-sec-0025"> <h3 class="title">Search methods for identification of studies</h3> <p>The Cochrane ENT Information Specialist conducted systematic searches for randomised controlled trials and controlled clinical trials. There were no language, publication year or publication status restrictions. We contacted original authors for clarification and further data if trial reports were unclear, and we arranged translations of papers where necessary. The date of the search was 20 January 2023. </p> <section id="CD015253-sec-0026"> <h4 class="title">Electronic searches</h4> <p>The Information Specialist searched:</p> <p> <ul id="CD015253-list-0014"> <li> <p>the Cochrane ENT Register (searched via the Cochrane Register of Studies to 20 January 2023); </p> </li> <li> <p>the Cochrane Central Register of Controlled Trials (CENTRAL 2023, Issue 1) (searched via the Cochrane Register of Studies to 20 January 2023); </p> </li> <li> <p>Ovid MEDLINE(R) Epub Ahead of Print, In‐Process &amp; Other Non‐Indexed Citations, Ovid MEDLINE(R) Daily and Ovid MEDLINE(R) (1946 to 20 January 2023); </p> </li> <li> <p>Ovid EMBASE (1974 to 20 January 2023);</p> </li> <li> <p>Web of Science (1945 to 20 January 2023);</p> </li> <li> <p>ClinicalTrials.gov, <a href="http://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov</a>: </p> <ul id="CD015253-list-0015"> <li> <p>searched via the Cochrane Register of Studies to 20 January 2023;</p> </li> <li> <p>searched via <a href="http://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov</a> to 20 January 2023; </p> </li> </ul> </li> <li> <p>World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP), <a href="https://apps.who.int/trialsearch/" target="_blank">https://apps.who.int/trialsearch/</a>: </p> <ul id="CD015253-list-0016"> <li> <p>searched via the Cochrane Register of Studies to 20 January 2023;</p> </li> <li> <p>searched via <a href="https://apps.who.int/trialsearch/" target="_blank">https://apps.who.int/trialsearch/</a> to 20 January 2023. </p> </li> </ul> </li> </ul> </p> <p>The Information Specialist modelled subject strategies for databases on the search strategy designed for CENTRAL. The search strategies were designed to identify all relevant studies for a suite of reviews on various interventions for OME. Where appropriate, they were combined with subject strategy adaptations of the highly sensitive search strategy designed by Cochrane for identifying randomised controlled trials and controlled clinical trials (as described in the Technical Supplement to Chapter 4 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> version 6.1) (<a href="./references#CD015253-bbs2-0066" title="LefebvreC , GlanvilleJ , BriscoeS , LittlewoodA , MarshallC , Metzendorf M-I, et al. Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.">Lefebvre 2020</a>). Search strategies for major databases including CENTRAL are provided in <a href="./appendices#CD015253-sec-0104">Appendix 1</a>. </p> </section> <section id="CD015253-sec-0027"> <h4 class="title">Searching other resources</h4> <p>We scanned the reference lists of identified publications for additional trials and contacted trial authors where necessary. The Information Specialist also ran non‐systematic searches of Google Scholar to retrieve grey literature and other sources of potential trials. </p> <p>We did not perform a separate search for adverse effects. We considered adverse effects described in included studies only. </p> </section> </section> <section id="CD015253-sec-0028"> <h3 class="title" id="CD015253-sec-0028">Data collection and analysis</h3> <section id="CD015253-sec-0029"> <h4 class="title">Selection of studies</h4> <p>The Cochrane ENT Information Specialist used Cochrane's Screen4Me workflow to help assess the search results. Screen4Me comprises three components: </p> <p> <ul id="CD015253-list-0017"> <li> <p>Known assessments – a service that matches records in the search results to records that have already been screened in Cochrane Crowd and been labelled as 'a RCT' or as 'not a RCT'. </p> </li> <li> <p>The machine learning classifier (RCT model) (<a href="./references#CD015253-bbs2-0097" title="WallaceBC , Noel-StorrA , MarshallIJ , CohenAM , SmalheiserNR , ThomasJ . Identifying reports of randomized controlled trials (RCTs) via a hybrid machine learning and crowdsourcing approach. Journal of the American Medical Informatics Association2017;24(6):1165-8.">Wallace 2017</a>), available in the Cochrane Register of Studies (CRS‐Web), which assigns a probability of being a true RCT (from 0 to 100) to each citation. Citations that are assigned a probability score below the cut‐point at a recall of 99% are assumed be non‐RCTs. For those that scored on or above the cut‐point we either manually dual screened these results or sent them to Cochrane Crowd for screening. </p> </li> <li> <p>Cochrane Crowd is Cochrane's citizen science platform where the Crowd help to identify and describe health evidence. For more information about Screen4Me and the evaluations that have been done, please go to the Screen4Me website on the Cochrane Information Specialist's <a href="https://community.cochrane.org/organizational-info/resources/resources-groups/information-specialists-portal" target="_blank">portal</a> and see <a href="./references#CD015253-bbs2-0071" title="MarshallJ , Noel-StorrAH , KuiperJ , ThomasJ , WallaceBC . Machine learning for identifying randomized controlled trials: an evaluation and practitioner's guide. Research Synthesis Methods2018;9(4):602-14. [DOI: 10.1002/jrsm.1287]">Marshall 2018</a>; <a href="./references#CD015253-bbs2-0074" title="McDonaldS , Noel-StorrAH , ThomasJ . Harnessing the efficiencies of machine learning and Cochrane Crowd to identify randomised trials for individual Cochrane reviews. In: Global Evidence Summit; 2017 Sep 13-17; Cape Town, South Africa. 2017.">McDonald 2017</a>; <a href="./references#CD015253-bbs2-0080" title="Noel-StorrAH . Cochrane Crowd: new ways of working together to produce health evidence. In: Evidence Live; 2018 Jun 18-20; Oxford, UK. 2018.">Noel‐Storr 2018</a>; <a href="./references#CD015253-bbs2-0094" title="ThomasJ , Noel-StorrAH , MarshallI , WallaceB , McDonaldS , MavergamesC , et al, Living Systematic Review Network. Living systematic reviews 2: combining human and machine effort. Journal of Clinical Epidemiology2017;91:31-7.">Thomas 2017</a>. </p> </li> </ul> </p> <p>Two review authors (KG, CM) independently screened the remaining titles and abstracts to identify potentially relevant studies. At least two review authors (of KG, SM, CM and KW) then independently evaluated the full text of each potentially relevant study to determine whether it met the inclusion/exclusion criteria for this review. Any differences were resolved by discussion and consensus, with the involvement of a third author where necessary. </p> </section> <section id="CD015253-sec-0030"> <h4 class="title">Screening eligible studies for trustworthiness</h4> <p>Two review authors (of KG, CM, MR, KW) used the screening tool developed by Cochrane Pregnancy and Childbirth to assess the trustworthiness of the included studies. This tool includes specified criteria to identify studies that are considered sufficiently trustworthy to be included in the review (see <a href="./appendices#CD015253-sec-0105">Appendix 2</a>). The process is outlined in <a href="#CD015253-fig-0001">Figure 1</a>. We had planned to exclude studies from the main analysis if there were concerns when using this tool. </p> <div class="figure" id="CD015253-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="The Cochrane Pregnancy and Childbirth Trustworthiness Screening Tool" data-id="CD015253-fig-0001" src="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-FIG-01.jpg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>The Cochrane Pregnancy and Childbirth Trustworthiness Screening Tool</p> </div> </div> </div> <p>However, for this review we identified some concerns with many of the studies that were assessed as suitable for inclusion. Issues that arose included a lack of prospective trial registration for studies published after 2010 (<a href="./references#CD015253-bbs2-0002" title="BanigoA , HuntA , RourkeT , WhitesideO , AldrenC . Does the Earpopper(®) device improve hearing outcomes in children with persistent otitis media with effusion? A randomised single-blinded controlled trial. Clinical Otolaryngology2016;41(1):59-65. [CENTRAL: CN-01078433] [EMBASE: 607683212] [PMID: 26095773]">Banigo 2016</a>; <a href="./references#CD015253-bbs2-0003" title="Bidarian-MoniriA , RamosMJ , EjnellH . Autoinflation for treatment of persistent otitis media with effusion in children: a cross-over study with a 12-month follow-up. International Journal of Pediatric Otorhinolaryngology2014;78(8):1298-305. [CENTRAL: CN-00994829] [EMBASE: 2014464001] [PMID: 24882460]">Bidarian‐Moniri 2014</a>; <a href="./references#CD015253-bbs2-0008" title="ScaddingG , RajputK , ParikhA , HilssS , Jansz JA , DarbyYC , et al. Double blind, placebo-controlled study of Flixonase with and without Otovent in the treatment of otitis media with effusion. In: 8th International Congress of Paediatric Otorhinolaryngology (ESPO); 2002 Sep 11-14; Oxford, UK. 2002:92-3. [ABSTRACT NUMBER: 21.04] [CENTRAL: CN-00431597] ScaddingGK , DarbyYC , JanszAJ , RichardsD , TateH , HillsS , et al. Double-blind, placebo controlled randomised trial of medical therapy in otitis media with effusion. Advances in Life Sciences and Health2014;1(2):1-11. [CENTRAL: CN-01043521] ">Scadding 2014</a>), equal numbers allocated to the control and intervention groups without the use of blocked randomisation (<a href="./references#CD015253-bbs2-0001" title="ArickD , SilmanS . Nonsurgical home treatment of middle ear effusion and associated hearing loss in children. Part I: clinical trial. Ear, Nose, &amp; Throat Journal2005;84(9):567-8, 570-4, 576 passim. [CENTRAL: CN-00552768] [EMBASE: 41864684] [PMID: 16261757]">Arick 2005</a>; <a href="./references#CD015253-bbs2-0002" title="BanigoA , HuntA , RourkeT , WhitesideO , AldrenC . Does the Earpopper(®) device improve hearing outcomes in children with persistent otitis media with effusion? A randomised single-blinded controlled trial. Clinical Otolaryngology2016;41(1):59-65. [CENTRAL: CN-01078433] [EMBASE: 607683212] [PMID: 26095773]">Banigo 2016</a>; <a href="./references#CD015253-bbs2-0007" title="ErcanI , CakirBC , KayaogluS , TurgutS . Long term effect of autoinflation in the treatment of otitis media with effusion. Elektronik Kulak Buran Bogaz ve Bas Boyun Cerrahisi Dergisi [Electronic Journal of Otolalryngology - Head and Neck Surgery]2005;4(4):166-70. [CENTRAL: CN-00849154] ">Ercan 2005</a>; <a href="./references#CD015253-bbs2-0009" title="StangerupS , TosM . Autoinflation in the treatment of Eustachian tube dysfunction, secretory otitis media and its sequelae. In: Mogi G (editor), editors(s). Recent Advances in Otitis Media. Amsterdam/New York: Kugler Publications, 1994:759-63. [CENTRAL: CN-01214464] StangerupSE , Sederberg-OlsenJ , BalleV . Autoinflation as a treatment of secretory otitis media. A randomized controlled study. Archives of Otolaryngology--Head &amp; Neck Surgery1992;118(2):149-52. [CENTRAL: CN-00082084] [PMID: 1540344]">Stangerup 1992</a>), and one study where the results on change in hearing were considered implausible (<a href="./references#CD015253-bbs2-0001" title="ArickD , SilmanS . Nonsurgical home treatment of middle ear effusion and associated hearing loss in children. Part I: clinical trial. Ear, Nose, &amp; Throat Journal2005;84(9):567-8, 570-4, 576 passim. [CENTRAL: CN-00552768] [EMBASE: 41864684] [PMID: 16261757]">Arick 2005</a>). In addition, some studies failed to describe the baseline characteristics of participants adequately, therefore we were unable to establish whether there was excessive similarity between the groups (<a href="./references#CD015253-bbs2-0001" title="ArickD , SilmanS . Nonsurgical home treatment of middle ear effusion and associated hearing loss in children. Part I: clinical trial. Ear, Nose, &amp; Throat Journal2005;84(9):567-8, 570-4, 576 passim. [CENTRAL: CN-00552768] [EMBASE: 41864684] [PMID: 16261757]">Arick 2005</a>; <a href="./references#CD015253-bbs2-0005" title="BrookerDS , McNeiceA . Autoinflation in the treatment of glue ear in children. Clinical Otolaryngology and Allied Sciences1992;17(4):289-90. [CENTRAL: CN-00262418] [PMID: 1526044]">Brooker 1992</a>; <a href="./references#CD015253-bbs2-0007" title="ErcanI , CakirBC , KayaogluS , TurgutS . Long term effect of autoinflation in the treatment of otitis media with effusion. Elektronik Kulak Buran Bogaz ve Bas Boyun Cerrahisi Dergisi [Electronic Journal of Otolalryngology - Head and Neck Surgery]2005;4(4):166-70. [CENTRAL: CN-00849154] ">Ercan 2005</a>; <a href="./references#CD015253-bbs2-0009" title="StangerupS , TosM . Autoinflation in the treatment of Eustachian tube dysfunction, secretory otitis media and its sequelae. In: Mogi G (editor), editors(s). Recent Advances in Otitis Media. Amsterdam/New York: Kugler Publications, 1994:759-63. [CENTRAL: CN-01214464] StangerupSE , Sederberg-OlsenJ , BalleV . Autoinflation as a treatment of secretory otitis media. A randomized controlled study. Archives of Otolaryngology--Head &amp; Neck Surgery1992;118(2):149-52. [CENTRAL: CN-00082084] [PMID: 1540344]">Stangerup 1992</a>). Only three of the included studies had no concerns when using this tool: <a href="./references#CD015253-bbs2-0006" title="ChanKH , BluestoneCD . Lack of efficacy of middle-ear inflation: treatment of otitis media with effusion in children. Otolaryngology--Head and Neck Surgery1989;100(4):317-23. [CENTRAL: CN-00060254] [PMID: 2498820]">Chan 1989</a>, <a href="./references#CD015253-bbs2-0010" title="ISRCTN55208702. An open randomised study of autoinflation in 4-11 year old school children with otitis media with effusion (OME) in primary care [Study of autoinflation in 4-11 year old school children with glue ear]. https://www.isrctn.com/ISRCTN55208702 (first received 16 June 2011). [CENTRAL: CN-01012774] WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. [CENTRAL: CN-01098789] [EMBASE: 606141685] [PMID: 26377389]WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , KellyS , et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ: Canadian Medical Association Journal2015;187(13):961-9. [CENTRAL: CN-01078404] [PMID: 26216608]">Williamson 2015a</a> and <a href="./references#CD015253-bbs2-0011" title="WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. ">Williamson 2015b</a>. </p> <p>We attempted to clarify these issues with the authors, where possible, but were not able to obtain additional information. However, we are uncertain whether the concerns highlighted by the trustworthiness tool represent genuine issues with the reliability of the data, or whether the tool may be highly sensitive to trial features that may or may not represent untrustworthy data. We note that this tool, and other tools used for the same purpose, have not yet been validated for use. </p> <p>We therefore took the decision to include all of these studies in the main analyses for this review. We have undertaken a sensitivity analysis where relevant, to exclude studies that failed to meet the criteria for this tool. </p> </section> <section id="CD015253-sec-0031"> <h4 class="title">Data extraction and management</h4> <p>At least two review authors (of KG, CM, MR, KW) independently extracted outcome data from each study using a standardised data collection form. Where a study had more than one publication, we retrieved all publications to ensure complete extraction of data. Any discrepancies in the data extracted by the two authors were checked against the original reports, and differences were resolved through discussion and consensus, with recourse to a third author where necessary. If required, we contacted the study authors for clarification. We included key characteristics of the studies, such as the study design, setting, sample size, population and the methods for defining or collecting outcome data in the studies. </p> <p>We extracted data on study findings according to treatment assignment, irrespective of whether study participants complied with treatment or received the treatment to which they were randomised. </p> <p>In addition to extracting pre‐specified information about study characteristics and aspects of methodology relevant to risk of bias, we extracted the following summary statistics for each study and outcome: </p> <p> <ul id="CD015253-list-0018"> <li> <p>For continuous data: the mean values, standard deviation and number of patients for each treatment group at the different time points for outcome measurement. Where endpoint data were not available, we extracted the values for change‐from‐baseline data instead. If values for the individual treatment groups were not reported, where possible we extracted summary statistics (e.g. mean difference) from the studies. </p> </li> <li> <p>For binary data: we extracted information on the number of participants experiencing an event, and the number of participants assessed at that time point. If values for the individual treatment groups were not reported, where possible we extracted summary statistics (e.g. risk ratio) from the studies. </p> </li> <li> <p>For ordinal scale data: we did not include any data from an ordinal scale in this review. </p> </li> </ul> </p> <p>We pre‐specified time points of interest for the outcomes in this review. Where studies reported data at multiple time points, we took the longest available follow‐up point within each of the specific time frames. For example, if a study reported an outcome at 4 months, 8 months and 12 months of follow‐up then we included the 12‐month data for the time point &gt; 3 months to ≤ 1 year. For adverse events, it was anticipated that some studies may report frequency data for events and it may not be possible to determine whether these events occurred in one patient on one occasion or more than one occasion. In such circumstances we reported the data narratively. </p> </section> <section id="CD015253-sec-0032"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>At least two authors (of KG, CM, MR, KW) undertook assessment of the risk of bias of the included studies independently, with the following taken into consideration, as guided by the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD015253-bbs2-0059" title="Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Handbook 2011</a>): </p> <p> <ul id="CD015253-list-0019"> <li> <p>sequence generation;</p> </li> <li> <p>allocation concealment;</p> </li> <li> <p>blinding;</p> </li> <li> <p>incomplete outcome data;</p> </li> <li> <p>selective outcome reporting; and</p> </li> <li> <p>other sources of bias.</p> </li> </ul> </p> <p>We used the Cochrane risk of bias tool in RevMan 5.3 (<a href="./references#CD015253-bbs2-0084" title="Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">RevMan 2014</a>), which involves describing each of these domains as reported in the study and then assigning a judgement about the adequacy of each entry: 'low', 'high' or 'unclear' risk of bias. </p> </section> <section id="CD015253-sec-0033"> <h4 class="title">Measures of treatment effect</h4> <p>We summarised dichotomous data, such as presence of OME, as risk ratios (RR) and 95% confidence intervals (CI) and we summarised continuous data as a mean difference (MD) and 95% CI. For the outcomes presented in the summary of findings tables, we provide both the relative and absolute measures of effect. </p> </section> <section id="CD015253-sec-0034"> <h4 class="title">Unit of analysis issues</h4> <p>We planned to include studies that randomised by participant or by cluster, but no cluster‐randomised studies were identified as part of this review. We did include cross‐over studies, but used data from the first phase of the trial only, prior to cross‐over. </p> <p>For this review we anticipated that the unit of analysis would be the child. However, some studies reported findings by ear and therefore we have used both the child and ear as the unit of analysis. </p> <p>All studies randomised participants to autoinflation or no treatment (watchful waiting) at the level of the child ‐ as this is an intervention that affects both ears. Some studies in this review included children with bilateral OME ‐ either exclusively (<a href="./references#CD015253-bbs2-0003" title="Bidarian-MoniriA , RamosMJ , EjnellH . Autoinflation for treatment of persistent otitis media with effusion in children: a cross-over study with a 12-month follow-up. International Journal of Pediatric Otorhinolaryngology2014;78(8):1298-305. [CENTRAL: CN-00994829] [EMBASE: 2014464001] [PMID: 24882460]">Bidarian‐Moniri 2014</a>; <a href="./references#CD015253-bbs2-0004" title="BlanshardJ , MawA , BawdenR . The treatment of otitis media with effusion in children by autoinflation. In: 2nd European Congress of Oto-Rhino-Laryngology and Cervico-facial Surgery. 1992:31-7. [CENTRAL: CN-01165327] BlanshardJD , MawAR , BawdenR . Conservative treatment of otitis-media with effusion by autoinflation of the middle-ear. Clinical Otolaryngology1993;18(3):188-92. [CENTRAL: CN-02472342] ">Blanshard 1993</a>), or as a proportion of included participants (<a href="./references#CD015253-bbs2-0001" title="ArickD , SilmanS . Nonsurgical home treatment of middle ear effusion and associated hearing loss in children. Part I: clinical trial. Ear, Nose, &amp; Throat Journal2005;84(9):567-8, 570-4, 576 passim. [CENTRAL: CN-00552768] [EMBASE: 41864684] [PMID: 16261757]">Arick 2005</a>; <a href="./references#CD015253-bbs2-0005" title="BrookerDS , McNeiceA . Autoinflation in the treatment of glue ear in children. Clinical Otolaryngology and Allied Sciences1992;17(4):289-90. [CENTRAL: CN-00262418] [PMID: 1526044]">Brooker 1992</a>; <a href="./references#CD015253-bbs2-0006" title="ChanKH , BluestoneCD . Lack of efficacy of middle-ear inflation: treatment of otitis media with effusion in children. Otolaryngology--Head and Neck Surgery1989;100(4):317-23. [CENTRAL: CN-00060254] [PMID: 2498820]">Chan 1989</a>; <a href="./references#CD015253-bbs2-0007" title="ErcanI , CakirBC , KayaogluS , TurgutS . Long term effect of autoinflation in the treatment of otitis media with effusion. Elektronik Kulak Buran Bogaz ve Bas Boyun Cerrahisi Dergisi [Electronic Journal of Otolalryngology - Head and Neck Surgery]2005;4(4):166-70. [CENTRAL: CN-00849154] ">Ercan 2005</a>; <a href="./references#CD015253-bbs2-0009" title="StangerupS , TosM . Autoinflation in the treatment of Eustachian tube dysfunction, secretory otitis media and its sequelae. In: Mogi G (editor), editors(s). Recent Advances in Otitis Media. Amsterdam/New York: Kugler Publications, 1994:759-63. [CENTRAL: CN-01214464] StangerupSE , Sederberg-OlsenJ , BalleV . Autoinflation as a treatment of secretory otitis media. A randomized controlled study. Archives of Otolaryngology--Head &amp; Neck Surgery1992;118(2):149-52. [CENTRAL: CN-00082084] [PMID: 1540344]">Stangerup 1992</a>; <a href="./references#CD015253-bbs2-0010" title="ISRCTN55208702. An open randomised study of autoinflation in 4-11 year old school children with otitis media with effusion (OME) in primary care [Study of autoinflation in 4-11 year old school children with glue ear]. https://www.isrctn.com/ISRCTN55208702 (first received 16 June 2011). [CENTRAL: CN-01012774] WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. [CENTRAL: CN-01098789] [EMBASE: 606141685] [PMID: 26377389]WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , KellyS , et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ: Canadian Medical Association Journal2015;187(13):961-9. [CENTRAL: CN-01078404] [PMID: 26216608]">Williamson 2015a</a>). This gave rise to a number of issues regarding the unit of analysis, as some studies reported outcomes (particularly the persistence of OME) for each ear. </p> <p>We considered that outcomes for ears within the same individual were likely to be correlated ‐ for example, if a child had resolution of OME in one ear, they may be more likely to experience resolution in the contralateral ear. There is not complete independence between ears of the same individual. Standard meta‐analysis techniques assume that all data are independent. Therefore inclusion of the raw data (for the number of ears) is likely to overestimate the precision of any effect, and result in an excessively narrow confidence interval. </p> <p>To account for this correlation, we used the suggested methods in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD015253-bbs2-0059" title="Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Handbook 2011</a>), which are more commonly employed in the analysis of cluster‐randomised trials. We treated individuals who contributed two ears to the analysis (all of those with bilateral disease) as a 'cluster' of two data points. We then attempted to account for the correlation in these clusters, by assuming a certain correlation between ears of the same individual. We could not identify a figure for this correlation in the published literature, so we used an estimated correlation of 0.5 in the main analysis, but conducted sensitivity analyses using correlations of 0 and 1, to test the limits of this assumption. We then reduced the effective size of the trials by the 'design effect' ‐ which accounts for correlation between ears, and the average cluster size (which would be 2 for trials where all children had bilateral disease, and less than 2 if trials included a mixture of children with bilateral and unilateral disease). </p> <p>Some trials also reported data both as a 'per ear' analysis, and as a 'per child' analysis ‐ where persistence was regarded as the presence of OME in either at least one ear, or all affected ears for children with bilateral disease. Where possible, we included these data as part of a sensitivity analysis, to assess whether the overall results were substantially altered. </p> </section> <section id="CD015253-sec-0035"> <h4 class="title">Dealing with missing data</h4> <p>We attempted to contact study authors by email where data on an outcome of interest to the review were not reported but the methods described in the paper suggest that the outcome was assessed, or if not all data required for meta‐analysis were reported. </p> </section> <section id="CD015253-sec-0036"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed clinical heterogeneity by examining the included studies for potential differences between them in the types of participants recruited, interventions or controls used, and the outcomes measured. We assessed statistical heterogeneity by considering both the I² statistic, which calculates the percentage of variability that is due to heterogeneity rather than chance (with values over 50% suggesting substantial heterogeneity), and the P value from the Chi² test (<a href="./references#CD015253-bbs2-0061" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.">Higgins 2021</a>). </p> </section> <section id="CD015253-sec-0037"> <h4 class="title">Assessment of reporting biases</h4> <p>We assessed reporting bias as within‐study outcome reporting bias and between‐study publication bias. </p> <section id="CD015253-sec-0038"> <h5 class="title">Outcome reporting bias (within‐study reporting bias)</h5> <p>We assessed within‐study reporting bias by comparing the outcomes reported in the published report against the study protocol or trial registry, whenever this could be obtained. If the protocol or trial registry entry was not available, we compared the outcomes reported to those listed in the methods section. If results are mentioned but not reported adequately in a way that allows analysis (e.g. the report only mentions whether the results were statistically significant or not), bias in a meta‐analysis is likely to occur. We then sought further information from the study authors. If no further information could be found, we noted this as being a 'high' risk of bias when the risk of bias tool was used. If there was insufficient information to judge the risk of bias we noted this as an 'unclear' risk of bias (<a href="./references#CD015253-bbs2-0059" title="Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Handbook 2011</a>). </p> </section> <section id="CD015253-sec-0039"> <h5 class="title">Publication bias (between‐study reporting bias)</h5> <p>If we were able to pool 10 or more studies in a single analysis, we planned to produce a funnel plot to explore possible publication biases. We planned to test for asymmetry using Egger's test (<a href="./references#CD015253-bbs2-0051" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta-analysis detected by a simple, graphical test. BMJ1997;315(7109):629-34. [DOI: 10.1136/bmj.315.7109.629]">Egger 1997</a>). However, we did not perform this test due to the paucity of data available for meta‐analysis. </p> </section> </section> <section id="CD015253-sec-0040"> <h4 class="title">Data synthesis</h4> <p>Where two or more studies reported the same outcome we performed a meta‐analysis using Review Manager 5 (<a href="./references#CD015253-bbs2-0084" title="Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">RevMan 2014</a>). We reported pooled effect measures for dichotomous outcomes as a risk ratio (RR) using the Mantel‐Haenszel methods. For continuous outcomes measured using the same scales we reported the mean difference (MD). We used a random‐effects model. </p> <p>Where it was not possible to pool the findings from studies in a meta‐analysis, we present the results of each study and provide a narrative synthesis of findings. </p> </section> <section id="CD015253-sec-0041"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We proposed the following subgroup analyses if sufficient data were available in study reports: </p> <p> <ul id="CD015253-list-0020"> <li> <p>children with mild hearing loss versus moderate or worse;</p> </li> <li> <p>children with allergy versus those without (using the trialists own definition);</p> </li> <li> <p>children aged six years and younger versus children older than six years;</p> </li> <li> <p>different types of autoinflation device;</p> </li> <li> <p>children with previous ventilation tubes versus those without ventilation tubes;</p> </li> <li> <p>children with cleft palate versus children without;</p> </li> <li> <p>children with Down syndrome versus children without.</p> </li> </ul> </p> <p>However, we did not find any data suitable for conducting these subgroup analyses. No studies provided subgroup data for children with different features (for example, for those with mild hearing loss, compared to those with moderate or worse hearing loss). Many of the trials did not provide sufficient background information (for example, on hearing level) for us to conduct subgroup analysis at the level of the individual study. Where data were provided, trials often recruited a mixed population that encompassed all subgroups (for example, most trials recruited children aged 3 to 10 years, not specifically children aged ≤ 6 years, or older than 6 years). </p> <p>We did have information on the different types of autoinflation device used in the trials. However, as many studies included custom‐made devices, we were unable to group these in a meaningful way to compare devices in a subgroup analysis. Therefore we took the decision to present only the summary effect. </p> </section> <section id="CD015253-sec-0042"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to carry out the following sensitivity analyses to assess whether our findings were robust to decisions made regarding analyses and inclusion of studies: </p> <p> <ul id="CD015253-list-0021"> <li> <p>Impact of model chosen: we compared the results using a random‐effects versus a fixed‐effect model. </p> </li> <li> <p>Inclusion of studies at high risk of bias: we planned to compare the results including all studies versus excluding studies at overall high risk of bias, that is four or more of the seven domains of bias are rated as high risk (see <a href="#CD015253-sec-0032">Assessment of risk of bias in included studies</a>). However, no study was rated at high risk of bias for four or more domains, therefore we did not conduct this analysis. </p> </li> <li> <p>Exclusion of studies with concerns over trustworthiness, as assessed by the Trustworthiness Screening Tool (<a href="#CD015253-fig-0001">Figure 1</a>). </p> </li> </ul> </p> </section> <section id="CD015253-sec-0043"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>At least two authors (KG, CM, KW) independently used the GRADE approach to rate the overall certainty of evidence using GRADEpro GDT (<a href="https://gradepro.org/" target="_blank">gradepro.org/</a>). The certainty of evidence reflects the extent to which we are confident that an estimate of effect is correct, and we have applied this in the interpretation of results. There are four possible ratings: high, moderate, low and very low. A rating of high certainty of evidence implies that we are confident in our estimate of effect and that further research is very unlikely to change our confidence in the estimate of effect. A rating of very low certainty implies that any estimate of effect obtained is very uncertain. </p> <p>The GRADE approach rates evidence from RCTs that do not have serious limitations as high certainty. However, several factors can lead to the downgrading of the evidence to moderate, low or very low. The degree of downgrading is determined by the seriousness of these factors: </p> <p> <ul id="CD015253-list-0022"> <li> <p>study limitations (risk of bias);</p> </li> <li> <p>inconsistency;</p> </li> <li> <p>indirectness of evidence;</p> </li> <li> <p>imprecision; and</p> </li> <li> <p>publication bias.</p> </li> </ul> </p> <p>We include a summary of findings table, constructed according to the recommendations described in Chapter 10 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD015253-bbs2-0061" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.">Higgins 2021</a>), for the following comparison(s): </p> <p> <ul id="CD015253-list-0023"> <li> <p>autoinflation versus watchful waiting;</p> </li> <li> <p>autoinflation versus non‐surgical treatment;</p> </li> <li> <p>autoinflation versus ventilation tubes.</p> </li> </ul> </p> <p>We include the following outcomes in the summary of findings table:</p> <p> <ul id="CD015253-list-0024"> <li> <p>hearing;</p> </li> <li> <p>disease‐specific quality of life;</p> </li> <li> <p>adverse events ‐ pain and distress caused by the procedure (otalgia);</p> </li> <li> <p>presence/persistence of OME.</p> </li> </ul> </p> <p>We prioritised data from the longest available time point for presentation in the summary of findings tables. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD015253-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD015253-sec-0044"></div> <section id="CD015253-sec-0045"> <h3 class="title">Description of studies</h3> <section id="CD015253-sec-0046"> <h4 class="title">Results of the search</h4> <p>The searches (September 2021 and January 2023) retrieved a total of 7441 records. This reduced to 4157 after the removal of duplicates. The Cochrane ENT Information Specialist sent all 4157 records to the Screen4Me workflow. The Screen4Me workflow identified 84 records as having previously been assessed: 50 had been rejected as not RCTs and 34 had been assessed as possible RCTs. The remaining 4073 references were sent to the RCT classifier, which rejected an additional 1514 records as not RCTs (with 99% sensitivity). The Cochrane Crowd assessed 2443 of the remaining references, rejecting 1313 as not RCTs and identifying 1130 as possible RCTs. Following this process, the Screen4Me workflow had rejected 2877 records and identified 1280 possible RCTs for title and abstract screening (see <a href="#CD015253-tbl-0002">Table 1</a>). </p> <div class="table" id="CD015253-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">RCTs identified through Cochrane Crowd and the RCT classifier</span></div> <tbody> <tr> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Possible RCTs</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Rejected</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Known assessments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT classifier</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2559</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1514</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cochrane Crowd</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1313</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1280</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2877</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>RCT: randomised controlled trial</p> </div> </div> <p>We identified 76 additional duplicates. We screened the titles and abstracts of the remaining 1204 records. We discarded 886 records and assessed 318 full‐text records. We subsequently discarded an additional 266 records and identified an additional five duplicates. </p> <p>We excluded 25 records with reasons recorded in the review (see <a href="#CD015253-sec-0062">Excluded studies</a> and <a href="./references#CD015253-sec-0117" title="">Characteristics of excluded studies</a>). </p> <p>We included 11 studies (15 records) where results were available (<a href="./references#CD015253-bbs2-0001" title="ArickD , SilmanS . Nonsurgical home treatment of middle ear effusion and associated hearing loss in children. Part I: clinical trial. Ear, Nose, &amp; Throat Journal2005;84(9):567-8, 570-4, 576 passim. [CENTRAL: CN-00552768] [EMBASE: 41864684] [PMID: 16261757]">Arick 2005</a>; <a href="./references#CD015253-bbs2-0002" title="BanigoA , HuntA , RourkeT , WhitesideO , AldrenC . Does the Earpopper(®) device improve hearing outcomes in children with persistent otitis media with effusion? A randomised single-blinded controlled trial. Clinical Otolaryngology2016;41(1):59-65. [CENTRAL: CN-01078433] [EMBASE: 607683212] [PMID: 26095773]">Banigo 2016</a>; <a href="./references#CD015253-bbs2-0003" title="Bidarian-MoniriA , RamosMJ , EjnellH . Autoinflation for treatment of persistent otitis media with effusion in children: a cross-over study with a 12-month follow-up. International Journal of Pediatric Otorhinolaryngology2014;78(8):1298-305. [CENTRAL: CN-00994829] [EMBASE: 2014464001] [PMID: 24882460]">Bidarian‐Moniri 2014</a>; <a href="./references#CD015253-bbs2-0004" title="BlanshardJ , MawA , BawdenR . The treatment of otitis media with effusion in children by autoinflation. In: 2nd European Congress of Oto-Rhino-Laryngology and Cervico-facial Surgery. 1992:31-7. [CENTRAL: CN-01165327] BlanshardJD , MawAR , BawdenR . Conservative treatment of otitis-media with effusion by autoinflation of the middle-ear. Clinical Otolaryngology1993;18(3):188-92. [CENTRAL: CN-02472342] ">Blanshard 1993</a>; <a href="./references#CD015253-bbs2-0005" title="BrookerDS , McNeiceA . Autoinflation in the treatment of glue ear in children. Clinical Otolaryngology and Allied Sciences1992;17(4):289-90. [CENTRAL: CN-00262418] [PMID: 1526044]">Brooker 1992</a>; <a href="./references#CD015253-bbs2-0006" title="ChanKH , BluestoneCD . Lack of efficacy of middle-ear inflation: treatment of otitis media with effusion in children. Otolaryngology--Head and Neck Surgery1989;100(4):317-23. [CENTRAL: CN-00060254] [PMID: 2498820]">Chan 1989</a>; <a href="./references#CD015253-bbs2-0007" title="ErcanI , CakirBC , KayaogluS , TurgutS . Long term effect of autoinflation in the treatment of otitis media with effusion. Elektronik Kulak Buran Bogaz ve Bas Boyun Cerrahisi Dergisi [Electronic Journal of Otolalryngology - Head and Neck Surgery]2005;4(4):166-70. [CENTRAL: CN-00849154] ">Ercan 2005</a>; <a href="./references#CD015253-bbs2-0008" title="ScaddingG , RajputK , ParikhA , HilssS , Jansz JA , DarbyYC , et al. Double blind, placebo-controlled study of Flixonase with and without Otovent in the treatment of otitis media with effusion. In: 8th International Congress of Paediatric Otorhinolaryngology (ESPO); 2002 Sep 11-14; Oxford, UK. 2002:92-3. [ABSTRACT NUMBER: 21.04] [CENTRAL: CN-00431597] ScaddingGK , DarbyYC , JanszAJ , RichardsD , TateH , HillsS , et al. Double-blind, placebo controlled randomised trial of medical therapy in otitis media with effusion. Advances in Life Sciences and Health2014;1(2):1-11. [CENTRAL: CN-01043521] ">Scadding 2014</a>; <a href="./references#CD015253-bbs2-0009" title="StangerupS , TosM . Autoinflation in the treatment of Eustachian tube dysfunction, secretory otitis media and its sequelae. In: Mogi G (editor), editors(s). Recent Advances in Otitis Media. Amsterdam/New York: Kugler Publications, 1994:759-63. [CENTRAL: CN-01214464] StangerupSE , Sederberg-OlsenJ , BalleV . Autoinflation as a treatment of secretory otitis media. A randomized controlled study. Archives of Otolaryngology--Head &amp; Neck Surgery1992;118(2):149-52. [CENTRAL: CN-00082084] [PMID: 1540344]">Stangerup 1992</a>; <a href="./references#CD015253-bbs2-0010" title="ISRCTN55208702. An open randomised study of autoinflation in 4-11 year old school children with otitis media with effusion (OME) in primary care [Study of autoinflation in 4-11 year old school children with glue ear]. https://www.isrctn.com/ISRCTN55208702 (first received 16 June 2011). [CENTRAL: CN-01012774] WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. [CENTRAL: CN-01098789] [EMBASE: 606141685] [PMID: 26377389]WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , KellyS , et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ: Canadian Medical Association Journal2015;187(13):961-9. [CENTRAL: CN-01078404] [PMID: 26216608]">Williamson 2015a</a>; <a href="./references#CD015253-bbs2-0011" title="WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. ">Williamson 2015b</a>). See <a href="./references#CD015253-sec-0116" title="">Characteristics of included studies</a>. </p> <p>We identified five ongoing studies (six records). See <a href="./references#CD015253-sec-0119" title="">Characteristics of ongoing studies</a> for further details of these studies. </p> <p>One study is awaiting classification as we were unable to obtain the full text for assessment (<a href="./references#CD015253-bbs2-0037" title="TawfikS , BelalA , SorourW . A comparative study of the different treatment modalities of otitis media with effusion in children. In: 8th International Congress of Paediatric Otorhinolaryngology (ESPO). Oxford, UK, 11-14 September, 2002. 2002:151. [ABSTRACT NUMBER: P2.26] [CENTRAL: CN-00508402] ">Tawfik 2002</a>). </p> <p>A flow chart of study retrieval and selection is provided in <a href="#CD015253-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD015253-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="original image" data-id="CD015253-fig-0002" src="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"></div> </div> </section> <section id="CD015253-sec-0047"> <h4 class="title">Included studies</h4> <p>We included 11 completed RCTs (<a href="./references#CD015253-bbs2-0001" title="ArickD , SilmanS . Nonsurgical home treatment of middle ear effusion and associated hearing loss in children. Part I: clinical trial. Ear, Nose, &amp; Throat Journal2005;84(9):567-8, 570-4, 576 passim. [CENTRAL: CN-00552768] [EMBASE: 41864684] [PMID: 16261757]">Arick 2005</a>; <a href="./references#CD015253-bbs2-0002" title="BanigoA , HuntA , RourkeT , WhitesideO , AldrenC . Does the Earpopper(®) device improve hearing outcomes in children with persistent otitis media with effusion? A randomised single-blinded controlled trial. Clinical Otolaryngology2016;41(1):59-65. [CENTRAL: CN-01078433] [EMBASE: 607683212] [PMID: 26095773]">Banigo 2016</a>; <a href="./references#CD015253-bbs2-0003" title="Bidarian-MoniriA , RamosMJ , EjnellH . Autoinflation for treatment of persistent otitis media with effusion in children: a cross-over study with a 12-month follow-up. International Journal of Pediatric Otorhinolaryngology2014;78(8):1298-305. [CENTRAL: CN-00994829] [EMBASE: 2014464001] [PMID: 24882460]">Bidarian‐Moniri 2014</a>; <a href="./references#CD015253-bbs2-0004" title="BlanshardJ , MawA , BawdenR . The treatment of otitis media with effusion in children by autoinflation. In: 2nd European Congress of Oto-Rhino-Laryngology and Cervico-facial Surgery. 1992:31-7. [CENTRAL: CN-01165327] BlanshardJD , MawAR , BawdenR . Conservative treatment of otitis-media with effusion by autoinflation of the middle-ear. Clinical Otolaryngology1993;18(3):188-92. [CENTRAL: CN-02472342] ">Blanshard 1993</a>; <a href="./references#CD015253-bbs2-0005" title="BrookerDS , McNeiceA . Autoinflation in the treatment of glue ear in children. Clinical Otolaryngology and Allied Sciences1992;17(4):289-90. [CENTRAL: CN-00262418] [PMID: 1526044]">Brooker 1992</a>; <a href="./references#CD015253-bbs2-0006" title="ChanKH , BluestoneCD . Lack of efficacy of middle-ear inflation: treatment of otitis media with effusion in children. Otolaryngology--Head and Neck Surgery1989;100(4):317-23. [CENTRAL: CN-00060254] [PMID: 2498820]">Chan 1989</a>; <a href="./references#CD015253-bbs2-0007" title="ErcanI , CakirBC , KayaogluS , TurgutS . Long term effect of autoinflation in the treatment of otitis media with effusion. Elektronik Kulak Buran Bogaz ve Bas Boyun Cerrahisi Dergisi [Electronic Journal of Otolalryngology - Head and Neck Surgery]2005;4(4):166-70. [CENTRAL: CN-00849154] ">Ercan 2005</a>; <a href="./references#CD015253-bbs2-0008" title="ScaddingG , RajputK , ParikhA , HilssS , Jansz JA , DarbyYC , et al. Double blind, placebo-controlled study of Flixonase with and without Otovent in the treatment of otitis media with effusion. In: 8th International Congress of Paediatric Otorhinolaryngology (ESPO); 2002 Sep 11-14; Oxford, UK. 2002:92-3. [ABSTRACT NUMBER: 21.04] [CENTRAL: CN-00431597] ScaddingGK , DarbyYC , JanszAJ , RichardsD , TateH , HillsS , et al. Double-blind, placebo controlled randomised trial of medical therapy in otitis media with effusion. Advances in Life Sciences and Health2014;1(2):1-11. [CENTRAL: CN-01043521] ">Scadding 2014</a>; <a href="./references#CD015253-bbs2-0009" title="StangerupS , TosM . Autoinflation in the treatment of Eustachian tube dysfunction, secretory otitis media and its sequelae. In: Mogi G (editor), editors(s). Recent Advances in Otitis Media. Amsterdam/New York: Kugler Publications, 1994:759-63. [CENTRAL: CN-01214464] StangerupSE , Sederberg-OlsenJ , BalleV . Autoinflation as a treatment of secretory otitis media. A randomized controlled study. Archives of Otolaryngology--Head &amp; Neck Surgery1992;118(2):149-52. [CENTRAL: CN-00082084] [PMID: 1540344]">Stangerup 1992</a>; <a href="./references#CD015253-bbs2-0010" title="ISRCTN55208702. An open randomised study of autoinflation in 4-11 year old school children with otitis media with effusion (OME) in primary care [Study of autoinflation in 4-11 year old school children with glue ear]. https://www.isrctn.com/ISRCTN55208702 (first received 16 June 2011). [CENTRAL: CN-01012774] WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. [CENTRAL: CN-01098789] [EMBASE: 606141685] [PMID: 26377389]WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , KellyS , et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ: Canadian Medical Association Journal2015;187(13):961-9. [CENTRAL: CN-01078404] [PMID: 26216608]">Williamson 2015a</a>; <a href="./references#CD015253-bbs2-0011" title="WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. ">Williamson 2015b</a>). One RCT, <a href="./references#CD015253-bbs2-0011" title="WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. ">Williamson 2015b</a>, was a pilot trial for another included RCT (<a href="./references#CD015253-bbs2-0010" title="ISRCTN55208702. An open randomised study of autoinflation in 4-11 year old school children with otitis media with effusion (OME) in primary care [Study of autoinflation in 4-11 year old school children with glue ear]. https://www.isrctn.com/ISRCTN55208702 (first received 16 June 2011). [CENTRAL: CN-01012774] WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. [CENTRAL: CN-01098789] [EMBASE: 606141685] [PMID: 26377389]WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , KellyS , et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ: Canadian Medical Association Journal2015;187(13):961-9. [CENTRAL: CN-01078404] [PMID: 26216608]">Williamson 2015a</a>). </p> <p>A summary of key participant characteristics, interventions, outcomes measured and follow‐up time is provided in <a href="#CD015253-tbl-0003">Table 2</a>. </p> <div class="table" id="CD015253-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Key characteristics of studies and participants</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Participants and ears randomised (N)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Autoinflation method</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Age (years) and whether unilateral or bilateral (if stated)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Outcomes assessed by study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Final follow‐up</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0001" title="ArickD , SilmanS . Nonsurgical home treatment of middle ear effusion and associated hearing loss in children. Part I: clinical trial. Ear, Nose, &amp; Throat Journal2005;84(9):567-8, 570-4, 576 passim. [CENTRAL: CN-00552768] [EMBASE: 41864684] [PMID: 16261757]">Arick 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94</p> <p>174 ears</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Modified Politzer device, used twice daily for 7 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 11</p> <p>Minimum 2‐month history of middle ear effusion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015253-list-0025"> <li> <p>Proportion children with hearing returned to normal</p> </li> <li> <p>Mean (SD) final hearing thresholds (dB) per ear assessed</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0002" title="BanigoA , HuntA , RourkeT , WhitesideO , AldrenC . Does the Earpopper(®) device improve hearing outcomes in children with persistent otitis media with effusion? A randomised single-blinded controlled trial. Clinical Otolaryngology2016;41(1):59-65. [CENTRAL: CN-01078433] [EMBASE: 607683212] [PMID: 26095773]">Banigo 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EarPopper device, used twice daily for 7 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 11</p> <p>3‐month history of persistent OME</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015253-list-0026"> <li> <p>Mean (SD) final hearing thresholds (dB), air conduction at 7 weeks</p> </li> <li> <p>Mean (SD) change in hearing thresholds (dB) from baseline, air conduction thresholds</p> </li> <li> <p>Presence/persistence of OME</p> </li> <li> <p>Adverse events: narrative summary</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0003" title="Bidarian-MoniriA , RamosMJ , EjnellH . Autoinflation for treatment of persistent otitis media with effusion in children: a cross-over study with a 12-month follow-up. International Journal of Pediatric Otorhinolaryngology2014;78(8):1298-305. [CENTRAL: CN-00994829] [EMBASE: 2014464001] [PMID: 24882460]">Bidarian‐Moniri 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>New autoinflation device consisting of an inflatable facemask, a T‐shaped junction tube connecting at one end to the facemask, another end to a balloon and the third end to a handheld pump covered by a teddy bear to improve compliance </p> <p>Used twice daily for 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 to 8</p> <p>All bilateral</p> <p>Persistent OME with a duration of at least 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015253-list-0027"> <li> <p>Proportion of ears with hearing returned to normal: hearing thresholds &gt; 20 dB</p> </li> <li> <p>Mean (SD) change in hearing thresholds (dB) from baseline (best ear): pure tone air conduction thresholds </p> </li> <li> <p>Presence/persistence of OME</p> </li> <li> <p>Adverse events: narrative summary</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks</p> <p>(Additional data at 1‐year follow‐up, but not relevant for this review)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0004" title="BlanshardJ , MawA , BawdenR . The treatment of otitis media with effusion in children by autoinflation. In: 2nd European Congress of Oto-Rhino-Laryngology and Cervico-facial Surgery. 1992:31-7. [CENTRAL: CN-01165327] BlanshardJD , MawAR , BawdenR . Conservative treatment of otitis-media with effusion by autoinflation of the middle-ear. Clinical Otolaryngology1993;18(3):188-92. [CENTRAL: CN-02472342] ">Blanshard 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Otovent device, used 3 times daily for 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 to 10</p> <p>Bilateral</p> <p>Confirmation of type B or C2 tympanograms on 2 occasions separated by ≥ 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015253-list-0028"> <li> <p>Mean (SD) change in hearing thresholds (dB) from baseline: pure tone audiometry</p> </li> <li> <p>Presence/persistence of OME</p> </li> <li> <p>Episodes of acute otitis media</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0005" title="BrookerDS , McNeiceA . Autoinflation in the treatment of glue ear in children. Clinical Otolaryngology and Allied Sciences1992;17(4):289-90. [CENTRAL: CN-00262418] [PMID: 1526044]">Brooker 1992</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> <p>78 ears</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Device comprised of a toy balloon attached to a carnival blower mouthpiece; used 3 times daily for 3 weeks </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 10 years</p> <p>Unilateral or bilateral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015253-list-0029"> <li> <p>Presence/persistence of OME</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0006" title="ChanKH , BluestoneCD . Lack of efficacy of middle-ear inflation: treatment of otitis media with effusion in children. Otolaryngology--Head and Neck Surgery1989;100(4):317-23. [CENTRAL: CN-00060254] [PMID: 2498820]">Chan 1989</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Modified Valsalva techniques ‐ a disposable anaesthesia mask attached to a floating ball‐type flowmeter. Child instructed to exhale through the nose through the mask (with mouth closed), as the pressure increased the ball in the flowmeter was propelled upwards. Used 3 times daily for 2 weeks. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 to 18</p> <p>Unilateral or bilateral</p> <p>Aimed to include those that had persistence for ≥ 3 months (although this was not everyone) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015253-list-0030"> <li> <p>Presence/persistence of OME</p> </li> <li> <p>Adverse events: narrative summary</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0007" title="ErcanI , CakirBC , KayaogluS , TurgutS . Long term effect of autoinflation in the treatment of otitis media with effusion. Elektronik Kulak Buran Bogaz ve Bas Boyun Cerrahisi Dergisi [Electronic Journal of Otolalryngology - Head and Neck Surgery]2005;4(4):166-70. [CENTRAL: CN-00849154] ">Ercan 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60</p> <p>93 ears</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Otovent, used 3 times daily for 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unilateral and bilateral</p> <p>Chronic OME for 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015253-list-0031"> <li> <p>Presence/persistence of OME</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0008" title="ScaddingG , RajputK , ParikhA , HilssS , Jansz JA , DarbyYC , et al. Double blind, placebo-controlled study of Flixonase with and without Otovent in the treatment of otitis media with effusion. In: 8th International Congress of Paediatric Otorhinolaryngology (ESPO); 2002 Sep 11-14; Oxford, UK. 2002:92-3. [ABSTRACT NUMBER: 21.04] [CENTRAL: CN-00431597] ScaddingGK , DarbyYC , JanszAJ , RichardsD , TateH , HillsS , et al. Double-blind, placebo controlled randomised trial of medical therapy in otitis media with effusion. Advances in Life Sciences and Health2014;1(2):1-11. [CENTRAL: CN-01043521] ">Scadding 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Otovent, used 3 times daily for 4 to 5 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 8</p> <p>With ≥ 3 months of glue ear or &gt; 2 episodes in the past 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015253-list-0032"> <li> <p>Presence/persistence of OME</p> </li> <li> <p>Adverse effects: narrative summary</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 years</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0009" title="StangerupS , TosM . Autoinflation in the treatment of Eustachian tube dysfunction, secretory otitis media and its sequelae. In: Mogi G (editor), editors(s). Recent Advances in Otitis Media. Amsterdam/New York: Kugler Publications, 1994:759-63. [CENTRAL: CN-01214464] StangerupSE , Sederberg-OlsenJ , BalleV . Autoinflation as a treatment of secretory otitis media. A randomized controlled study. Archives of Otolaryngology--Head &amp; Neck Surgery1992;118(2):149-52. [CENTRAL: CN-00082084] [PMID: 1540344]">Stangerup 1992</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tube designed by the author, with a balloon on the end, inserted in one nostril and blown up whilst occluding the other. Used 3 times daily for 2 to 4 weeks. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 to 10</p> <p>Unilateral and bilateral</p> <p>Secretory OM for ≥ 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015253-list-0033"> <li> <p>Presence/persistence of OME</p> </li> <li> <p>Episodes of acute otitis media</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0010" title="ISRCTN55208702. An open randomised study of autoinflation in 4-11 year old school children with otitis media with effusion (OME) in primary care [Study of autoinflation in 4-11 year old school children with glue ear]. https://www.isrctn.com/ISRCTN55208702 (first received 16 June 2011). [CENTRAL: CN-01012774] WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. [CENTRAL: CN-01098789] [EMBASE: 606141685] [PMID: 26377389]WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , KellyS , et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ: Canadian Medical Association Journal2015;187(13):961-9. [CENTRAL: CN-01078404] [PMID: 26216608]">Williamson 2015a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>320</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Otovent, used 3 times daily for between 1 and 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 11</p> <p>Unilateral and bilateral</p> <p>Parental concern with report of ≥ 1 relevant symptom/concern associated with OME in previous 3 months </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015253-list-0034"> <li> <p>Disease‐specific quality of life: OMQ‐14</p> </li> <li> <p>Presence/persistence of OME</p> </li> <li> <p>Receptive language: mean (SD) at endpoint</p> <ul id="CD015253-list-0035"> <li> <p>Auditory disability and speech reception tests and hearing tests</p> </li> </ul> </li> <li> <p>Other adverse effects</p> <ul id="CD015253-list-0036"> <li> <p>Nosebleeds</p> </li> <li> <p>URTI</p> </li> <li> <p>Unspecified RTI</p> </li> <li> <p>Lower RTI</p> </li> <li> <p>Otalgia</p> </li> <li> <p>Headache</p> </li> <li> <p>Hay fever</p> </li> <li> <p>Serious adverse event: hospitalisation</p> </li> </ul> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0011" title="WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. ">Williamson 2015b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Otovent, used 3 times daily for between 1 and 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 11</p> <p>Unilateral and bilateral</p> <p>Parental concern with report of ≥ 1 relevant symptom/concern associated with OME in previous 3 months </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015253-list-0037"> <li> <p>Presence/persistence of OME</p> </li> <li> <p>Adverse events: narrative summary</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>OME: otitis media with effusion; RTI: respiratory tract infection; SD: standard deviation; URTI: upper respiratory tract infection </p> </div> </div> <section id="CD015253-sec-0048"> <h5 class="title">Study design</h5> <p>All included trials were RCTs; one was a cross‐over trial so we only used data from the first stage of the trial, prior to cross‐over (<a href="./references#CD015253-bbs2-0003" title="Bidarian-MoniriA , RamosMJ , EjnellH . Autoinflation for treatment of persistent otitis media with effusion in children: a cross-over study with a 12-month follow-up. International Journal of Pediatric Otorhinolaryngology2014;78(8):1298-305. [CENTRAL: CN-00994829] [EMBASE: 2014464001] [PMID: 24882460]">Bidarian‐Moniri 2014</a>). While all studies recruited children, eight presented some findings by ear (<a href="./references#CD015253-bbs2-0001" title="ArickD , SilmanS . Nonsurgical home treatment of middle ear effusion and associated hearing loss in children. Part I: clinical trial. Ear, Nose, &amp; Throat Journal2005;84(9):567-8, 570-4, 576 passim. [CENTRAL: CN-00552768] [EMBASE: 41864684] [PMID: 16261757]">Arick 2005</a>; <a href="./references#CD015253-bbs2-0003" title="Bidarian-MoniriA , RamosMJ , EjnellH . Autoinflation for treatment of persistent otitis media with effusion in children: a cross-over study with a 12-month follow-up. International Journal of Pediatric Otorhinolaryngology2014;78(8):1298-305. [CENTRAL: CN-00994829] [EMBASE: 2014464001] [PMID: 24882460]">Bidarian‐Moniri 2014</a>; <a href="./references#CD015253-bbs2-0004" title="BlanshardJ , MawA , BawdenR . The treatment of otitis media with effusion in children by autoinflation. In: 2nd European Congress of Oto-Rhino-Laryngology and Cervico-facial Surgery. 1992:31-7. [CENTRAL: CN-01165327] BlanshardJD , MawAR , BawdenR . Conservative treatment of otitis-media with effusion by autoinflation of the middle-ear. Clinical Otolaryngology1993;18(3):188-92. [CENTRAL: CN-02472342] ">Blanshard 1993</a>; <a href="./references#CD015253-bbs2-0005" title="BrookerDS , McNeiceA . Autoinflation in the treatment of glue ear in children. Clinical Otolaryngology and Allied Sciences1992;17(4):289-90. [CENTRAL: CN-00262418] [PMID: 1526044]">Brooker 1992</a>; <a href="./references#CD015253-bbs2-0006" title="ChanKH , BluestoneCD . Lack of efficacy of middle-ear inflation: treatment of otitis media with effusion in children. Otolaryngology--Head and Neck Surgery1989;100(4):317-23. [CENTRAL: CN-00060254] [PMID: 2498820]">Chan 1989</a>; <a href="./references#CD015253-bbs2-0007" title="ErcanI , CakirBC , KayaogluS , TurgutS . Long term effect of autoinflation in the treatment of otitis media with effusion. Elektronik Kulak Buran Bogaz ve Bas Boyun Cerrahisi Dergisi [Electronic Journal of Otolalryngology - Head and Neck Surgery]2005;4(4):166-70. [CENTRAL: CN-00849154] ">Ercan 2005</a>; <a href="./references#CD015253-bbs2-0009" title="StangerupS , TosM . Autoinflation in the treatment of Eustachian tube dysfunction, secretory otitis media and its sequelae. In: Mogi G (editor), editors(s). Recent Advances in Otitis Media. Amsterdam/New York: Kugler Publications, 1994:759-63. [CENTRAL: CN-01214464] StangerupSE , Sederberg-OlsenJ , BalleV . Autoinflation as a treatment of secretory otitis media. A randomized controlled study. Archives of Otolaryngology--Head &amp; Neck Surgery1992;118(2):149-52. [CENTRAL: CN-00082084] [PMID: 1540344]">Stangerup 1992</a>; <a href="./references#CD015253-bbs2-0010" title="ISRCTN55208702. An open randomised study of autoinflation in 4-11 year old school children with otitis media with effusion (OME) in primary care [Study of autoinflation in 4-11 year old school children with glue ear]. https://www.isrctn.com/ISRCTN55208702 (first received 16 June 2011). [CENTRAL: CN-01012774] WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. [CENTRAL: CN-01098789] [EMBASE: 606141685] [PMID: 26377389]WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , KellyS , et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ: Canadian Medical Association Journal2015;187(13):961-9. [CENTRAL: CN-01078404] [PMID: 26216608]">Williamson 2015a</a>). The majority of studies followed participants for three months. The shortest follow‐up time was two weeks (<a href="./references#CD015253-bbs2-0006" title="ChanKH , BluestoneCD . Lack of efficacy of middle-ear inflation: treatment of otitis media with effusion in children. Otolaryngology--Head and Neck Surgery1989;100(4):317-23. [CENTRAL: CN-00060254] [PMID: 2498820]">Chan 1989</a>) and the longest was two years (<a href="./references#CD015253-bbs2-0008" title="ScaddingG , RajputK , ParikhA , HilssS , Jansz JA , DarbyYC , et al. Double blind, placebo-controlled study of Flixonase with and without Otovent in the treatment of otitis media with effusion. In: 8th International Congress of Paediatric Otorhinolaryngology (ESPO); 2002 Sep 11-14; Oxford, UK. 2002:92-3. [ABSTRACT NUMBER: 21.04] [CENTRAL: CN-00431597] ScaddingGK , DarbyYC , JanszAJ , RichardsD , TateH , HillsS , et al. Double-blind, placebo controlled randomised trial of medical therapy in otitis media with effusion. Advances in Life Sciences and Health2014;1(2):1-11. [CENTRAL: CN-01043521] ">Scadding 2014</a>). </p> </section> <section id="CD015253-sec-0049"> <h5 class="title">Participants</h5> <p>A total of 1036 participants were included. The majority of studies aimed to recruit children aged approximately 3 to 11 years old. <a href="./references#CD015253-bbs2-0006" title="ChanKH , BluestoneCD . Lack of efficacy of middle-ear inflation: treatment of otitis media with effusion in children. Otolaryngology--Head and Neck Surgery1989;100(4):317-23. [CENTRAL: CN-00060254] [PMID: 2498820]">Chan 1989</a> recruited children up to the age of 18 years, although most were aged three to six years. Most studies recruited children with at least a three‐month history of OME (<a href="./references#CD015253-bbs2-0002" title="BanigoA , HuntA , RourkeT , WhitesideO , AldrenC . Does the Earpopper(®) device improve hearing outcomes in children with persistent otitis media with effusion? A randomised single-blinded controlled trial. Clinical Otolaryngology2016;41(1):59-65. [CENTRAL: CN-01078433] [EMBASE: 607683212] [PMID: 26095773]">Banigo 2016</a>; <a href="./references#CD015253-bbs2-0003" title="Bidarian-MoniriA , RamosMJ , EjnellH . Autoinflation for treatment of persistent otitis media with effusion in children: a cross-over study with a 12-month follow-up. International Journal of Pediatric Otorhinolaryngology2014;78(8):1298-305. [CENTRAL: CN-00994829] [EMBASE: 2014464001] [PMID: 24882460]">Bidarian‐Moniri 2014</a>; <a href="./references#CD015253-bbs2-0004" title="BlanshardJ , MawA , BawdenR . The treatment of otitis media with effusion in children by autoinflation. In: 2nd European Congress of Oto-Rhino-Laryngology and Cervico-facial Surgery. 1992:31-7. [CENTRAL: CN-01165327] BlanshardJD , MawAR , BawdenR . Conservative treatment of otitis-media with effusion by autoinflation of the middle-ear. Clinical Otolaryngology1993;18(3):188-92. [CENTRAL: CN-02472342] ">Blanshard 1993</a>; <a href="./references#CD015253-bbs2-0006" title="ChanKH , BluestoneCD . Lack of efficacy of middle-ear inflation: treatment of otitis media with effusion in children. Otolaryngology--Head and Neck Surgery1989;100(4):317-23. [CENTRAL: CN-00060254] [PMID: 2498820]">Chan 1989</a>; <a href="./references#CD015253-bbs2-0008" title="ScaddingG , RajputK , ParikhA , HilssS , Jansz JA , DarbyYC , et al. Double blind, placebo-controlled study of Flixonase with and without Otovent in the treatment of otitis media with effusion. In: 8th International Congress of Paediatric Otorhinolaryngology (ESPO); 2002 Sep 11-14; Oxford, UK. 2002:92-3. [ABSTRACT NUMBER: 21.04] [CENTRAL: CN-00431597] ScaddingGK , DarbyYC , JanszAJ , RichardsD , TateH , HillsS , et al. Double-blind, placebo controlled randomised trial of medical therapy in otitis media with effusion. Advances in Life Sciences and Health2014;1(2):1-11. [CENTRAL: CN-01043521] ">Scadding 2014</a>; <a href="./references#CD015253-bbs2-0009" title="StangerupS , TosM . Autoinflation in the treatment of Eustachian tube dysfunction, secretory otitis media and its sequelae. In: Mogi G (editor), editors(s). Recent Advances in Otitis Media. Amsterdam/New York: Kugler Publications, 1994:759-63. [CENTRAL: CN-01214464] StangerupSE , Sederberg-OlsenJ , BalleV . Autoinflation as a treatment of secretory otitis media. A randomized controlled study. Archives of Otolaryngology--Head &amp; Neck Surgery1992;118(2):149-52. [CENTRAL: CN-00082084] [PMID: 1540344]">Stangerup 1992</a>; <a href="./references#CD015253-bbs2-0010" title="ISRCTN55208702. An open randomised study of autoinflation in 4-11 year old school children with otitis media with effusion (OME) in primary care [Study of autoinflation in 4-11 year old school children with glue ear]. https://www.isrctn.com/ISRCTN55208702 (first received 16 June 2011). [CENTRAL: CN-01012774] WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. [CENTRAL: CN-01098789] [EMBASE: 606141685] [PMID: 26377389]WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , KellyS , et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ: Canadian Medical Association Journal2015;187(13):961-9. [CENTRAL: CN-01078404] [PMID: 26216608]">Williamson 2015a</a>; <a href="./references#CD015253-bbs2-0011" title="WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. ">Williamson 2015b</a>). <a href="./references#CD015253-bbs2-0007" title="ErcanI , CakirBC , KayaogluS , TurgutS . Long term effect of autoinflation in the treatment of otitis media with effusion. Elektronik Kulak Buran Bogaz ve Bas Boyun Cerrahisi Dergisi [Electronic Journal of Otolalryngology - Head and Neck Surgery]2005;4(4):166-70. [CENTRAL: CN-00849154] ">Ercan 2005</a> recruited children with a four‐week history of OME, <a href="./references#CD015253-bbs2-0001" title="ArickD , SilmanS . Nonsurgical home treatment of middle ear effusion and associated hearing loss in children. Part I: clinical trial. Ear, Nose, &amp; Throat Journal2005;84(9):567-8, 570-4, 576 passim. [CENTRAL: CN-00552768] [EMBASE: 41864684] [PMID: 16261757]">Arick 2005</a> recruited children with a two‐month history of OME, and <a href="./references#CD015253-bbs2-0005" title="BrookerDS , McNeiceA . Autoinflation in the treatment of glue ear in children. Clinical Otolaryngology and Allied Sciences1992;17(4):289-90. [CENTRAL: CN-00262418] [PMID: 1526044]">Brooker 1992</a> did not report the duration of OME. Some studies included children with bilateral disease, whilst others recruited participants with either bilateral or unilateral OME. </p> </section> <section id="CD015253-sec-0050"> <h5 class="title">Interventions and comparisons</h5> <p>We identified studies that assessed two of our three comparisons of interest.</p> <section id="CD015253-sec-0051"> <h6 class="title">Comparison 1: autoinflation versus no treatment (watchful waiting)</h6> <p>Eleven completed RCTs assessed this comparison:</p> <p> <ul id="CD015253-list-0038"> <li> <p><a href="./references#CD015253-bbs2-0001" title="ArickD , SilmanS . Nonsurgical home treatment of middle ear effusion and associated hearing loss in children. Part I: clinical trial. Ear, Nose, &amp; Throat Journal2005;84(9):567-8, 570-4, 576 passim. [CENTRAL: CN-00552768] [EMBASE: 41864684] [PMID: 16261757]">Arick 2005</a> (94 participants, 174 ears) </p> </li> <li> <p><a href="./references#CD015253-bbs2-0002" title="BanigoA , HuntA , RourkeT , WhitesideO , AldrenC . Does the Earpopper(®) device improve hearing outcomes in children with persistent otitis media with effusion? A randomised single-blinded controlled trial. Clinical Otolaryngology2016;41(1):59-65. [CENTRAL: CN-01078433] [EMBASE: 607683212] [PMID: 26095773]">Banigo 2016</a> (30 participants) </p> </li> <li> <p><a href="./references#CD015253-bbs2-0003" title="Bidarian-MoniriA , RamosMJ , EjnellH . Autoinflation for treatment of persistent otitis media with effusion in children: a cross-over study with a 12-month follow-up. International Journal of Pediatric Otorhinolaryngology2014;78(8):1298-305. [CENTRAL: CN-00994829] [EMBASE: 2014464001] [PMID: 24882460]">Bidarian‐Moniri 2014</a> (45 participants) </p> </li> <li> <p><a href="./references#CD015253-bbs2-0004" title="BlanshardJ , MawA , BawdenR . The treatment of otitis media with effusion in children by autoinflation. In: 2nd European Congress of Oto-Rhino-Laryngology and Cervico-facial Surgery. 1992:31-7. [CENTRAL: CN-01165327] BlanshardJD , MawAR , BawdenR . Conservative treatment of otitis-media with effusion by autoinflation of the middle-ear. Clinical Otolaryngology1993;18(3):188-92. [CENTRAL: CN-02472342] ">Blanshard 1993</a> (85 participants) </p> </li> <li> <p><a href="./references#CD015253-bbs2-0005" title="BrookerDS , McNeiceA . Autoinflation in the treatment of glue ear in children. Clinical Otolaryngology and Allied Sciences1992;17(4):289-90. [CENTRAL: CN-00262418] [PMID: 1526044]">Brooker 1992</a> (40 participants, 78 ears) </p> </li> <li> <p><a href="./references#CD015253-bbs2-0006" title="ChanKH , BluestoneCD . Lack of efficacy of middle-ear inflation: treatment of otitis media with effusion in children. Otolaryngology--Head and Neck Surgery1989;100(4):317-23. [CENTRAL: CN-00060254] [PMID: 2498820]">Chan 1989</a> (41 participants) </p> </li> <li> <p><a href="./references#CD015253-bbs2-0007" title="ErcanI , CakirBC , KayaogluS , TurgutS . Long term effect of autoinflation in the treatment of otitis media with effusion. Elektronik Kulak Buran Bogaz ve Bas Boyun Cerrahisi Dergisi [Electronic Journal of Otolalryngology - Head and Neck Surgery]2005;4(4):166-70. [CENTRAL: CN-00849154] ">Ercan 2005</a> (60 participants, 93 ears) </p> </li> <li> <p><a href="./references#CD015253-bbs2-0008" title="ScaddingG , RajputK , ParikhA , HilssS , Jansz JA , DarbyYC , et al. Double blind, placebo-controlled study of Flixonase with and without Otovent in the treatment of otitis media with effusion. In: 8th International Congress of Paediatric Otorhinolaryngology (ESPO); 2002 Sep 11-14; Oxford, UK. 2002:92-3. [ABSTRACT NUMBER: 21.04] [CENTRAL: CN-00431597] ScaddingGK , DarbyYC , JanszAJ , RichardsD , TateH , HillsS , et al. Double-blind, placebo controlled randomised trial of medical therapy in otitis media with effusion. Advances in Life Sciences and Health2014;1(2):1-11. [CENTRAL: CN-01043521] ">Scadding 2014</a> (200 participants) </p> </li> <li> <p><a href="./references#CD015253-bbs2-0009" title="StangerupS , TosM . Autoinflation in the treatment of Eustachian tube dysfunction, secretory otitis media and its sequelae. In: Mogi G (editor), editors(s). Recent Advances in Otitis Media. Amsterdam/New York: Kugler Publications, 1994:759-63. [CENTRAL: CN-01214464] StangerupSE , Sederberg-OlsenJ , BalleV . Autoinflation as a treatment of secretory otitis media. A randomized controlled study. Archives of Otolaryngology--Head &amp; Neck Surgery1992;118(2):149-52. [CENTRAL: CN-00082084] [PMID: 1540344]">Stangerup 1992</a> (100 participants) </p> </li> <li> <p><a href="./references#CD015253-bbs2-0010" title="ISRCTN55208702. An open randomised study of autoinflation in 4-11 year old school children with otitis media with effusion (OME) in primary care [Study of autoinflation in 4-11 year old school children with glue ear]. https://www.isrctn.com/ISRCTN55208702 (first received 16 June 2011). [CENTRAL: CN-01012774] WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. [CENTRAL: CN-01098789] [EMBASE: 606141685] [PMID: 26377389]WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , KellyS , et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ: Canadian Medical Association Journal2015;187(13):961-9. [CENTRAL: CN-01078404] [PMID: 26216608]">Williamson 2015a</a> (320 participants) </p> </li> <li> <p><a href="./references#CD015253-bbs2-0011" title="WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. ">Williamson 2015b</a> (21 participants) </p> </li> </ul> </p> <p>All provided data we could use in this review except for <a href="./references#CD015253-bbs2-0008" title="ScaddingG , RajputK , ParikhA , HilssS , Jansz JA , DarbyYC , et al. Double blind, placebo-controlled study of Flixonase with and without Otovent in the treatment of otitis media with effusion. In: 8th International Congress of Paediatric Otorhinolaryngology (ESPO); 2002 Sep 11-14; Oxford, UK. 2002:92-3. [ABSTRACT NUMBER: 21.04] [CENTRAL: CN-00431597] ScaddingGK , DarbyYC , JanszAJ , RichardsD , TateH , HillsS , et al. Double-blind, placebo controlled randomised trial of medical therapy in otitis media with effusion. Advances in Life Sciences and Health2014;1(2):1-11. [CENTRAL: CN-01043521] ">Scadding 2014</a>, which did not provide data for any of our outcomes of interest. </p> <p>Of these 11 trials, five used an Otovent as the autoinflation intervention (<a href="./references#CD015253-bbs2-0004" title="BlanshardJ , MawA , BawdenR . The treatment of otitis media with effusion in children by autoinflation. In: 2nd European Congress of Oto-Rhino-Laryngology and Cervico-facial Surgery. 1992:31-7. [CENTRAL: CN-01165327] BlanshardJD , MawAR , BawdenR . Conservative treatment of otitis-media with effusion by autoinflation of the middle-ear. Clinical Otolaryngology1993;18(3):188-92. [CENTRAL: CN-02472342] ">Blanshard 1993</a>; <a href="./references#CD015253-bbs2-0007" title="ErcanI , CakirBC , KayaogluS , TurgutS . Long term effect of autoinflation in the treatment of otitis media with effusion. Elektronik Kulak Buran Bogaz ve Bas Boyun Cerrahisi Dergisi [Electronic Journal of Otolalryngology - Head and Neck Surgery]2005;4(4):166-70. [CENTRAL: CN-00849154] ">Ercan 2005</a>; <a href="./references#CD015253-bbs2-0008" title="ScaddingG , RajputK , ParikhA , HilssS , Jansz JA , DarbyYC , et al. Double blind, placebo-controlled study of Flixonase with and without Otovent in the treatment of otitis media with effusion. In: 8th International Congress of Paediatric Otorhinolaryngology (ESPO); 2002 Sep 11-14; Oxford, UK. 2002:92-3. [ABSTRACT NUMBER: 21.04] [CENTRAL: CN-00431597] ScaddingGK , DarbyYC , JanszAJ , RichardsD , TateH , HillsS , et al. Double-blind, placebo controlled randomised trial of medical therapy in otitis media with effusion. Advances in Life Sciences and Health2014;1(2):1-11. [CENTRAL: CN-01043521] ">Scadding 2014</a>; <a href="./references#CD015253-bbs2-0010" title="ISRCTN55208702. An open randomised study of autoinflation in 4-11 year old school children with otitis media with effusion (OME) in primary care [Study of autoinflation in 4-11 year old school children with glue ear]. https://www.isrctn.com/ISRCTN55208702 (first received 16 June 2011). [CENTRAL: CN-01012774] WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. [CENTRAL: CN-01098789] [EMBASE: 606141685] [PMID: 26377389]WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , KellyS , et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ: Canadian Medical Association Journal2015;187(13):961-9. [CENTRAL: CN-01078404] [PMID: 26216608]">Williamson 2015a</a>; <a href="./references#CD015253-bbs2-0011" title="WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. ">Williamson 2015b</a>), one used an EarPopper (<a href="./references#CD015253-bbs2-0002" title="BanigoA , HuntA , RourkeT , WhitesideO , AldrenC . Does the Earpopper(®) device improve hearing outcomes in children with persistent otitis media with effusion? A randomised single-blinded controlled trial. Clinical Otolaryngology2016;41(1):59-65. [CENTRAL: CN-01078433] [EMBASE: 607683212] [PMID: 26095773]">Banigo 2016</a>), and one used a modified Politzer device (<a href="./references#CD015253-bbs2-0001" title="ArickD , SilmanS . Nonsurgical home treatment of middle ear effusion and associated hearing loss in children. Part I: clinical trial. Ear, Nose, &amp; Throat Journal2005;84(9):567-8, 570-4, 576 passim. [CENTRAL: CN-00552768] [EMBASE: 41864684] [PMID: 16261757]">Arick 2005</a>). Three trials used devices designed by the trial authors (<a href="./references#CD015253-bbs2-0003" title="Bidarian-MoniriA , RamosMJ , EjnellH . Autoinflation for treatment of persistent otitis media with effusion in children: a cross-over study with a 12-month follow-up. International Journal of Pediatric Otorhinolaryngology2014;78(8):1298-305. [CENTRAL: CN-00994829] [EMBASE: 2014464001] [PMID: 24882460]">Bidarian‐Moniri 2014</a>; <a href="./references#CD015253-bbs2-0005" title="BrookerDS , McNeiceA . Autoinflation in the treatment of glue ear in children. Clinical Otolaryngology and Allied Sciences1992;17(4):289-90. [CENTRAL: CN-00262418] [PMID: 1526044]">Brooker 1992</a>; <a href="./references#CD015253-bbs2-0009" title="StangerupS , TosM . Autoinflation in the treatment of Eustachian tube dysfunction, secretory otitis media and its sequelae. In: Mogi G (editor), editors(s). Recent Advances in Otitis Media. Amsterdam/New York: Kugler Publications, 1994:759-63. [CENTRAL: CN-01214464] StangerupSE , Sederberg-OlsenJ , BalleV . Autoinflation as a treatment of secretory otitis media. A randomized controlled study. Archives of Otolaryngology--Head &amp; Neck Surgery1992;118(2):149-52. [CENTRAL: CN-00082084] [PMID: 1540344]">Stangerup 1992</a>) and one used a modified Valsalva technique (<a href="./references#CD015253-bbs2-0006" title="ChanKH , BluestoneCD . Lack of efficacy of middle-ear inflation: treatment of otitis media with effusion in children. Otolaryngology--Head and Neck Surgery1989;100(4):317-23. [CENTRAL: CN-00060254] [PMID: 2498820]">Chan 1989</a>). </p> <p>In nine trials, the comparison group received no treatment (<a href="./references#CD015253-bbs2-0001" title="ArickD , SilmanS . Nonsurgical home treatment of middle ear effusion and associated hearing loss in children. Part I: clinical trial. Ear, Nose, &amp; Throat Journal2005;84(9):567-8, 570-4, 576 passim. [CENTRAL: CN-00552768] [EMBASE: 41864684] [PMID: 16261757]">Arick 2005</a>; <a href="./references#CD015253-bbs2-0002" title="BanigoA , HuntA , RourkeT , WhitesideO , AldrenC . Does the Earpopper(®) device improve hearing outcomes in children with persistent otitis media with effusion? A randomised single-blinded controlled trial. Clinical Otolaryngology2016;41(1):59-65. [CENTRAL: CN-01078433] [EMBASE: 607683212] [PMID: 26095773]">Banigo 2016</a>; <a href="./references#CD015253-bbs2-0003" title="Bidarian-MoniriA , RamosMJ , EjnellH . Autoinflation for treatment of persistent otitis media with effusion in children: a cross-over study with a 12-month follow-up. International Journal of Pediatric Otorhinolaryngology2014;78(8):1298-305. [CENTRAL: CN-00994829] [EMBASE: 2014464001] [PMID: 24882460]">Bidarian‐Moniri 2014</a>; <a href="./references#CD015253-bbs2-0004" title="BlanshardJ , MawA , BawdenR . The treatment of otitis media with effusion in children by autoinflation. In: 2nd European Congress of Oto-Rhino-Laryngology and Cervico-facial Surgery. 1992:31-7. [CENTRAL: CN-01165327] BlanshardJD , MawAR , BawdenR . Conservative treatment of otitis-media with effusion by autoinflation of the middle-ear. Clinical Otolaryngology1993;18(3):188-92. [CENTRAL: CN-02472342] ">Blanshard 1993</a>; <a href="./references#CD015253-bbs2-0005" title="BrookerDS , McNeiceA . Autoinflation in the treatment of glue ear in children. Clinical Otolaryngology and Allied Sciences1992;17(4):289-90. [CENTRAL: CN-00262418] [PMID: 1526044]">Brooker 1992</a>; <a href="./references#CD015253-bbs2-0006" title="ChanKH , BluestoneCD . Lack of efficacy of middle-ear inflation: treatment of otitis media with effusion in children. Otolaryngology--Head and Neck Surgery1989;100(4):317-23. [CENTRAL: CN-00060254] [PMID: 2498820]">Chan 1989</a>; <a href="./references#CD015253-bbs2-0009" title="StangerupS , TosM . Autoinflation in the treatment of Eustachian tube dysfunction, secretory otitis media and its sequelae. In: Mogi G (editor), editors(s). Recent Advances in Otitis Media. Amsterdam/New York: Kugler Publications, 1994:759-63. [CENTRAL: CN-01214464] StangerupSE , Sederberg-OlsenJ , BalleV . Autoinflation as a treatment of secretory otitis media. A randomized controlled study. Archives of Otolaryngology--Head &amp; Neck Surgery1992;118(2):149-52. [CENTRAL: CN-00082084] [PMID: 1540344]">Stangerup 1992</a>; <a href="./references#CD015253-bbs2-0010" title="ISRCTN55208702. An open randomised study of autoinflation in 4-11 year old school children with otitis media with effusion (OME) in primary care [Study of autoinflation in 4-11 year old school children with glue ear]. https://www.isrctn.com/ISRCTN55208702 (first received 16 June 2011). [CENTRAL: CN-01012774] WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. [CENTRAL: CN-01098789] [EMBASE: 606141685] [PMID: 26377389]WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , KellyS , et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ: Canadian Medical Association Journal2015;187(13):961-9. [CENTRAL: CN-01078404] [PMID: 26216608]">Williamson 2015a</a>; <a href="./references#CD015253-bbs2-0011" title="WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. ">Williamson 2015b</a>). In one trial, both the intervention and control group were treated with nasal saline irrigation three times a day for six weeks (<a href="./references#CD015253-bbs2-0007" title="ErcanI , CakirBC , KayaogluS , TurgutS . Long term effect of autoinflation in the treatment of otitis media with effusion. Elektronik Kulak Buran Bogaz ve Bas Boyun Cerrahisi Dergisi [Electronic Journal of Otolalryngology - Head and Neck Surgery]2005;4(4):166-70. [CENTRAL: CN-00849154] ">Ercan 2005</a>), and in the trial <a href="./references#CD015253-bbs2-0008" title="ScaddingG , RajputK , ParikhA , HilssS , Jansz JA , DarbyYC , et al. Double blind, placebo-controlled study of Flixonase with and without Otovent in the treatment of otitis media with effusion. In: 8th International Congress of Paediatric Otorhinolaryngology (ESPO); 2002 Sep 11-14; Oxford, UK. 2002:92-3. [ABSTRACT NUMBER: 21.04] [CENTRAL: CN-00431597] ScaddingGK , DarbyYC , JanszAJ , RichardsD , TateH , HillsS , et al. Double-blind, placebo controlled randomised trial of medical therapy in otitis media with effusion. Advances in Life Sciences and Health2014;1(2):1-11. [CENTRAL: CN-01043521] ">Scadding 2014</a> there were four treatment arms including autoinflation, autoinflation and nasal steroids, nasal steroids and placebo. </p> <p>Three ongoing studies are investigating this comparison but provide no usable data for this current review (<a href="./references#CD015253-bbs2-0038" title="ACTRN12617001652369. Autoinflation for Aboriginal and Torres Strait Islander children with bilateral OME (middle ear infection) [A multi-centre randomised controlled trial to compare the efficacy of nasal balloon autoinflation versus no nasal balloon autoinflation for bilateral otitis media with effusion in Aboriginal and Torres Strait Islander children]. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12617001652369 (first received 2017). [CENTRAL: CN-01896354] WalshR , ReathJ , GunasekeraH , LeachA , KongK , AskewD , et al. INFLATE: a protocol for a randomised controlled trial comparing nasal balloon autoinflation to no nasal balloon autoinflation for otitis media with effusion in Aboriginal and Torres Strait Islander children. Trials2022;23(1):309. ">INFLATE (ACTRN12617001652369)</a>; <a href="./references#CD015253-bbs2-0039" title="NCT00393159. The influence of The Ear Popper on serous otitis media and on the accompanying conductive hearing loss in children. https://clinicaltrials.gov/show/NCT00393159 (first received 26 October 2006). Accessed 15/01/2023. [CENTRAL: CN-01038104] ">NCT00393159</a>; <a href="./references#CD015253-bbs2-0042" title="NCT05324696. Autoinflation: alternative in the treatment of otitis media with effusion (OME). https://clinicaltrials.gov/show/NCT05324696 (first received 12 April 2022). Accessed 15/01/2023. ">NCT05324696</a>). <a href="./references#CD015253-bbs2-0038" title="ACTRN12617001652369. Autoinflation for Aboriginal and Torres Strait Islander children with bilateral OME (middle ear infection) [A multi-centre randomised controlled trial to compare the efficacy of nasal balloon autoinflation versus no nasal balloon autoinflation for bilateral otitis media with effusion in Aboriginal and Torres Strait Islander children]. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12617001652369 (first received 2017). [CENTRAL: CN-01896354] WalshR , ReathJ , GunasekeraH , LeachA , KongK , AskewD , et al. INFLATE: a protocol for a randomised controlled trial comparing nasal balloon autoinflation to no nasal balloon autoinflation for otitis media with effusion in Aboriginal and Torres Strait Islander children. Trials2022;23(1):309. ">INFLATE (ACTRN12617001652369)</a> uses Otovent as the intervention and the comparison is usual care, while <a href="./references#CD015253-bbs2-0040" title="NCT02038400. Evaluation of the efficiency of KINETUBE® in the recurrent chronic tubal ear otitis care (otitis media with effusion, atelectatic otitis or retraction) in children with an age range of 7-15 years. https://clinicaltrials.gov/show/NCT02038400 (first received 16 January 2014). Accessed 15/01/2023. [CENTRAL: CN-00921546] ">NCT02038400</a> uses EarPopper and the comparison is no treatment. <a href="./references#CD015253-bbs2-0042" title="NCT05324696. Autoinflation: alternative in the treatment of otitis media with effusion (OME). https://clinicaltrials.gov/show/NCT05324696 (first received 12 April 2022). Accessed 15/01/2023. ">NCT05324696</a> uses a custom‐made device (based on the one used by <a href="./references#CD015253-bbs2-0003" title="Bidarian-MoniriA , RamosMJ , EjnellH . Autoinflation for treatment of persistent otitis media with effusion in children: a cross-over study with a 12-month follow-up. International Journal of Pediatric Otorhinolaryngology2014;78(8):1298-305. [CENTRAL: CN-00994829] [EMBASE: 2014464001] [PMID: 24882460]">Bidarian‐Moniri 2014</a>), and will compare this to the use of a sham device. </p> </section> <section id="CD015253-sec-0052"> <h6 class="title">Comparison 2: autoinflation versus ventilation tubes</h6> <p>Two ongoing studies will assess this comparison but do not provide any data we could use (<a href="./references#CD015253-bbs2-0040" title="NCT02038400. Evaluation of the efficiency of KINETUBE® in the recurrent chronic tubal ear otitis care (otitis media with effusion, atelectatic otitis or retraction) in children with an age range of 7-15 years. https://clinicaltrials.gov/show/NCT02038400 (first received 16 January 2014). Accessed 15/01/2023. [CENTRAL: CN-00921546] ">NCT02038400</a>; <a href="./references#CD015253-bbs2-0041" title="NCT02546518. A comparison of surgical and a new non-surgical treatment methods for secretory otitis media in children- hearing and socioeconomic aspects. https://clinicaltrials.gov/show/nct02546518 (first received 11 September 2015). Accessed 15/01/2023. [CENTRAL: CN-01102072] ">NCT02546518</a>). For one trial, autoinflation is achieved using a Kinetube, and the other will use a custom‐made device, similar to that used by <a href="./references#CD015253-bbs2-0003" title="Bidarian-MoniriA , RamosMJ , EjnellH . Autoinflation for treatment of persistent otitis media with effusion in children: a cross-over study with a 12-month follow-up. International Journal of Pediatric Otorhinolaryngology2014;78(8):1298-305. [CENTRAL: CN-00994829] [EMBASE: 2014464001] [PMID: 24882460]">Bidarian‐Moniri 2014</a>. </p> </section> </section> <section id="CD015253-sec-0053"> <h5 class="title">Outcomes</h5> <section id="CD015253-sec-0054"> <h6 class="title">Hearing</h6> <p>Assessment of hearing varied across the studies. Two studies considered the proportion of children whose hearing returned to normal. Normal hearing was defined in one study as a hearing threshold of &lt; 20 dB HL (<a href="./references#CD015253-bbs2-0003" title="Bidarian-MoniriA , RamosMJ , EjnellH . Autoinflation for treatment of persistent otitis media with effusion in children: a cross-over study with a 12-month follow-up. International Journal of Pediatric Otorhinolaryngology2014;78(8):1298-305. [CENTRAL: CN-00994829] [EMBASE: 2014464001] [PMID: 24882460]">Bidarian‐Moniri 2014</a>), and simply stated as 'normal hearing' with no definition by <a href="./references#CD015253-bbs2-0001" title="ArickD , SilmanS . Nonsurgical home treatment of middle ear effusion and associated hearing loss in children. Part I: clinical trial. Ear, Nose, &amp; Throat Journal2005;84(9):567-8, 570-4, 576 passim. [CENTRAL: CN-00552768] [EMBASE: 41864684] [PMID: 16261757]">Arick 2005</a>. Three other studies measured the mean hearing level using pure tone audiometry and reported this as a pure tone average, or as separate values for the different frequencies. </p> <p>Three studies provided some data related to hearing, which we could not use in our analyses. <a href="./references#CD015253-bbs2-0002" title="BanigoA , HuntA , RourkeT , WhitesideO , AldrenC . Does the Earpopper(®) device improve hearing outcomes in children with persistent otitis media with effusion? A randomised single-blinded controlled trial. Clinical Otolaryngology2016;41(1):59-65. [CENTRAL: CN-01078433] [EMBASE: 607683212] [PMID: 26095773]">Banigo 2016</a> reported on the number of children who were no longer listed for ventilation tube insertion, as their hearing had improved, and they failed to meet the criteria for ventilation tube insertion. However, the threshold used for this appeared to be a hearing threshold of &lt; 25 dB HL, which may not be regarded as 'normal hearing'. In addition, other factors were taken into account when assessing whether ventilation tubes should be fitted. Therefore we considered that these data could not be used as a surrogate measure for 'children with normal hearing'. <a href="./references#CD015253-bbs2-0005" title="BrookerDS , McNeiceA . Autoinflation in the treatment of glue ear in children. Clinical Otolaryngology and Allied Sciences1992;17(4):289-90. [CENTRAL: CN-00262418] [PMID: 1526044]">Brooker 1992</a> reported on the number of children with improvement in hearing (10 dB HL in the pure tone audiogram frequencies from 250 Hz to 2000 Hz) and who developed a peak in a previously flat tympanogram. As this only considers 'improvement', these data will not include all children with normal hearing at the end of follow‐up, therefore they were not included. <a href="./references#CD015253-bbs2-0008" title="ScaddingG , RajputK , ParikhA , HilssS , Jansz JA , DarbyYC , et al. Double blind, placebo-controlled study of Flixonase with and without Otovent in the treatment of otitis media with effusion. In: 8th International Congress of Paediatric Otorhinolaryngology (ESPO); 2002 Sep 11-14; Oxford, UK. 2002:92-3. [ABSTRACT NUMBER: 21.04] [CENTRAL: CN-00431597] ScaddingGK , DarbyYC , JanszAJ , RichardsD , TateH , HillsS , et al. Double-blind, placebo controlled randomised trial of medical therapy in otitis media with effusion. Advances in Life Sciences and Health2014;1(2):1-11. [CENTRAL: CN-01043521] ">Scadding 2014</a> reported a composite outcome of the proportion of children who had persistent hearing loss ≥ 30 dB HL, or grommet insertion, by the time of follow‐up. </p> </section> <section id="CD015253-sec-0055"> <h6 class="title">Disease‐specific health‐related quality of life</h6> <p>This was reported by only one of the included studies, using the Otitis Media Questionnaire‐14 (OMQ‐14) (<a href="./references#CD015253-bbs2-0010" title="ISRCTN55208702. An open randomised study of autoinflation in 4-11 year old school children with otitis media with effusion (OME) in primary care [Study of autoinflation in 4-11 year old school children with glue ear]. https://www.isrctn.com/ISRCTN55208702 (first received 16 June 2011). [CENTRAL: CN-01012774] WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. [CENTRAL: CN-01098789] [EMBASE: 606141685] [PMID: 26377389]WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , KellyS , et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ: Canadian Medical Association Journal2015;187(13):961-9. [CENTRAL: CN-01078404] [PMID: 26216608]">Williamson 2015a</a>). </p> </section> <section id="CD015253-sec-0056"> <h6 class="title">Pain and distress at the time of the procedure</h6> <p>This broad outcome measure was not reported by any of the included studies. However, we considered that 'otalgia' should be viewed as part of this outcome measure. One study did report on the presence of otalgia in both groups (<a href="./references#CD015253-bbs2-0010" title="ISRCTN55208702. An open randomised study of autoinflation in 4-11 year old school children with otitis media with effusion (OME) in primary care [Study of autoinflation in 4-11 year old school children with glue ear]. https://www.isrctn.com/ISRCTN55208702 (first received 16 June 2011). [CENTRAL: CN-01012774] WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. [CENTRAL: CN-01098789] [EMBASE: 606141685] [PMID: 26377389]WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , KellyS , et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ: Canadian Medical Association Journal2015;187(13):961-9. [CENTRAL: CN-01078404] [PMID: 26216608]">Williamson 2015a</a>). </p> </section> <section id="CD015253-sec-0057"> <h6 class="title">Presence/persistence of OME</h6> <p>Trial authors often described "resolution" of OME (rather than persistence), and this was frequently assessed by tympanometry. For example, <a href="./references#CD015253-bbs2-0010" title="ISRCTN55208702. An open randomised study of autoinflation in 4-11 year old school children with otitis media with effusion (OME) in primary care [Study of autoinflation in 4-11 year old school children with glue ear]. https://www.isrctn.com/ISRCTN55208702 (first received 16 June 2011). [CENTRAL: CN-01012774] WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. [CENTRAL: CN-01098789] [EMBASE: 606141685] [PMID: 26377389]WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , KellyS , et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ: Canadian Medical Association Journal2015;187(13):961-9. [CENTRAL: CN-01078404] [PMID: 26216608]">Williamson 2015a</a> defined resolution of OME as "a change from at least one type B (fluid) to A/C1 (clear) tympanogram". Where studies reported resolution we took the inverse data to assess presence or persistence of OME. </p> </section> <section id="CD015253-sec-0058"> <h6 class="title">Adverse events</h6> <p>Five studies reported some information regarding adverse events (<a href="./references#CD015253-bbs2-0002" title="BanigoA , HuntA , RourkeT , WhitesideO , AldrenC . Does the Earpopper(®) device improve hearing outcomes in children with persistent otitis media with effusion? A randomised single-blinded controlled trial. Clinical Otolaryngology2016;41(1):59-65. [CENTRAL: CN-01078433] [EMBASE: 607683212] [PMID: 26095773]">Banigo 2016</a>; <a href="./references#CD015253-bbs2-0003" title="Bidarian-MoniriA , RamosMJ , EjnellH . Autoinflation for treatment of persistent otitis media with effusion in children: a cross-over study with a 12-month follow-up. International Journal of Pediatric Otorhinolaryngology2014;78(8):1298-305. [CENTRAL: CN-00994829] [EMBASE: 2014464001] [PMID: 24882460]">Bidarian‐Moniri 2014</a>; <a href="./references#CD015253-bbs2-0006" title="ChanKH , BluestoneCD . Lack of efficacy of middle-ear inflation: treatment of otitis media with effusion in children. Otolaryngology--Head and Neck Surgery1989;100(4):317-23. [CENTRAL: CN-00060254] [PMID: 2498820]">Chan 1989</a>; <a href="./references#CD015253-bbs2-0008" title="ScaddingG , RajputK , ParikhA , HilssS , Jansz JA , DarbyYC , et al. Double blind, placebo-controlled study of Flixonase with and without Otovent in the treatment of otitis media with effusion. In: 8th International Congress of Paediatric Otorhinolaryngology (ESPO); 2002 Sep 11-14; Oxford, UK. 2002:92-3. [ABSTRACT NUMBER: 21.04] [CENTRAL: CN-00431597] ScaddingGK , DarbyYC , JanszAJ , RichardsD , TateH , HillsS , et al. Double-blind, placebo controlled randomised trial of medical therapy in otitis media with effusion. Advances in Life Sciences and Health2014;1(2):1-11. [CENTRAL: CN-01043521] ">Scadding 2014</a>; <a href="./references#CD015253-bbs2-0010" title="ISRCTN55208702. An open randomised study of autoinflation in 4-11 year old school children with otitis media with effusion (OME) in primary care [Study of autoinflation in 4-11 year old school children with glue ear]. https://www.isrctn.com/ISRCTN55208702 (first received 16 June 2011). [CENTRAL: CN-01012774] WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. [CENTRAL: CN-01098789] [EMBASE: 606141685] [PMID: 26377389]WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , KellyS , et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ: Canadian Medical Association Journal2015;187(13):961-9. [CENTRAL: CN-01078404] [PMID: 26216608]">Williamson 2015a</a>). </p> </section> <section id="CD015253-sec-0059"> <h6 class="title">Compliance</h6> <p>A number of studies gave a narrative report of the levels of compliance with the intervention.</p> </section> <section id="CD015253-sec-0060"> <h6 class="title">Receptive language skills</h6> <p><a href="./references#CD015253-bbs2-0010" title="ISRCTN55208702. An open randomised study of autoinflation in 4-11 year old school children with otitis media with effusion (OME) in primary care [Study of autoinflation in 4-11 year old school children with glue ear]. https://www.isrctn.com/ISRCTN55208702 (first received 16 June 2011). [CENTRAL: CN-01012774] WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. [CENTRAL: CN-01098789] [EMBASE: 606141685] [PMID: 26377389]WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , KellyS , et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ: Canadian Medical Association Journal2015;187(13):961-9. [CENTRAL: CN-01078404] [PMID: 26216608]">Williamson 2015a</a> was the only included study to assess developmental outcomes, in this case receptive language skills. However, due to problems with the website‐based assessment and late ethics permission, insufficient numbers of children completed this follow‐up test, and the data were not reported. </p> </section> <section id="CD015253-sec-0061"> <h6 class="title">Number of doctor‐diagnosed episodes of acute otitis media</h6> <p>Four studies provided some information for this outcome, over different durations of follow‐up. </p> <p>Our other outcomes of interest were not reported by any of the included studies. This included speech development, cognitive development, psychosocial outcomes, listening skills, generic health‐related quality of life, parental stress and vestibular function. </p> </section> </section> </section> <section id="CD015253-sec-0062"> <h4 class="title">Excluded studies</h4> <p>We excluded 25 studies from this review for the following reasons:</p> <p> <ul id="CD015253-list-0039"> <li> <p>Eleven studies were not randomised controlled trials (<a href="./references#CD015253-bbs2-0013" title="Bidarian-MoniriA . Autoinflation reduces middle ear effusion in children with otitis media with effusion. Evidence Based Medicine2016;21(2):65-5. [CENTRAL: CN-02197786] ">Bidarian‐Moniri 2016</a>; <a href="./references#CD015253-bbs2-0020" title="GibsonPG , StuartJE , WlodarczykJ , OlsonLG , HensleyMJ . Nasal inflammation and chronic ear disease in Australian Aboriginal children. Journal of Paediatrics and Child Health1996;32(2):143-7. [CENTRAL: CN-00131589] [PMID: 8860389]">Gibson 1996</a>; <a href="./references#CD015253-bbs2-0021" title="HeadM . Does nose blowing help hearing in glue ear?Nursing Times1992;88(3):53. [CENTRAL: CN-00081595] [PMID: 1738677]">Head 1992</a>; <a href="./references#CD015253-bbs2-0023" title="IinoY , IshitoyaJ , IkedaM , ItoY , UsamiM , KawashiroN , et al. Factors on delayed recovery of otitis media with effusion in children--clinical and bacteriological study. Nihon Jibiinkoka Gakkai Kaiho1989;92(8):1183-91. [CENTRAL: CN-00063873] [PMID: 2685215]">Iino 1989</a>; <a href="./references#CD015253-bbs2-0026" title="LiSN , HuangYY , HouSL , WuY , ShenJL , WangL , et al. Effect of autoflation on the prognosis of otitis media with effusion in children. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke za Zhi [Chinese Journal of Otorhinolaryngology Head and Neck Surgery]2021;56(6):573-8. [PMID: 34256480]">Li 2021</a>; <a href="./references#CD015253-bbs2-0029" title="ParadiseJ , CampbellT , DollaghanC , FeldmanH , BernardB , ColbornK , et al. Receptive vocabulary, cognition, and parent-rated behavior at age 3 years in relation to otitis media in the first 3 years of life. In: Abstract Book of the Association of Health Service Research. Vol. 14. 1997:350-1. [CENTRAL: CN-00452820] ">Paradise 1997</a>; <a href="./references#CD015253-bbs2-0030" title="ParleaE , GeorgescuM , CalarasuR . Tympanometry as a predictor factor in the evolution of otitis media with effusion. Journal of Medicine and Life2012;5(4):452-4. [CENTRAL: CN-00850240] [EMBASE: 369159817] [PMID: 23346249]">Parlea 2012</a>; <a href="./references#CD015253-bbs2-0032" title="ShubichI . Otitis media with effusion and allergy control in children: a prospective study. In: Sixth International Symposium on Otitis Media; 1996; Fort Lauderdale (FL). 1996:173-4. [CENTRAL: CN-00452904] ">Shubich 1996</a>; <a href="./references#CD015253-bbs2-0033" title="SilmanS , ArickDS , EmmerMB . Nonsurgical home treatment of middle ear effusion and associated hearing loss in children. Part II: validation study. Ear Nose &amp; Throat Journal2005;84(10):646-50. [CENTRAL: CN-00597170] [PMID: 16261757]">Silman 2005</a>; <a href="./references#CD015253-bbs2-0035" title="StenstromR , PlessIB , BernardP . Hearing thresholds and tympanic membrane sequelae in children managed medically or surgically for otitis media with effusion. Archives of Pediatrics &amp; Adolescent Medicine2005;159(12):1151-6. [CENTRAL: CN-00532329] [PMID: 16330739]">Stenstrom 2005</a>; <a href="./references#CD015253-bbs2-0036" title="ThamT , RahmanL , CostantinoP . Efficacy of a non-invasive middle ear aeration device in children with recurrent otitis media: a randomized controlled trial protocol. Contemporary Clinical Trials Communications2018;12:92-7. [CENTRAL: CN-01652639] [EMBASE: 2001167167] [PMID: 30320237]">Tham 2018</a>). </p> </li> <li> <p>Two studies included an incorrect population ‐ one included adult participants and one included children with recurrent acute otitis media, not OME (<a href="./references#CD015253-bbs2-0019" title="FerraraS , SammartanoD , FerraraP . Long-term management of recurrent otitis media with effusion in children. In: XVIII International Federation of Otorhinolaryngology Societies (IFOS) World Congress 2005 Jun 25-30; Rome (Italy). 2005. [CENTRAL: CN-00526409] ">Ferrara 2005</a>; <a href="./references#CD015253-bbs2-0025" title="LiH , ZhouY , HuangJ , ZhangL , LouZ . Treatment of secretory otitis media with balloon dilation and tympanostomy tube insertion: a randomized controlled trial. Basic &amp; Clinical Pharmacology &amp; Toxicology2020;127(Suppl 1):292-3. [CENTRAL: CN-02230226] [EMBASE: 633830686]">Li 2020</a>). </p> </li> <li> <p>Ten studies considered an intervention that was not relevant for this review (<a href="./references#CD015253-bbs2-0012" title="ArdehaliMM , SerajJM , AsiabarMK , AdibiH . The possible role of gastroesophageal reflux disease in children suffering from chronic otitis media with effusion. Acta Medica Iranica2008;46(1):33-7. [CENTRAL: CN-00708224] [EMBASE: 351792703]">Ardehali 2008</a>; <a href="./references#CD015253-bbs2-0014" title="ChiCTR2000035008. Multicenter randomized controlled study of APONSTEM eustachian tube balloon as a treatment for children with recurrent chronic secretory otitis media. http://www.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR2000035008 (first received 2020). [CENTRAL: CN-02184651] ">ChiCTR2000035008</a>; <a href="./references#CD015253-bbs2-0015" title="ChoungYH , ShinYR , ChoiSJ , ParkK , ParkHY , LeeJB , et al. Management for the children with otitis media with effusion in the tertiary hospital. Clinical and Experimental Otorhinolaryngology2008;1(4):201-5. [CENTRAL: CN-00671567] ">Choung 2008</a>; <a href="./references#CD015253-bbs2-0016" title="De NobiliE , BellomoA , De NobiliE , BellomoA . Comparative evaluation of efficacy of crenotherapeutic Politzer with sulphurous water versus crenotherapeutic Politzer and autoinsufflation (Otovent) in patients with tubaric dysfunction and secretory otitis media [Studio comparativo dell’efficacia del Politzer crenoterapico con acqua sulfurea versus Politzer crenoterapico e autoinsufflazione domiciliare (metodo Otovent®) in pazienti affetti da disfunzione tubarica e otite media secretiva]. Medicina Clinica e Termale2008;20(64):30-4. [CENTRAL: CN-00675975] ">De Nobili 2008</a>; <a href="./references#CD015253-bbs2-0017" title="El HachemN , HalimiM . New technique for the passive opening of the Eustachian tube. Tympanometry assessment of the effect of a new manipulation technique on the opening of the Eustachian tube in children less than six years with otitis media with or without effusion [Nouvelle technique passive d'ouverture de la trompe d'Eustache. Evaluation par tympanometrie de l'effet d'une nouvelle manipulation sur l'ouverture de la trompe d'Eustache chez les enfants de moins de six ans atteints d'une otite moyenne avec ou sans effusion]. Kinesitherapie2012;132:25-33. ">El Hachem 2012</a>; <a href="./references#CD015253-bbs2-0018" title="EndoLH , AntunesAB , VidolinC , BileckiMM , MagalhaesKVB . Secretory media otitis: clinical treatment vs placebo [Otite media secretora: tratamento clinco versus placebo]. Revista Brasileira de Otorrinolaringologia1997;63(2):116-9. [CENTRAL: CN-00187118] [EMBASE: 27225833]">Endo 1997</a>; <a href="./references#CD015253-bbs2-0022" title="HeafM , HutchingsS , BunchK . Does nose blowing improve hearing in serous otitis? A community study. British Journal of General Practice1991;41(350):377-9. [CENTRAL: CN-00612450] [PMID: 1793648]">Heaf 1991</a>; <a href="./references#CD015253-bbs2-0027" title="MarchisioP , PrincipiN , PassaliD , SalpietroDC , BoschiG , ChetriG , et al. Epidemiology and treatment of otitis media with effusion in children in the first year of primary school. Acta Oto-laryngologica1998;118(4):557-62. [CENTRAL: CN-00154484] [EMBASE: 1998254893] [PMID: 9726683]">Marchisio 1998</a>; <a href="./references#CD015253-bbs2-0031" title="RohailA , GillZI , ButtMR . A comparison of medical treatment versus surgical treatment for the management of otitis media with effusion. Annals of King Edward Medical College2006;12(1):64-7. [CENTRAL: CN-00597368] ">Rohail 2006</a>; <a href="./references#CD015253-bbs2-0034" title="VelepicM , StarcevicR , BonifacicM , TicacR , KujundzicM , UdovicDS , et al. The clinical status of the eardrum: an inclusion criterion for the treatment of chronic secretory otitis media in children. International Journal of Pediatric Otorhinolaryngology2011;75(5):686-90. [CENTRAL: CN-00784332] [EMBASE: 51315541] [PMID: 21397957]">Starcevic 2011</a>). Some of these studies are included in other reviews in this suite. </p> </li> <li> <p>One study included an incorrect comparison. Autoinflation was used before and after adenoidectomy, and compared to adenoidectomy alone (<a href="./references#CD015253-bbs2-0024" title="LeunigA , MeesK . Autoinflation of the middle ear with Otovent [Mittelohrbeluftung mit dem otovent-latexmembran-system]. Laryngo- Rhino- Otologie1995;74(6):352-4. [CENTRAL: CN-00392275] [EMBASE: 25203663]">Leunig 1995</a>). </p> </li> <li> <p>Finally, one study was withdrawn before any data were available (<a href="./references#CD015253-bbs2-0028" title="NCT03534219. Efficacy of the Earpopper device in children with recurrent otitis media [Efficacy of the Earpopper device in children with recurrent otitis media: a randomized controlled trial]. https://clinicaltrials.gov/show/nct03534219 (first received 11 May 2018). [CENTRAL: CN-01601566] ">NCT03534219</a>). </p> </li> </ul> </p> </section> </section> <section id="CD015253-sec-0063"> <h3 class="title">Risk of bias in included studies</h3> <p>The risk of bias in the included studies shows a mixed picture of low, unclear and high‐risk ratings. See <a href="#CD015253-fig-0003">Figure 3</a> for the risk of bias graph (our judgements about each risk of bias item presented as percentages across all included studies) and <a href="#CD015253-fig-0004">Figure 4</a> for the risk of bias summary (our judgements about each risk of bias item for each included study). </p> <div class="figure" id="CD015253-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph (our judgements about each risk of bias item presented as percentages across all included studies)." data-id="CD015253-fig-0003" src="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph (our judgements about each risk of bias item presented as percentages across all included studies). </p> </div> </div> </div> <div class="figure" id="CD015253-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Risk of bias summary (our judgements about each risk of bias item for each included study)." data-id="CD015253-fig-0004" src="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary (our judgements about each risk of bias item for each included study). </p> </div> </div> </div> <section id="CD015253-sec-0064"> <h4 class="title">Allocation</h4> <p>We rated seven of the studies at low risk of bias when assessing random sequence generation (<a href="./references#CD015253-bbs2-0002" title="BanigoA , HuntA , RourkeT , WhitesideO , AldrenC . Does the Earpopper(®) device improve hearing outcomes in children with persistent otitis media with effusion? A randomised single-blinded controlled trial. Clinical Otolaryngology2016;41(1):59-65. [CENTRAL: CN-01078433] [EMBASE: 607683212] [PMID: 26095773]">Banigo 2016</a>; <a href="./references#CD015253-bbs2-0003" title="Bidarian-MoniriA , RamosMJ , EjnellH . Autoinflation for treatment of persistent otitis media with effusion in children: a cross-over study with a 12-month follow-up. International Journal of Pediatric Otorhinolaryngology2014;78(8):1298-305. [CENTRAL: CN-00994829] [EMBASE: 2014464001] [PMID: 24882460]">Bidarian‐Moniri 2014</a>; <a href="./references#CD015253-bbs2-0004" title="BlanshardJ , MawA , BawdenR . The treatment of otitis media with effusion in children by autoinflation. In: 2nd European Congress of Oto-Rhino-Laryngology and Cervico-facial Surgery. 1992:31-7. [CENTRAL: CN-01165327] BlanshardJD , MawAR , BawdenR . Conservative treatment of otitis-media with effusion by autoinflation of the middle-ear. Clinical Otolaryngology1993;18(3):188-92. [CENTRAL: CN-02472342] ">Blanshard 1993</a>; <a href="./references#CD015253-bbs2-0006" title="ChanKH , BluestoneCD . Lack of efficacy of middle-ear inflation: treatment of otitis media with effusion in children. Otolaryngology--Head and Neck Surgery1989;100(4):317-23. [CENTRAL: CN-00060254] [PMID: 2498820]">Chan 1989</a>; <a href="./references#CD015253-bbs2-0008" title="ScaddingG , RajputK , ParikhA , HilssS , Jansz JA , DarbyYC , et al. Double blind, placebo-controlled study of Flixonase with and without Otovent in the treatment of otitis media with effusion. In: 8th International Congress of Paediatric Otorhinolaryngology (ESPO); 2002 Sep 11-14; Oxford, UK. 2002:92-3. [ABSTRACT NUMBER: 21.04] [CENTRAL: CN-00431597] ScaddingGK , DarbyYC , JanszAJ , RichardsD , TateH , HillsS , et al. Double-blind, placebo controlled randomised trial of medical therapy in otitis media with effusion. Advances in Life Sciences and Health2014;1(2):1-11. [CENTRAL: CN-01043521] ">Scadding 2014</a>; <a href="./references#CD015253-bbs2-0010" title="ISRCTN55208702. An open randomised study of autoinflation in 4-11 year old school children with otitis media with effusion (OME) in primary care [Study of autoinflation in 4-11 year old school children with glue ear]. https://www.isrctn.com/ISRCTN55208702 (first received 16 June 2011). [CENTRAL: CN-01012774] WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. [CENTRAL: CN-01098789] [EMBASE: 606141685] [PMID: 26377389]WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , KellyS , et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ: Canadian Medical Association Journal2015;187(13):961-9. [CENTRAL: CN-01078404] [PMID: 26216608]">Williamson 2015a</a>; <a href="./references#CD015253-bbs2-0011" title="WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. ">Williamson 2015b</a>), but we rated the risk as unclear for the remaining five studies. We rated only three studies at low risk of bias for allocation concealment (<a href="./references#CD015253-bbs2-0008" title="ScaddingG , RajputK , ParikhA , HilssS , Jansz JA , DarbyYC , et al. Double blind, placebo-controlled study of Flixonase with and without Otovent in the treatment of otitis media with effusion. In: 8th International Congress of Paediatric Otorhinolaryngology (ESPO); 2002 Sep 11-14; Oxford, UK. 2002:92-3. [ABSTRACT NUMBER: 21.04] [CENTRAL: CN-00431597] ScaddingGK , DarbyYC , JanszAJ , RichardsD , TateH , HillsS , et al. Double-blind, placebo controlled randomised trial of medical therapy in otitis media with effusion. Advances in Life Sciences and Health2014;1(2):1-11. [CENTRAL: CN-01043521] ">Scadding 2014</a>; <a href="./references#CD015253-bbs2-0010" title="ISRCTN55208702. An open randomised study of autoinflation in 4-11 year old school children with otitis media with effusion (OME) in primary care [Study of autoinflation in 4-11 year old school children with glue ear]. https://www.isrctn.com/ISRCTN55208702 (first received 16 June 2011). [CENTRAL: CN-01012774] WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. [CENTRAL: CN-01098789] [EMBASE: 606141685] [PMID: 26377389]WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , KellyS , et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ: Canadian Medical Association Journal2015;187(13):961-9. [CENTRAL: CN-01078404] [PMID: 26216608]">Williamson 2015a</a>; <a href="./references#CD015253-bbs2-0011" title="WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. ">Williamson 2015b</a>); we rated the remaining six at unclear risk, due to insufficient information. </p> </section> <section id="CD015253-sec-0065"> <h4 class="title">Blinding</h4> <p>We rated all 11 studies to be at high risk of performance bias as it was not possible to blind study participants and personnel to treatment group. </p> <p>We rated six studies at high risk of detection bias (<a href="./references#CD015253-bbs2-0004" title="BlanshardJ , MawA , BawdenR . The treatment of otitis media with effusion in children by autoinflation. In: 2nd European Congress of Oto-Rhino-Laryngology and Cervico-facial Surgery. 1992:31-7. [CENTRAL: CN-01165327] BlanshardJD , MawAR , BawdenR . Conservative treatment of otitis-media with effusion by autoinflation of the middle-ear. Clinical Otolaryngology1993;18(3):188-92. [CENTRAL: CN-02472342] ">Blanshard 1993</a>; <a href="./references#CD015253-bbs2-0005" title="BrookerDS , McNeiceA . Autoinflation in the treatment of glue ear in children. Clinical Otolaryngology and Allied Sciences1992;17(4):289-90. [CENTRAL: CN-00262418] [PMID: 1526044]">Brooker 1992</a>; <a href="./references#CD015253-bbs2-0006" title="ChanKH , BluestoneCD . Lack of efficacy of middle-ear inflation: treatment of otitis media with effusion in children. Otolaryngology--Head and Neck Surgery1989;100(4):317-23. [CENTRAL: CN-00060254] [PMID: 2498820]">Chan 1989</a>; <a href="./references#CD015253-bbs2-0007" title="ErcanI , CakirBC , KayaogluS , TurgutS . Long term effect of autoinflation in the treatment of otitis media with effusion. Elektronik Kulak Buran Bogaz ve Bas Boyun Cerrahisi Dergisi [Electronic Journal of Otolalryngology - Head and Neck Surgery]2005;4(4):166-70. [CENTRAL: CN-00849154] ">Ercan 2005</a>; <a href="./references#CD015253-bbs2-0008" title="ScaddingG , RajputK , ParikhA , HilssS , Jansz JA , DarbyYC , et al. Double blind, placebo-controlled study of Flixonase with and without Otovent in the treatment of otitis media with effusion. In: 8th International Congress of Paediatric Otorhinolaryngology (ESPO); 2002 Sep 11-14; Oxford, UK. 2002:92-3. [ABSTRACT NUMBER: 21.04] [CENTRAL: CN-00431597] ScaddingGK , DarbyYC , JanszAJ , RichardsD , TateH , HillsS , et al. Double-blind, placebo controlled randomised trial of medical therapy in otitis media with effusion. Advances in Life Sciences and Health2014;1(2):1-11. [CENTRAL: CN-01043521] ">Scadding 2014</a>; <a href="./references#CD015253-bbs2-0009" title="StangerupS , TosM . Autoinflation in the treatment of Eustachian tube dysfunction, secretory otitis media and its sequelae. In: Mogi G (editor), editors(s). Recent Advances in Otitis Media. Amsterdam/New York: Kugler Publications, 1994:759-63. [CENTRAL: CN-01214464] StangerupSE , Sederberg-OlsenJ , BalleV . Autoinflation as a treatment of secretory otitis media. A randomized controlled study. Archives of Otolaryngology--Head &amp; Neck Surgery1992;118(2):149-52. [CENTRAL: CN-00082084] [PMID: 1540344]">Stangerup 1992</a>). These studies did not state that outcome assessors were blinded, therefore we considered that it is unlikely that they were. We rated <a href="./references#CD015253-bbs2-0001" title="ArickD , SilmanS . Nonsurgical home treatment of middle ear effusion and associated hearing loss in children. Part I: clinical trial. Ear, Nose, &amp; Throat Journal2005;84(9):567-8, 570-4, 576 passim. [CENTRAL: CN-00552768] [EMBASE: 41864684] [PMID: 16261757]">Arick 2005</a> as unclear and the remaining studies as at low risk of detection bias. </p> </section> <section id="CD015253-sec-0066"> <h4 class="title">Incomplete outcome data</h4> <p>We rated eight studies at low risk of attrition bias. We rated <a href="./references#CD015253-bbs2-0008" title="ScaddingG , RajputK , ParikhA , HilssS , Jansz JA , DarbyYC , et al. Double blind, placebo-controlled study of Flixonase with and without Otovent in the treatment of otitis media with effusion. In: 8th International Congress of Paediatric Otorhinolaryngology (ESPO); 2002 Sep 11-14; Oxford, UK. 2002:92-3. [ABSTRACT NUMBER: 21.04] [CENTRAL: CN-00431597] ScaddingGK , DarbyYC , JanszAJ , RichardsD , TateH , HillsS , et al. Double-blind, placebo controlled randomised trial of medical therapy in otitis media with effusion. Advances in Life Sciences and Health2014;1(2):1-11. [CENTRAL: CN-01043521] ">Scadding 2014</a> and <a href="./references#CD015253-bbs2-0009" title="StangerupS , TosM . Autoinflation in the treatment of Eustachian tube dysfunction, secretory otitis media and its sequelae. In: Mogi G (editor), editors(s). Recent Advances in Otitis Media. Amsterdam/New York: Kugler Publications, 1994:759-63. [CENTRAL: CN-01214464] StangerupSE , Sederberg-OlsenJ , BalleV . Autoinflation as a treatment of secretory otitis media. A randomized controlled study. Archives of Otolaryngology--Head &amp; Neck Surgery1992;118(2):149-52. [CENTRAL: CN-00082084] [PMID: 1540344]">Stangerup 1992</a> as high risk. <a href="./references#CD015253-bbs2-0008" title="ScaddingG , RajputK , ParikhA , HilssS , Jansz JA , DarbyYC , et al. Double blind, placebo-controlled study of Flixonase with and without Otovent in the treatment of otitis media with effusion. In: 8th International Congress of Paediatric Otorhinolaryngology (ESPO); 2002 Sep 11-14; Oxford, UK. 2002:92-3. [ABSTRACT NUMBER: 21.04] [CENTRAL: CN-00431597] ScaddingGK , DarbyYC , JanszAJ , RichardsD , TateH , HillsS , et al. Double-blind, placebo controlled randomised trial of medical therapy in otitis media with effusion. Advances in Life Sciences and Health2014;1(2):1-11. [CENTRAL: CN-01043521] ">Scadding 2014</a> reported an attrition rate of 38% and <a href="./references#CD015253-bbs2-0009" title="StangerupS , TosM . Autoinflation in the treatment of Eustachian tube dysfunction, secretory otitis media and its sequelae. In: Mogi G (editor), editors(s). Recent Advances in Otitis Media. Amsterdam/New York: Kugler Publications, 1994:759-63. [CENTRAL: CN-01214464] StangerupSE , Sederberg-OlsenJ , BalleV . Autoinflation as a treatment of secretory otitis media. A randomized controlled study. Archives of Otolaryngology--Head &amp; Neck Surgery1992;118(2):149-52. [CENTRAL: CN-00082084] [PMID: 1540344]">Stangerup 1992</a> reported many results as a 'per protocol' analysis ‐ only for those who successfully carried out autoinflation. We rated <a href="./references#CD015253-bbs2-0010" title="ISRCTN55208702. An open randomised study of autoinflation in 4-11 year old school children with otitis media with effusion (OME) in primary care [Study of autoinflation in 4-11 year old school children with glue ear]. https://www.isrctn.com/ISRCTN55208702 (first received 16 June 2011). [CENTRAL: CN-01012774] WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. [CENTRAL: CN-01098789] [EMBASE: 606141685] [PMID: 26377389]WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , KellyS , et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ: Canadian Medical Association Journal2015;187(13):961-9. [CENTRAL: CN-01078404] [PMID: 26216608]">Williamson 2015a</a> at unclear risk of attrition bias: although loss to follow‐up was similar across the groups, sensitivity analyses from the main publication indicated that imputation for missing data resulted in a loss of the significant difference between the two groups for some outcome measures. </p> </section> <section id="CD015253-sec-0067"> <h4 class="title">Selective reporting</h4> <p>We rated two studies at low risk of reporting bias as we found a published protocol for the trials (<a href="./references#CD015253-bbs2-0010" title="ISRCTN55208702. An open randomised study of autoinflation in 4-11 year old school children with otitis media with effusion (OME) in primary care [Study of autoinflation in 4-11 year old school children with glue ear]. https://www.isrctn.com/ISRCTN55208702 (first received 16 June 2011). [CENTRAL: CN-01012774] WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. [CENTRAL: CN-01098789] [EMBASE: 606141685] [PMID: 26377389]WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , KellyS , et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ: Canadian Medical Association Journal2015;187(13):961-9. [CENTRAL: CN-01078404] [PMID: 26216608]">Williamson 2015a</a>; <a href="./references#CD015253-bbs2-0011" title="WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. ">Williamson 2015b</a>). We rated the remaining nine trials at unclear risk of reporting bias as we could not locate protocols for these trials. </p> </section> <section id="CD015253-sec-0068"> <h4 class="title">Other potential sources of bias</h4> <p>We rated seven trials at low risk of other bias. We rated <a href="./references#CD015253-bbs2-0002" title="BanigoA , HuntA , RourkeT , WhitesideO , AldrenC . Does the Earpopper(®) device improve hearing outcomes in children with persistent otitis media with effusion? A randomised single-blinded controlled trial. Clinical Otolaryngology2016;41(1):59-65. [CENTRAL: CN-01078433] [EMBASE: 607683212] [PMID: 26095773]">Banigo 2016</a>, <a href="./references#CD015253-bbs2-0003" title="Bidarian-MoniriA , RamosMJ , EjnellH . Autoinflation for treatment of persistent otitis media with effusion in children: a cross-over study with a 12-month follow-up. International Journal of Pediatric Otorhinolaryngology2014;78(8):1298-305. [CENTRAL: CN-00994829] [EMBASE: 2014464001] [PMID: 24882460]">Bidarian‐Moniri 2014</a>, <a href="./references#CD015253-bbs2-0005" title="BrookerDS , McNeiceA . Autoinflation in the treatment of glue ear in children. Clinical Otolaryngology and Allied Sciences1992;17(4):289-90. [CENTRAL: CN-00262418] [PMID: 1526044]">Brooker 1992</a> and <a href="./references#CD015253-bbs2-0006" title="ChanKH , BluestoneCD . Lack of efficacy of middle-ear inflation: treatment of otitis media with effusion in children. Otolaryngology--Head and Neck Surgery1989;100(4):317-23. [CENTRAL: CN-00060254] [PMID: 2498820]">Chan 1989</a> at unclear risk of other bias due to a short follow‐up period that did not allow sufficient time for changes in the control (no treatment) groups. </p> </section> </section> <section id="CD015253-sec-0069"> <h3 class="title" id="CD015253-sec-0069">Effects of interventions</h3> <p>See: <a href="./full#CD015253-tbl-0001"><b>Summary of findings 1</b> Autoinflation compared to no treatment for otitis media with effusion (OME) in children</a> </p> <section id="CD015253-sec-0070"> <h4 class="title">Comparison 1: Autoinflation versus no treatment</h4> <p>See <a href="./full#CD015253-tbl-0001">summary of findings Table 1</a> for details of the primary outcome measures. </p> <section id="CD015253-sec-0071"> <h5 class="title">Hearing</h5> <section id="CD015253-sec-0072"> <h6 class="title">Proportion of children whose hearing is normal</h6> <section id="CD015253-sec-0073"> <p><b>Very short‐term follow‐up (&lt; 6 weeks)</b></p> <p>One study provided data for this outcome (<a href="./references#CD015253-bbs2-0003" title="Bidarian-MoniriA , RamosMJ , EjnellH . Autoinflation for treatment of persistent otitis media with effusion in children: a cross-over study with a 12-month follow-up. International Journal of Pediatric Otorhinolaryngology2014;78(8):1298-305. [CENTRAL: CN-00994829] [EMBASE: 2014464001] [PMID: 24882460]">Bidarian‐Moniri 2014</a>). As <a href="./references#CD015253-bbs2-0003" title="Bidarian-MoniriA , RamosMJ , EjnellH . Autoinflation for treatment of persistent otitis media with effusion in children: a cross-over study with a 12-month follow-up. International Journal of Pediatric Otorhinolaryngology2014;78(8):1298-305. [CENTRAL: CN-00994829] [EMBASE: 2014464001] [PMID: 24882460]">Bidarian‐Moniri 2014</a> reported this outcome by ear, we adjusted the data using a correlation coefficient of 0.5, to account for correlation between ears of the same participant. The mean difference in the likelihood of achieving a hearing threshold of &lt; 20 dB HL using autoinflation was 4.45 (95% confidence interval (CI) 2.14 to 9.27; 86% versus 19%; 1 study, 45 participants; <a href="./references#CD015253-fig-0005" title="">Analysis 1.1</a>; very low‐certainty evidence). Sensitivity analyses using different correlation coefficients of either 1 (<a href="./references#CD015253-fig-0014" title="">Analysis 1.10</a>) or 0 (<a href="./references#CD015253-fig-0015" title="">Analysis 1.11</a>) produced little change in the findings. </p> </section> <section id="CD015253-sec-0074"> <p><b>Short‐term follow‐up (6 weeks to 3 months)</b></p> <p><a href="./references#CD015253-bbs2-0001" title="ArickD , SilmanS . Nonsurgical home treatment of middle ear effusion and associated hearing loss in children. Part I: clinical trial. Ear, Nose, &amp; Throat Journal2005;84(9):567-8, 570-4, 576 passim. [CENTRAL: CN-00552768] [EMBASE: 41864684] [PMID: 16261757]">Arick 2005</a> provided data for this outcome (<a href="./references#CD015253-fig-0006" title="">Analysis 1.2</a>). <a href="./references#CD015253-bbs2-0001" title="ArickD , SilmanS . Nonsurgical home treatment of middle ear effusion and associated hearing loss in children. Part I: clinical trial. Ear, Nose, &amp; Throat Journal2005;84(9):567-8, 570-4, 576 passim. [CENTRAL: CN-00552768] [EMBASE: 41864684] [PMID: 16261757]">Arick 2005</a> used a modified Politzer method for autoinflation and reported a risk ratio of 2.67 for the return to normal hearing (in at least one ear) in those who received autoinflation (95% CI 1.73 to 4.12; 85% versus 32%; 1 study, 94 participants; <a href="./references#CD015253-fig-0006" title="">Analysis 1.2</a>; very low‐certainty evidence). </p> </section> <section id="CD015253-sec-0075"> <p><b>Medium‐term follow‐up (&gt; 3 months to ≤ 1 year)</b></p> <p>This outcome was not assessed at this time point by any of the included studies.</p> </section> </section> <section id="CD015253-sec-0076"> <h6 class="title">Hearing threshold</h6> <section id="CD015253-sec-0077"> <p><b>Very short‐term follow‐up (&lt; 6 weeks)</b></p> <p>A single study reported this outcome at this time point. The change from baseline in average pure‐tone air conduction threshold was estimated to be ‐5.00 dB HL lower in those who received autoinflation compared to those who received no intervention (95% CI ‐10.1 to 0.1; 1 study, 45 participants; <a href="./references#CD015253-fig-0007" title="">Analysis 1.3</a>; very low‐certainty evidence). These data were reported in the original text with a mean value, median value and full range, therefore we used the reported mean values, and estimated the standard deviation using the methods given by <a href="./references#CD015253-bbs2-0098" title="WanX , WangW , LiuJ , TongT . Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Medical Research Methodology2014;14:135. [DOI: https://doi.org/10.1186/1471-2288-14-135]">Wan 2014</a>. </p> </section> <section id="CD015253-sec-0078"> <p><b>Short‐term follow‐up (6 weeks to 3 months)</b></p> <p>Two studies reported this outcome. Data in both studies were reported separately for four different frequencies. We were unable to pool these data (and estimate the pure tone average) due to insufficient information regarding the correlation between hearing at different frequencies. Therefore, we have presented the data separately for the four frequencies assessed. At each frequency the direction of effect was in favour of autoinflation (mean differences between groups ranging from ‐9.04 to ‐12.88 dB HL, 95% CI ranging from ‐2.83 to ‐17.85; 2 studies, 113 participants; I<sup>2</sup> from 0% to 57%; <a href="./references#CD015253-fig-0008" title="">Analysis 1.4</a>; low‐certainty evidence). One study reported data separately for the left and right ear. We used data from the right ears for the main analysis, but sensitivity analysis showed little difference when using data from the left ears (<a href="./references#CD015253-fig-0017" title="">Analysis 1.13</a>). </p> <p>Additional data were reported by <a href="./references#CD015253-bbs2-0004" title="BlanshardJ , MawA , BawdenR . The treatment of otitis media with effusion in children by autoinflation. In: 2nd European Congress of Oto-Rhino-Laryngology and Cervico-facial Surgery. 1992:31-7. [CENTRAL: CN-01165327] BlanshardJD , MawAR , BawdenR . Conservative treatment of otitis-media with effusion by autoinflation of the middle-ear. Clinical Otolaryngology1993;18(3):188-92. [CENTRAL: CN-02472342] ">Blanshard 1993</a>. After three months of follow‐up, the mean change in hearing threshold (as assessed with pure tone audiometry) was reported for those who had high adherence with the use of Otovent, those with low adherence and those in the control group. The mean change overall for the Otovent group (38 ears) was an increase (worsening) of hearing threshold by 0.98 dB HL, although outcomes were better for those with high adherence (an improvement of ‐2.13 dB HL in 19 ears) than those with low adherence (a worsening of 4.08 dB HL in 19 ears). This compared to a worsening of 0.52 dB HL in the control group (34 ears). As no standard deviations were reported, we were unable to include these data in the meta‐analysis, although they are suggestive of a trivial difference between the groups. </p> </section> </section> </section> <section id="CD015253-sec-0079"> <h5 class="title">Disease‐specific quality of life</h5> <section id="CD015253-sec-0080"> <h6 class="title">Short‐term follow‐up</h6> <p>A single study reported this outcome (<a href="./references#CD015253-bbs2-0010" title="ISRCTN55208702. An open randomised study of autoinflation in 4-11 year old school children with otitis media with effusion (OME) in primary care [Study of autoinflation in 4-11 year old school children with glue ear]. https://www.isrctn.com/ISRCTN55208702 (first received 16 June 2011). [CENTRAL: CN-01012774] WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. [CENTRAL: CN-01098789] [EMBASE: 606141685] [PMID: 26377389]WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , KellyS , et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ: Canadian Medical Association Journal2015;187(13):961-9. [CENTRAL: CN-01078404] [PMID: 26216608]">Williamson 2015a</a>). The authors used a standardised version of the OMQ‐14, measured with a 14‐item scale. Total raw scores are then converted using a weighted scoring system into a standardised score. The range of this score is not explicit, but appears to be between approximately ‐3 and +3, with lower scores reflecting better quality of life. The mean difference was adjusted for potential confounders, including sex, age, centre (primary care trust), baseline values and baseline severity of disease. The adjusted mean difference was ‐0.42 for those who received autoinflation (95% CI ‐0.62 to ‐0.22; 1 study, 247 participants; <a href="./references#CD015253-fig-0009" title="">Analysis 1.5</a>; low‐certainty evidence). The authors report that a change of 0.3 on this scale would be regarded as clinically meaningful, indicating that this would represent a moderate improvement in quality of life. </p> </section> </section> <section id="CD015253-sec-0081"> <h5 class="title">Pain and distress at the time of the procedure</h5> <p>This broad outcome measure was not reported by any of the included studies. However, one study did report specifically on otalgia, and the results of this analysis are presented here. </p> <section id="CD015253-sec-0082"> <h6 class="title">Otalgia</h6> <p>A single study reported on otalgia as a complication of treatment. No definition of otalgia was given. The risk ratio was 3.50 for those who carried out autoinflation (95% CI 0.74 to 16.59; absolute risk 7/160 participants in the autoinflation group, compared to 2/160 in the no treatment group; 1 study, 320 participants; <a href="./references#CD015253-fig-0010" title="">Analysis 1.6</a>; very low‐certainty evidence). </p> </section> </section> <section id="CD015253-sec-0083"> <h5 class="title">Persistence of OME</h5> <p>Please see <a href="#CD015253-sec-0034">Unit of analysis issues</a> for further details on how these analyses were conducted. </p> <section id="CD015253-sec-0084"> <h6 class="title">Very short‐term follow‐up (&lt; 6 weeks)</h6> <p>Seven studies reported this outcome at between two weeks and six weeks of follow‐up.</p> <p>Overall, a risk ratio of 0.86 was found for the persistence of OME at &lt; 6 weeks in children who received autoinflation (95% CI 0.72 to 1.04; 67% versus 78%; 7 studies, 688 participants; I<sup>2</sup> = 74%; <a href="./references#CD015253-fig-0011" title="">Analysis 1.7</a>; very low‐certainty evidence). It should be noted that there is considerable inconsistency in this analysis, with one study appearing to favour no intervention, and two studies showing little difference between the two groups. As described above, most data were reported 'per ear', therefore to account for correlation between ears of the same individual we have carried out some adjustment of the data. Imputing different correlation coefficients, and the use of 'per child' rather than 'per ear' data where reported, made little difference to the overall result (<a href="./references#CD015253-fig-0018" title="">Analysis 1.14</a>; <a href="./references#CD015253-fig-0019" title="">Analysis 1.15</a>; <a href="./references#CD015253-fig-0020" title="">Analysis 1.16</a>). </p> </section> <section id="CD015253-sec-0085"> <h6 class="title">Short‐term follow‐up (&gt; 6 weeks to ≤ 3 months)</h6> <p>Four studies also reported at this time point. The risk ratio of 0.88 was similar to that seen at earlier time points (95% CI 0.80 to 0.97; 65% versus 74%; 4 studies, 483 participants; I<sup>2</sup> = 0%; <a href="./references#CD015253-fig-0012" title="">Analysis 1.8</a>; low‐certainty evidence). Again, adjustment using different correlation coefficients, or assessing 'per child' data made very little difference to the overall effect estimate (<a href="./references#CD015253-fig-0021" title="">Analysis 1.17</a>; <a href="./references#CD015253-fig-0022" title="">Analysis 1.18</a>; <a href="./references#CD015253-fig-0023" title="">Analysis 1.19</a>). </p> <p>The study <a href="./references#CD015253-bbs2-0002" title="BanigoA , HuntA , RourkeT , WhitesideO , AldrenC . Does the Earpopper(®) device improve hearing outcomes in children with persistent otitis media with effusion? A randomised single-blinded controlled trial. Clinical Otolaryngology2016;41(1):59-65. [CENTRAL: CN-01078433] [EMBASE: 607683212] [PMID: 26095773]">Banigo 2016</a> also reported the number of children who "still had hearing loss and met the criteria set by NICE (including history, otoscopic examination, tympanometry and audiometry findings) so they had ventilation tubes inserted" after seven weeks of follow‐up. However, we considered that some children with a persistent effusion may not meet the criteria required for surgery, and would not be included, therefore this could not be used as a proxy for 'persistence of OME'. </p> </section> </section> <section id="CD015253-sec-0086"> <h5 class="title">Adverse events</h5> <section id="CD015253-sec-0087"> <h6 class="title">Perforation of the tympanic membrane</h6> <p>This was not described in any of the studies. As described below, for some studies we are unsure if this is because no tympanic membrane perforations occurred, or because this outcome was not fully assessed or reported. </p> </section> <section id="CD015253-sec-0088"> <h6 class="title">Other adverse events</h6> <p>Five studies provided very limited information on adverse events:</p> <p> <ul id="CD015253-list-0040"> <li> <p><a href="./references#CD015253-bbs2-0002" title="BanigoA , HuntA , RourkeT , WhitesideO , AldrenC . Does the Earpopper(®) device improve hearing outcomes in children with persistent otitis media with effusion? A randomised single-blinded controlled trial. Clinical Otolaryngology2016;41(1):59-65. [CENTRAL: CN-01078433] [EMBASE: 607683212] [PMID: 26095773]">Banigo 2016</a> reported, "The most common complaint from the children in treatment group was ear discomfort and a blocked sensation in the ears immediately following its use, which was short‐lived and did not affect compliance". </p> </li> <li> <p><a href="./references#CD015253-bbs2-0003" title="Bidarian-MoniriA , RamosMJ , EjnellH . Autoinflation for treatment of persistent otitis media with effusion in children: a cross-over study with a 12-month follow-up. International Journal of Pediatric Otorhinolaryngology2014;78(8):1298-305. [CENTRAL: CN-00994829] [EMBASE: 2014464001] [PMID: 24882460]">Bidarian‐Moniri 2014</a> reported, "No adverse effects were observed". </p> </li> <li> <p><a href="./references#CD015253-bbs2-0006" title="ChanKH , BluestoneCD . Lack of efficacy of middle-ear inflation: treatment of otitis media with effusion in children. Otolaryngology--Head and Neck Surgery1989;100(4):317-23. [CENTRAL: CN-00060254] [PMID: 2498820]">Chan 1989</a> reported, "Of the 40 subjects who returned for the two‐week visit, none reported any untoward side effects related to performing autoinflation during the study period". It is not clear whether the side effects prioritised in this review were specifically assessed. </p> </li> <li> <p><a href="./references#CD015253-bbs2-0008" title="ScaddingG , RajputK , ParikhA , HilssS , Jansz JA , DarbyYC , et al. Double blind, placebo-controlled study of Flixonase with and without Otovent in the treatment of otitis media with effusion. In: 8th International Congress of Paediatric Otorhinolaryngology (ESPO); 2002 Sep 11-14; Oxford, UK. 2002:92-3. [ABSTRACT NUMBER: 21.04] [CENTRAL: CN-00431597] ScaddingGK , DarbyYC , JanszAJ , RichardsD , TateH , HillsS , et al. Double-blind, placebo controlled randomised trial of medical therapy in otitis media with effusion. Advances in Life Sciences and Health2014;1(2):1-11. [CENTRAL: CN-01043521] ">Scadding 2014</a> reported that no adverse events were seen in their trial. The authors state that "Minor adverse events were recorded, but none was of sufficient severity to cause cessation of the treatment or withdrawal from the trial. The commonest was minor epistaxis which occurred in fewer than 10% of subjects." </p> </li> <li> <p><a href="./references#CD015253-bbs2-0011" title="WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. ">Williamson 2015b</a> reported that one child experienced nosebleeds while using autoinflation. The parent reported that the child had suffered from previous recurrent nosebleeds, but chose to continue with the study anyway. </p> </li> </ul> </p> <p>Six studies did not report any information on adverse events. It is not clear whether this was because no events occurred, or because they were not assessed or reported (<a href="./references#CD015253-bbs2-0001" title="ArickD , SilmanS . Nonsurgical home treatment of middle ear effusion and associated hearing loss in children. Part I: clinical trial. Ear, Nose, &amp; Throat Journal2005;84(9):567-8, 570-4, 576 passim. [CENTRAL: CN-00552768] [EMBASE: 41864684] [PMID: 16261757]">Arick 2005</a>; <a href="./references#CD015253-bbs2-0004" title="BlanshardJ , MawA , BawdenR . The treatment of otitis media with effusion in children by autoinflation. In: 2nd European Congress of Oto-Rhino-Laryngology and Cervico-facial Surgery. 1992:31-7. [CENTRAL: CN-01165327] BlanshardJD , MawAR , BawdenR . Conservative treatment of otitis-media with effusion by autoinflation of the middle-ear. Clinical Otolaryngology1993;18(3):188-92. [CENTRAL: CN-02472342] ">Blanshard 1993</a>; <a href="./references#CD015253-bbs2-0005" title="BrookerDS , McNeiceA . Autoinflation in the treatment of glue ear in children. Clinical Otolaryngology and Allied Sciences1992;17(4):289-90. [CENTRAL: CN-00262418] [PMID: 1526044]">Brooker 1992</a>; <a href="./references#CD015253-bbs2-0007" title="ErcanI , CakirBC , KayaogluS , TurgutS . Long term effect of autoinflation in the treatment of otitis media with effusion. Elektronik Kulak Buran Bogaz ve Bas Boyun Cerrahisi Dergisi [Electronic Journal of Otolalryngology - Head and Neck Surgery]2005;4(4):166-70. [CENTRAL: CN-00849154] ">Ercan 2005</a>; <a href="./references#CD015253-bbs2-0009" title="StangerupS , TosM . Autoinflation in the treatment of Eustachian tube dysfunction, secretory otitis media and its sequelae. In: Mogi G (editor), editors(s). Recent Advances in Otitis Media. Amsterdam/New York: Kugler Publications, 1994:759-63. [CENTRAL: CN-01214464] StangerupSE , Sederberg-OlsenJ , BalleV . Autoinflation as a treatment of secretory otitis media. A randomized controlled study. Archives of Otolaryngology--Head &amp; Neck Surgery1992;118(2):149-52. [CENTRAL: CN-00082084] [PMID: 1540344]">Stangerup 1992</a>; <a href="./references#CD015253-bbs2-0010" title="ISRCTN55208702. An open randomised study of autoinflation in 4-11 year old school children with otitis media with effusion (OME) in primary care [Study of autoinflation in 4-11 year old school children with glue ear]. https://www.isrctn.com/ISRCTN55208702 (first received 16 June 2011). [CENTRAL: CN-01012774] WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. [CENTRAL: CN-01098789] [EMBASE: 606141685] [PMID: 26377389]WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , KellyS , et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ: Canadian Medical Association Journal2015;187(13):961-9. [CENTRAL: CN-01078404] [PMID: 26216608]">Williamson 2015a</a>). </p> </section> </section> <section id="CD015253-sec-0089"> <h5 class="title">Compliance</h5> <p>Details on compliance of study participants with autoinflation are provided in <a href="#CD015253-tbl-0004">Table 3</a>. Overall, most trials that reported compliance seemed to rate this as satisfactory or good. </p> <div class="table" id="CD015253-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Compliance with autoinflation</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Treatment requirements</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Compliance monitoring and definition</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Age</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Compliance</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0001" title="ArickD , SilmanS . Nonsurgical home treatment of middle ear effusion and associated hearing loss in children. Part I: clinical trial. Ear, Nose, &amp; Throat Journal2005;84(9):567-8, 570-4, 576 passim. [CENTRAL: CN-00552768] [EMBASE: 41864684] [PMID: 16261757]">Arick 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twice a day, alternating nostrils with each treatment for 7 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Daily log to track compliance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 11 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Complete compliance in 46 of 47 experimental patients (97.9%), moderate compliance in remaining patient </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0002" title="BanigoA , HuntA , RourkeT , WhitesideO , AldrenC . Does the Earpopper(®) device improve hearing outcomes in children with persistent otitis media with effusion? A randomised single-blinded controlled trial. Clinical Otolaryngology2016;41(1):59-65. [CENTRAL: CN-01078433] [EMBASE: 607683212] [PMID: 26095773]">Banigo 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Use twice a day and on each occasion to be used twice in each nostril for 7 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diary card, no definition</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment</p> <p>Mean 5.94 years (range 4.36 to 8.19)</p> <p>Control</p> <p>Mean 5.55 (range 3.96 to 7.79)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94% on average</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0003" title="Bidarian-MoniriA , RamosMJ , EjnellH . Autoinflation for treatment of persistent otitis media with effusion in children: a cross-over study with a 12-month follow-up. International Journal of Pediatric Otorhinolaryngology2014;78(8):1298-305. [CENTRAL: CN-00994829] [EMBASE: 2014464001] [PMID: 24882460]">Bidarian‐Moniri 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Use the device twice a day to perform 20 inflations at each session (approximately 5 to 10 minutes) for 4 weeks </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diary and full compliance was defined as using the device twice a day to perform 20 inflations at each session (approximately 5 to 10 minutes) during a period of 4 weeks </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment: 68 months</p> <p>Control: 53 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All children from 2 years and 9 months of age were able to use the device after demonstration by a doctor or nurse. In one case, the compliance was not satisfactory to complete the 4‐week treatment. The overall compliance for the total treatment time was satisfactory. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0004" title="BlanshardJ , MawA , BawdenR . The treatment of otitis media with effusion in children by autoinflation. In: 2nd European Congress of Oto-Rhino-Laryngology and Cervico-facial Surgery. 1992:31-7. [CENTRAL: CN-01165327] BlanshardJD , MawAR , BawdenR . Conservative treatment of otitis-media with effusion by autoinflation of the middle-ear. Clinical Otolaryngology1993;18(3):188-92. [CENTRAL: CN-02472342] ">Blanshard 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One nostril 3 times a day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Compliance was measured as the number of times the device was used as a percentage of the maximum possible </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment</p> <p>HC (high compliance) n = 19</p> <p>Mean 62.7 months (SD 17.5)</p> <p>LC (low compliance) n = 23</p> <p>Mean 52.8 months (SD 8.9)</p> <p>Control n = 41</p> <p>Mean 59.9 months (SD 18.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Of 42 children in the treatment group, 19 (45%) used it as prescribed (&gt; 70%), 18 (43%) used it irregularly and 5 (12%) were unable to use it at all. Treatment group was divided into those with a high compliance (HC) of greater than 70%, (n = 19) and those with a low compliance (LC) of &lt; 70% (n = 23). In the LC group compliance deteriorated from 45% to 29% over the course of the treatment. </p> <p>See table 1 in <a href="./references#CD015253-bbs2-0004" title="BlanshardJ , MawA , BawdenR . The treatment of otitis media with effusion in children by autoinflation. In: 2nd European Congress of Oto-Rhino-Laryngology and Cervico-facial Surgery. 1992:31-7. [CENTRAL: CN-01165327] BlanshardJD , MawAR , BawdenR . Conservative treatment of otitis-media with effusion by autoinflation of the middle-ear. Clinical Otolaryngology1993;18(3):188-92. [CENTRAL: CN-02472342] ">Blanshard 1993</a> for further information </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0005" title="BrookerDS , McNeiceA . Autoinflation in the treatment of glue ear in children. Clinical Otolaryngology and Allied Sciences1992;17(4):289-90. [CENTRAL: CN-00262418] [PMID: 1526044]">Brooker 1992</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inflate balloon nasally 3 times a day for 3 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information on compliance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age 3 to 10 years, mean 5.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information on compliance</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0006" title="ChanKH , BluestoneCD . Lack of efficacy of middle-ear inflation: treatment of otitis media with effusion in children. Otolaryngology--Head and Neck Surgery1989;100(4):317-23. [CENTRAL: CN-00060254] [PMID: 2498820]">Chan 1989</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 times daily for 2 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants stratified according to their ability of tubal opening during autoinflation</p> <p>Parents asked to record number of exercise cycles completed each day and to hand in a score card at the end of the 2‐week study as a method to monitor patient compliance </p> <p>Ability to autoinflate</p> <p>Autoinflation</p> <p>No 4 (21.1)</p> <p>Yes 15 (78.9)</p> <p>Control</p> <p>No 5 (22.7)</p> <p>Yes 17 (77.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age between 3 and 18 years of age</p> <p>Autoinflation</p> <p>3 to 6 years: 14 (73.6)</p> <p>7 to 11 years: 4 (21.1)</p> <p>&gt; 12 years: 1 (5.3)</p> <p>Control</p> <p>3 to 6 years: 13 (59.1)</p> <p>7 to 11 years: 7 (31.8)</p> <p>&gt; 12 years: 2 (9.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No further details on compliance</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0007" title="ErcanI , CakirBC , KayaogluS , TurgutS . Long term effect of autoinflation in the treatment of otitis media with effusion. Elektronik Kulak Buran Bogaz ve Bas Boyun Cerrahisi Dergisi [Electronic Journal of Otolalryngology - Head and Neck Surgery]2005;4(4):166-70. [CENTRAL: CN-00849154] ">Ercan 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Autoinflation 3 times a day for 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean age 6.2 years (range 4 to 10 years)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>“The compliance of the children to the autoinflation was satisfactory and the autoinflation was somehow amusing for the children” </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0008" title="ScaddingG , RajputK , ParikhA , HilssS , Jansz JA , DarbyYC , et al. Double blind, placebo-controlled study of Flixonase with and without Otovent in the treatment of otitis media with effusion. In: 8th International Congress of Paediatric Otorhinolaryngology (ESPO); 2002 Sep 11-14; Oxford, UK. 2002:92-3. [ABSTRACT NUMBER: 21.04] [CENTRAL: CN-00431597] ScaddingGK , DarbyYC , JanszAJ , RichardsD , TateH , HillsS , et al. Double-blind, placebo controlled randomised trial of medical therapy in otitis media with effusion. Advances in Life Sciences and Health2014;1(2):1-11. [CENTRAL: CN-01043521] ">Scadding 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Otovent 3 times daily for approximately 4 to 5 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Compliance assessed by questioning child and parent/guardian and by number of bottles used. Those who reported spray use on at least 3 days a week remained in the study. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aged between 4 and 8 years</p> <p>Treatment 5.7 (SD 1.3)</p> <p>Placebo</p> <p>5.7 years (SD 1.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Those who reported spray use on at least 3 days a week remained in the study</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0009" title="StangerupS , TosM . Autoinflation in the treatment of Eustachian tube dysfunction, secretory otitis media and its sequelae. In: Mogi G (editor), editors(s). Recent Advances in Otitis Media. Amsterdam/New York: Kugler Publications, 1994:759-63. [CENTRAL: CN-01214464] StangerupSE , Sederberg-OlsenJ , BalleV . Autoinflation as a treatment of secretory otitis media. A randomized controlled study. Archives of Otolaryngology--Head &amp; Neck Surgery1992;118(2):149-52. [CENTRAL: CN-00082084] [PMID: 1540344]">Stangerup 1992</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 times a day for 2 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At second visit the use of the nose balloon was scored: 0 not used, 1 used a few times, 2 used as prescribed </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aged 3 to 10 years “some children younger than 3 years of age had difficulty performing autoinflation” </p> <p>Median age 5.3 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 children had not performed autoinflation, 10 only once, 33 had followed instructions</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0010" title="ISRCTN55208702. An open randomised study of autoinflation in 4-11 year old school children with otitis media with effusion (OME) in primary care [Study of autoinflation in 4-11 year old school children with glue ear]. https://www.isrctn.com/ISRCTN55208702 (first received 16 June 2011). [CENTRAL: CN-01012774] WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. [CENTRAL: CN-01098789] [EMBASE: 606141685] [PMID: 26377389]WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , KellyS , et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ: Canadian Medical Association Journal2015;187(13):961-9. [CENTRAL: CN-01078404] [PMID: 26216608]">Williamson 2015a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Otovent 3 times per day for 1 to 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weekly diary of compliance, sticker book</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Autoinflation group: mean 5.4 years (SD 1.24)</p> <p>Control group: mean 5.4 years (SD 1.04)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89% (116/130) used ‘most’ or ‘all of the time’ in the first month</p> <p>80% in months 2 and 3 (68/85, 805)</p> <p>See table 22 in <a href="./references#CD015253-bbs2-0010" title="ISRCTN55208702. An open randomised study of autoinflation in 4-11 year old school children with otitis media with effusion (OME) in primary care [Study of autoinflation in 4-11 year old school children with glue ear]. https://www.isrctn.com/ISRCTN55208702 (first received 16 June 2011). [CENTRAL: CN-01012774] WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. [CENTRAL: CN-01098789] [EMBASE: 606141685] [PMID: 26377389]WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , KellyS , et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ: Canadian Medical Association Journal2015;187(13):961-9. [CENTRAL: CN-01078404] [PMID: 26216608]">Williamson 2015a</a> for more information </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0011" title="WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. ">Williamson 2015b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Otovent 3 times per day for 1 to 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Recorded using a daily sticker reward chart</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age:</p> <p>Autoinflation group:</p> <p>4 to 5 years: 3</p> <p>5 to 6 years: 4</p> <p>6 to 10 years: 0</p> <p>7 to 11 years: 2</p> <p>Control group:</p> <p>4 to 5 years: 2</p> <p>5 to 6 years: 8</p> <p>6 to 10 years: 0</p> <p>7 to 11 years: 0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Compliance described as “excellent” and pilot study answered major unknown issue about “whether or not children were able to perform the technique and achieve sufficient compliance over 1 month in a primary care setting” </p> <p>See table 4 in <a href="./references#CD015253-bbs2-0010" title="ISRCTN55208702. An open randomised study of autoinflation in 4-11 year old school children with otitis media with effusion (OME) in primary care [Study of autoinflation in 4-11 year old school children with glue ear]. https://www.isrctn.com/ISRCTN55208702 (first received 16 June 2011). [CENTRAL: CN-01012774] WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. [CENTRAL: CN-01098789] [EMBASE: 606141685] [PMID: 26377389]WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , KellyS , et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ: Canadian Medical Association Journal2015;187(13):961-9. [CENTRAL: CN-01078404] [PMID: 26216608]">Williamson 2015a</a> for more information </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>SD: standard deviation</p> </div> </div> </section> <section id="CD015253-sec-0090"> <h5 class="title">Episodes of acute otitis media</h5> <p>Two studies assessed the occurrence of acute otitis media during short‐term follow‐up. The risk ratio was 0.82 for those who carried out autoinflation, although the confidence intervals were wide (95% CI 0.49 to 1.36; 2 studies, 403 participants; I<sup>2</sup> = 0%; <a href="./references#CD015253-fig-0013" title="">Analysis 1.9</a>; very low‐certainty evidence). </p> <p>Two further studies reported this outcome. However, we were not able to include the data in the meta‐analysis: </p> <p> <ul id="CD015253-list-0041"> <li> <p><a href="./references#CD015253-bbs2-0009" title="StangerupS , TosM . Autoinflation in the treatment of Eustachian tube dysfunction, secretory otitis media and its sequelae. In: Mogi G (editor), editors(s). Recent Advances in Otitis Media. Amsterdam/New York: Kugler Publications, 1994:759-63. [CENTRAL: CN-01214464] StangerupSE , Sederberg-OlsenJ , BalleV . Autoinflation as a treatment of secretory otitis media. A randomized controlled study. Archives of Otolaryngology--Head &amp; Neck Surgery1992;118(2):149-52. [CENTRAL: CN-00082084] [PMID: 1540344]">Stangerup 1992</a> used a 'per protocol' analysis ‐ data were only reported for participants who regularly underwent autoinflation, not for the whole group of individuals who were allocated to autoinflation. Therefore, these data were not included in the review. </p> </li> <li> <p><a href="./references#CD015253-bbs2-0002" title="BanigoA , HuntA , RourkeT , WhitesideO , AldrenC . Does the Earpopper(®) device improve hearing outcomes in children with persistent otitis media with effusion? A randomised single-blinded controlled trial. Clinical Otolaryngology2016;41(1):59-65. [CENTRAL: CN-01078433] [EMBASE: 607683212] [PMID: 26095773]">Banigo 2016</a> provided a narrative report, stating "There was no report of an acute otitis media during EarPopper use". No details are provided regarding whether any episodes occurred in the control group, therefore we were unable to provide an accurate comparison of the two groups. </p> </li> </ul> </p> <p>See <a href="#CD015253-tbl-0005">Table 4</a> for the results of the sensitivity analyses conducted as part of this review. </p> <div class="table" id="CD015253-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Sensitivity analyses</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Outcome</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Main analysis result</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Sensitivity analysis</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Sensitivity analysis result</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.5.1 Hearing threshold (short‐term, &gt; 6 weeks to ≤ 3 months): 0.5 kHz</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐9.13 (‐15.14 to ‐3.13)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fixed‐effect model</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐10.17 (‐13.63 to ‐6.71)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.5.2 Hearing threshold (short‐term, &gt; 6 weeks to ≤ 3 months): 1 kHz</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐10.34 (‐17.85 to ‐2.83)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fixed‐effect model</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐11.77 (‐15.73 to ‐7.82)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.5.3 Hearing threshold (short‐term, &gt; 6 weeks to ≤ 3 months): 2 kHz</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐9.04 (‐14.84 to ‐3.25)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fixed‐effect model</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐9.85 (‐13.61 to ‐6.10)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.5.4 Hearing threshold (short‐term, &gt; 6 weeks to ≤ 3 months): 4 kHz</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐12.88 (‐17.01 to ‐8.75)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fixed‐effect model</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐12.88 (‐17.01 to ‐8.75)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.7 Persistence of OME (very short‐term, &lt; 6 weeks)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.86 (0.72 to 1.04)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fixed‐effect model</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.83 (0.76 to 0.92)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.7 Persistence of OME (very short‐term, &lt; 6 weeks)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.86 (0.72 to 1.04)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excluding studies at high risk using the trustworthiness tool</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.94 (0.81 to 1.09)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.8 Persistence of OME (short‐term, &gt; 6 weeks to ≤ 3 months)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.88 (0.80 to 0.97)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fixed‐effect model</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.86 (0.77 to 0.97)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.8 Persistence of OME (short‐term, &gt; 6 weeks to ≤ 3 months)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.88 (0.80 to 0.97)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excluding studies at high risk using the trustworthiness tool</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.88 (0.74 to 1.04)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.9 Episodes of acute otitis media (short‐term, &gt; 6 weeks to ≤ 3 months)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.82 (0.49 to 1.36)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fixed‐effect model</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.85 (0.51 to 1.41)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.9 Episodes of acute otitis media (short‐term, &gt; 6 weeks to ≤ 3 months)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.82 (0.49 to 1.36)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excluding studies at high risk using the trustworthiness tool</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.25 (0.34 to 4.57)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>MD: mean difference; OME: otitis media with effusion; RR: risk ratio</p> <p>Numbers in brackets represent 95% confidence intervals.</p> </div> </div> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD015253-sec-0091" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD015253-sec-0091"></div> <p>It should be noted that most of the studies included in this review lasted up to three months, and required children to perform autoinflation two to three times per day. Furthermore, outcomes were reported just after treatment had been completed. Therefore, we are uncertain whether any effects of autoinflation persist into the longer term. As we did not assess the proportion of children who went on to receive medical or surgical treatment for OME, we do not know whether the use of autoinflation has any impact on this. It may simply hasten recovery for children in whom OME would have resolved anyway. </p> <section id="CD015253-sec-0092"> <h3 class="title" id="CD015253-sec-0092">Summary of main results</h3> <p><b>Short‐term effects (up to three months)</b> </p> <p>Overall, autoinflation may slightly increase the proportion of children whose hearing returns to normal at up to three months follow‐up, but the evidence was very uncertain. We are uncertain whether mean hearing threshold is an appropriate method of assessing hearing in this condition (see below). Nonetheless, at less than six weeks there appeared to be little difference in the mean hearing threshold between those who received autoinflation and no treatment, but the evidence was very uncertain. After six weeks to three months of follow‐up, autoinflation may result in a small improvement in hearing threshold. It may also result in an improvement in quality of life. </p> <p>Autoinflation may also result in a reduction in the proportion of children with persistent OME at six weeks to three months of follow‐up, although the evidence at the earlier time point (less than six weeks) was very uncertain. After three months of follow‐up, there may be a very slight reduction in the proportion of children who experience acute otitis media, but the evidence was very uncertain. The evidence about ear pain was also very uncertain, but the occurrence of pain may increase with the use of autoinflation. </p> <p>We did not identify any evidence on generic quality of life, expressive or receptive language skills, cognitive development, psychosocial outcomes, listening skills, parental stress or vestibular function. </p> <p><b>Longer‐term effects (over three months)</b> </p> <p>We did not identify evidence for any outcomes over this time frame.</p> </section> <section id="CD015253-sec-0093"> <h3 class="title" id="CD015253-sec-0093">Overall completeness and applicability of evidence</h3> <p>Most of the studies included recruited children aged over three years. Autoinflation may be difficult for children in younger age groups to perform, therefore we considered that this was an appropriate population. However, it should be noted that few studies provide any evidence regarding the use of autoinflation in children aged less than three years. </p> <p>We intended to include studies where children had craniofacial anomalies, or conditions such as Down syndrome. However, a number of studies specifically excluded children with these conditions (<a href="./references#CD015253-bbs2-0003" title="Bidarian-MoniriA , RamosMJ , EjnellH . Autoinflation for treatment of persistent otitis media with effusion in children: a cross-over study with a 12-month follow-up. International Journal of Pediatric Otorhinolaryngology2014;78(8):1298-305. [CENTRAL: CN-00994829] [EMBASE: 2014464001] [PMID: 24882460]">Bidarian‐Moniri 2014</a>; <a href="./references#CD015253-bbs2-0004" title="BlanshardJ , MawA , BawdenR . The treatment of otitis media with effusion in children by autoinflation. In: 2nd European Congress of Oto-Rhino-Laryngology and Cervico-facial Surgery. 1992:31-7. [CENTRAL: CN-01165327] BlanshardJD , MawAR , BawdenR . Conservative treatment of otitis-media with effusion by autoinflation of the middle-ear. Clinical Otolaryngology1993;18(3):188-92. [CENTRAL: CN-02472342] ">Blanshard 1993</a>; <a href="./references#CD015253-bbs2-0006" title="ChanKH , BluestoneCD . Lack of efficacy of middle-ear inflation: treatment of otitis media with effusion in children. Otolaryngology--Head and Neck Surgery1989;100(4):317-23. [CENTRAL: CN-00060254] [PMID: 2498820]">Chan 1989</a>; <a href="./references#CD015253-bbs2-0007" title="ErcanI , CakirBC , KayaogluS , TurgutS . Long term effect of autoinflation in the treatment of otitis media with effusion. Elektronik Kulak Buran Bogaz ve Bas Boyun Cerrahisi Dergisi [Electronic Journal of Otolalryngology - Head and Neck Surgery]2005;4(4):166-70. [CENTRAL: CN-00849154] ">Ercan 2005</a>; <a href="./references#CD015253-bbs2-0008" title="ScaddingG , RajputK , ParikhA , HilssS , Jansz JA , DarbyYC , et al. Double blind, placebo-controlled study of Flixonase with and without Otovent in the treatment of otitis media with effusion. In: 8th International Congress of Paediatric Otorhinolaryngology (ESPO); 2002 Sep 11-14; Oxford, UK. 2002:92-3. [ABSTRACT NUMBER: 21.04] [CENTRAL: CN-00431597] ScaddingGK , DarbyYC , JanszAJ , RichardsD , TateH , HillsS , et al. Double-blind, placebo controlled randomised trial of medical therapy in otitis media with effusion. Advances in Life Sciences and Health2014;1(2):1-11. [CENTRAL: CN-01043521] ">Scadding 2014</a>; <a href="./references#CD015253-bbs2-0010" title="ISRCTN55208702. An open randomised study of autoinflation in 4-11 year old school children with otitis media with effusion (OME) in primary care [Study of autoinflation in 4-11 year old school children with glue ear]. https://www.isrctn.com/ISRCTN55208702 (first received 16 June 2011). [CENTRAL: CN-01012774] WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. [CENTRAL: CN-01098789] [EMBASE: 606141685] [PMID: 26377389]WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , KellyS , et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ: Canadian Medical Association Journal2015;187(13):961-9. [CENTRAL: CN-01078404] [PMID: 26216608]">Williamson 2015a</a>; <a href="./references#CD015253-bbs2-0011" title="WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. ">Williamson 2015b</a>). The remaining studies did not state that children with these conditions were excluded, but none specifically recruited children with these high‐risk conditions. Therefore, we do not know whether the efficacy of autoinflation may differ for these children. </p> <p>Many of the studies included in this review enrolled children who had OME for at least three months, however children with a shorter duration of disease were also included. It is not clear whether the efficacy of the intervention may vary depending on the duration of the disease, or perhaps according to prior treatment. Further information is required to identify whether this intervention may be more suitable for use in a primary care setting, as an early intervention for OME, or whether it is better suited to use in secondary care, for children with persistent or treatment‐resistant disease. </p> <p>A variety of devices and techniques were used to carry out autoinflation, ranging from custom‐made devices to commercially available products such as Otovent. We did not have enough data to consider this as part of a subgroup analysis, so cannot say if one method works better than another. </p> <p>The data obtained as part of this review on adherence to treatment were encouraging, showing moderate or good adherence when using autoinflation devices. However, we note that a substantial proportion of studies did not assess compliance. In addition, the studies that did provide an assessment of compliance used different measures to assess this. We are aware that compliance may differ in routine clinical practice, as compared to a trial setting. As highlighted in the review, autoinflation may be associated with an increase in ear pain, and the willingness of children to engage with the procedure may wane over time, which may impact on efficacy. </p> <p>We have concerns that assessment of hearing using the mean difference in final hearing threshold (or mean change in hearing threshold) may not be the most appropriate way to assess hearing. OME has a high spontaneous resolution rate. Consequently, we would anticipate that the change in hearing threshold for most children will be similar across the groups – as many children will improve with or without treatment. Therefore, even if a subset of children had substantial benefit from the intervention, the overall mean difference between the two groups would appear to be small. When assessed using the mean difference, the marked benefit seen in a subgroup of participants is ‘diluted’ by the children who get better regardless of treatment. Therefore, an apparently small mean difference between the two groups may actually be consistent with a substantial change in the number of children in whom hearing returns to normal. It should be noted that persistence (or resolution) of OME is always expressed as a proportion. Most children included in these studies would be expected to have a return to normal hearing alongside resolution of OME. In the absence of our preferred outcome measure of proportion of children with return to normal hearing it may be that presence (and resolution) of OME provides a better or more useful estimate of effect on hearing in these studies. </p> <p>Finally, we did not assess the number of children who received further treatment for OME (including medical or surgical interventions) as part of this review. Therefore, we do not have data to show whether this intervention prevents children from ultimately receiving surgery and ventilation tube insertion as a treatment for OME. However, this is likely to be an important consideration when deciding on a treatment strategy for OME. </p> </section> <section id="CD015253-sec-0094"> <h3 class="title" id="CD015253-sec-0094">Quality of the evidence</h3> <p>We rated the evidence included in this review as low‐ or very low‐certainty. This was due to a number of issues. Firstly, many of the outcomes were affected by the potential for bias in the individual studies. We rated all the studies at high risk of performance bias, as participants and study personnel were aware of the group allocation. Some studies also had additional problems, including detection bias (where outcome assessors were also aware of the group allocation for participants), loss to follow‐up or extremely short follow‐up times. </p> <p>As well as the potential for bias, the effect estimates for many of the outcomes had confidence intervals that crossed from a threshold of potential benefit or harm to a trivial effect, leading to uncertainty in the overall effect estimates. For some analyses very few participants were included, which resulted in extremely wide confidence intervals and more uncertainty in the overall result. </p> </section> <section id="CD015253-sec-0095"> <h3 class="title" id="CD015253-sec-0095">Potential biases in the review process</h3> <p>As part of the development of this review we conducted comprehensive searches, and made significant efforts to locate and include all relevant studies on this topic. Not all of our outcomes of interest were reported by every study. If these outcome data were assessed but not reported, then there is a risk of bias in the meta‐analysis results. </p> <p>We acknowledge that there is little consensus on the definition of 'normal hearing'. Consequently, our selection of a hearing threshold of ≤ 20 dB HL as 'normal' was based on discussion between the author team, review of earlier studies and a pragmatic choice of outcome measure. However, we were as inclusive as possible with this outcome measure, and have included data where authors provided an alternative definition of normal hearing. If we had rigidly used a definition of ≤ 20 dB HL then the data included in this review would have been even more sparse. </p> <p>During the preparation of this review, we had to consider the definition of autoinflation. We originally included one study that utilised nose‐blowing as an autoinflation technique (<a href="./references#CD015253-bbs2-0022" title="HeafM , HutchingsS , BunchK . Does nose blowing improve hearing in serous otitis? A community study. British Journal of General Practice1991;41(350):377-9. [CENTRAL: CN-00612450] [PMID: 1793648]">Heaf 1991</a>). However, in response to comments from our peer reviewers, we subsequently excluded this study from the review. Different definitions of 'autoinflation' could therefore lead to inclusion of different studies, and potentially impact on the findings of the review. </p> </section> <section id="CD015253-sec-0096"> <h3 class="title" id="CD015253-sec-0096">Agreements and disagreements with other studies or reviews</h3> <p>The previous Cochrane Review on this topic included eight studies, with a total of 702 participants (<a href="./references#CD015253-bbs2-0081" title="PereraR , GlasziouP , HeneghanCJ , McLellanJ , WilliamsonI . Autoinflation for hearing loss associated with otitis media with effusion. Cochrane Database of Systematic Reviews2013, Issue 5. Art. No: CD006285. [DOI: 10.1002/14651858.CD006285.pub2]">Perera 2013</a>). The review authors concluded that autoinflation has a beneficial effect on resolution of OME. However, the authors noted that none of the included studies were rated as high quality, and many of the effect estimates had wide confidence intervals and failed to reach conventional statistical significance. This review differs slightly, as we have used the GRADE approach to formally assess the certainty of the evidence for each outcome. Given some concerns over the potential for bias in the included studies, and the imprecision in some effect estimates, the overall certainty of the evidence is therefore rated as low or very low. In addition, the outcome measures used for the original review and this updated review differ slightly. However, despite these differences, the summary of both reviews is similar ‐ that there may be some small benefit from autoinflation for some outcomes, but that longer follow‐up is required, including an assessment of quality of life and developmental outcomes. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD015253-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/urn:x-wiley:14651858:media:CD015253:CD015253-FIG-01" target="_blank"><b></b></a></p> </div><img alt="The Cochrane Pregnancy and Childbirth Trustworthiness Screening Tool" data-id="CD015253-fig-0001" src="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-FIG-01.jpg"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>The Cochrane Pregnancy and Childbirth Trustworthiness Screening Tool</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/full#CD015253-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-FIG-01.jpg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015253-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/urn:x-wiley:14651858:media:CD015253:CD015253-FIG-02" target="_blank"><b></b></a></p> </div><img alt="original image" data-id="CD015253-fig-0002" src="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_t/tCD015253-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/full#CD015253-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015253-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/urn:x-wiley:14651858:media:CD015253:CD015253-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph (our judgements about each risk of bias item presented as percentages across all included studies)." data-id="CD015253-fig-0003" src="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_t/tCD015253-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph (our judgements about each risk of bias item presented as percentages across all included studies). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/full#CD015253-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015253-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/urn:x-wiley:14651858:media:CD015253:CD015253-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary (our judgements about each risk of bias item for each included study)." data-id="CD015253-fig-0004" src="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_t/tCD015253-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Risk of bias summary (our judgements about each risk of bias item for each included study). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/full#CD015253-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015253-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/urn:x-wiley:14651858:media:CD015253:CD015253-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 1: Proportion of children whose hearing is normal (very short‐term, &lt; 6 weeks)" data-id="CD015253-fig-0005" src="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_t/tCD015253-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 1: Proportion of children whose hearing is normal (very short‐term, &lt; 6 weeks) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/references#CD015253-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015253-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/urn:x-wiley:14651858:media:CD015253:CD015253-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 2: Proportion of children whose hearing is normal (short‐term, &gt; 6 weeks to ≤ 3 months)" data-id="CD015253-fig-0006" src="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_t/tCD015253-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 2: Proportion of children whose hearing is normal (short‐term, &gt; 6 weeks to ≤ 3 months) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/references#CD015253-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015253-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/urn:x-wiley:14651858:media:CD015253:CD015253-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 3: Hearing threshold (very short‐term, &lt; 6 weeks)" data-id="CD015253-fig-0007" src="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_t/tCD015253-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 3: Hearing threshold (very short‐term, &lt; 6 weeks) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/references#CD015253-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015253-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/urn:x-wiley:14651858:media:CD015253:CD015253-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 4: Hearing threshold (short‐term, &gt; 6 weeks to ≤ 3 months)" data-id="CD015253-fig-0008" src="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_t/tCD015253-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 4: Hearing threshold (short‐term, &gt; 6 weeks to ≤ 3 months) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/references#CD015253-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015253-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/urn:x-wiley:14651858:media:CD015253:CD015253-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 5: Disease‐specific quality of life (short‐term, &gt; 6 weeks to ≤ 3 months)" data-id="CD015253-fig-0009" src="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_t/tCD015253-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 5: Disease‐specific quality of life (short‐term, &gt; 6 weeks to ≤ 3 months) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/references#CD015253-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015253-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/urn:x-wiley:14651858:media:CD015253:CD015253-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 6: Adverse events ‐ pain and distress caused by the procedure (otalgia)" data-id="CD015253-fig-0010" src="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_t/tCD015253-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 6: Adverse events ‐ pain and distress caused by the procedure (otalgia) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/references#CD015253-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015253-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/urn:x-wiley:14651858:media:CD015253:CD015253-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 7: Persistence of OME (very short‐term, &lt; 6 weeks)" data-id="CD015253-fig-0011" src="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_t/tCD015253-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 7: Persistence of OME (very short‐term, &lt; 6 weeks) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/references#CD015253-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015253-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/urn:x-wiley:14651858:media:CD015253:CD015253-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 8: Persistence of OME (short‐term, &gt; 6 weeks to ≤ 3 months)" data-id="CD015253-fig-0012" src="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_t/tCD015253-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 8: Persistence of OME (short‐term, &gt; 6 weeks to ≤ 3 months) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/references#CD015253-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015253-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/urn:x-wiley:14651858:media:CD015253:CD015253-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 9: Episodes of acute otitis media (short‐term, &gt; 6 weeks to ≤ 3 months)" data-id="CD015253-fig-0013" src="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_t/tCD015253-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 9: Episodes of acute otitis media (short‐term, &gt; 6 weeks to ≤ 3 months) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/references#CD015253-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015253-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/urn:x-wiley:14651858:media:CD015253:CD015253-CMP-001.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 10: Sensitivity analysis: Proportion of children whose hearing is normal (very short‐term, &lt; 6 weeks). Per ear data (ICC of 1, complete correlation between ears)" data-id="CD015253-fig-0014" src="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_t/tCD015253-CMP-001.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 10: Sensitivity analysis: Proportion of children whose hearing is normal (very short‐term, &lt; 6 weeks). Per ear data (ICC of 1, complete correlation between ears) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/references#CD015253-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015253-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/urn:x-wiley:14651858:media:CD015253:CD015253-CMP-001.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 11: Sensitivity analysis: Proportion of children whose hearing is normal (very short‐term, &lt; 6 weeks). Per ear data (ICC of 0, no correlation between ears)" data-id="CD015253-fig-0015" src="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_t/tCD015253-CMP-001.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 11: Sensitivity analysis: Proportion of children whose hearing is normal (very short‐term, &lt; 6 weeks). Per ear data (ICC of 0, no correlation between ears) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/references#CD015253-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015253-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/urn:x-wiley:14651858:media:CD015253:CD015253-CMP-001.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 12: Sensitivity analysis: Hearing threshold (short‐term, &gt; 6 weeks to ≤ 3 months). Right ear data" data-id="CD015253-fig-0016" src="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_t/tCD015253-CMP-001.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 12: Sensitivity analysis: Hearing threshold (short‐term, &gt; 6 weeks to ≤ 3 months). Right ear data </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/references#CD015253-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015253-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/urn:x-wiley:14651858:media:CD015253:CD015253-CMP-001.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 13: Sensitivity analysis: Hearing threshold (short‐term, &gt; 6 weeks to ≤ 3 months). Left ear data" data-id="CD015253-fig-0017" src="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_t/tCD015253-CMP-001.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 13: Sensitivity analysis: Hearing threshold (short‐term, &gt; 6 weeks to ≤ 3 months). Left ear data </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/references#CD015253-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015253-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/urn:x-wiley:14651858:media:CD015253:CD015253-CMP-001.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 14: Sensitivity analysis: Persistence of OME (very short‐term, &lt; 6 weeks). Per ear data (ICC of 0)" data-id="CD015253-fig-0018" src="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_t/tCD015253-CMP-001.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 14: Sensitivity analysis: Persistence of OME (very short‐term, &lt; 6 weeks). Per ear data (ICC of 0) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/references#CD015253-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015253-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/urn:x-wiley:14651858:media:CD015253:CD015253-CMP-001.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 15: Sensitivity analysis: Persistence of OME (very short‐term, &lt; 6 weeks). Per ear data (ICC of 1)" data-id="CD015253-fig-0019" src="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_t/tCD015253-CMP-001.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 15: Sensitivity analysis: Persistence of OME (very short‐term, &lt; 6 weeks). Per ear data (ICC of 1) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/references#CD015253-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015253-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/urn:x-wiley:14651858:media:CD015253:CD015253-CMP-001.16" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 16: Sensitivity analysis: Persistence of OME (very short‐term, &lt; 6 weeks). Per child data, where available" data-id="CD015253-fig-0020" src="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.16.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_t/tCD015253-CMP-001.16.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 16: Sensitivity analysis: Persistence of OME (very short‐term, &lt; 6 weeks). Per child data, where available </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/references#CD015253-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.16.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015253-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/urn:x-wiley:14651858:media:CD015253:CD015253-CMP-001.17" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 17: Sensitivity analysis: Persistence of OME (short‐term, &gt; 6 weeks to ≤ 3 months). Per ear data (ICC of 0)" data-id="CD015253-fig-0021" src="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.17.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_t/tCD015253-CMP-001.17.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 17: Sensitivity analysis: Persistence of OME (short‐term, &gt; 6 weeks to ≤ 3 months). Per ear data (ICC of 0) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/references#CD015253-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.17.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015253-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/urn:x-wiley:14651858:media:CD015253:CD015253-CMP-001.18" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 18: Sensitivity analysis: Persistence of OME (short‐term, &gt; 6 weeks to ≤ 3 months). Per ear data (ICC of 1)" data-id="CD015253-fig-0022" src="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.18.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_t/tCD015253-CMP-001.18.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 18: Sensitivity analysis: Persistence of OME (short‐term, &gt; 6 weeks to ≤ 3 months). Per ear data (ICC of 1) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/references#CD015253-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.18.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD015253-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/urn:x-wiley:14651858:media:CD015253:CD015253-CMP-001.19" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 19: Sensitivity analysis: Persistence of OME (short‐term, &gt; 6 weeks to ≤ 3 months). Per child data, where available" data-id="CD015253-fig-0023" src="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.19.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_t/tCD015253-CMP-001.19.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1: Autoinflation versus watchful waiting/no treatment, Outcome 19: Sensitivity analysis: Persistence of OME (short‐term, &gt; 6 weeks to ≤ 3 months). Per child data, where available </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/references#CD015253-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/media/CDSR/CD015253/image_n/nCD015253-CMP-001.19.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD015253-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Autoinflation compared to no treatment for otitis media with effusion (OME) in children</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="bottom"> <p><b>Autoinflation compared to no treatment for otitis media with effusion (OME) in children</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="bottom"> <p><b>Patient or population:</b> otitis media with effusion (OME) in children aged 6 months to 12 years<br/><b>Setting:</b> outpatient<br/><b>Intervention:</b> autoinflation <br/><b>Comparison:</b> no treatment </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell table-tint" colspan="3" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>What happens</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Without autoinflation</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>With autoinflation</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Difference</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of children whose hearing is normal</p> <p>Follow‐up: up to 3 months</p> <p>№ of participants: 94<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>RR 2.67 (1.73 to 4.12)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>31.9%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85.2%<br/>(55.2 to 100) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53.3% more<br/>(23.3 more to 68.1more) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>1,2,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence is very uncertain about the effect of autoinflation on return to normal hearing at 3 months. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Disease‐specific quality of life</p> <p>Mean difference in standardised OMQ‐14 scores (lower score is favourable)</p> <p>Follow‐up: 3 months (short‐term)</p> <p>№ of participants: 247<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.42 lower<br/>(0.62 lower to 0.22 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>1,4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that autoinflation may improve disease‐specific quality of life at 3 months. The study authors reported a change of 0.3 as clinically meaningful. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain and distress related to the procedure: otalgia</p> <p>Follow‐up: 3 months (short‐term)</p> <p>№ of participants: 320<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>RR 3.50 (0.74 to 16.59)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1.3%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.4%</p> <p>(1 to 22.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.1% more (0.3% fewer to 19.5% more)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>1,5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Autoinflation may slightly increase the risk of ear pain (otalgia), but the evidence is very uncertain. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Persistence of OME</p> <p>Follow‐up: 3 months (short‐term)</p> <p>№ of participants: 483<br/>(4 RCTs) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>RR 0.88<br/>(0.80 to 0.97) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>74.1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65.2%<br/>(59.3 to 71.9) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8.9% fewer<br/>(14.8 fewer to 2.2 fewer) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>1,6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The evidence suggests that autoinflation may slightly reduce persistence of OME at 3 months. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br/><br/><b>CI:</b> confidence interval; <b>OME:</b> otitis media with effusion; <b>OMQ‐14:</b> Otitis Media Questionnaire‐14; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by one level for a risk of performance bias. </p> <p><sup>2</sup>Downgraded by one level for indirectness, as no description of 'normal hearing' was provided. </p> <p><sup>3</sup>Downgraded by one level for imprecision, as the optimal information size (OIS) was not reached (&lt; 300 events). </p> <p><sup>4</sup>Downgraded by one level for imprecision, as the OIS was not reached (&lt; 400 participants). </p> <p><sup>5</sup>Downgraded by two levels for imprecision, as the OIS was not reached (&lt; 300 events) and the confidence interval crosses two decision thresholds (RR 0.8 and 1.25). </p> <p><sup>6</sup>Downgraded by one level for a risk of detection bias. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Autoinflation compared to no treatment for otitis media with effusion (OME) in children</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/full#CD015253-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD015253-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">RCTs identified through Cochrane Crowd and the RCT classifier</span></div> <tbody> <tr> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Possible RCTs</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Rejected</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Known assessments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RCT classifier</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2559</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1514</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cochrane Crowd</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1313</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Total</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1280</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2877</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p>RCT: randomised controlled trial</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">RCTs identified through Cochrane Crowd and the RCT classifier</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/full#CD015253-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD015253-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Key characteristics of studies and participants</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Participants and ears randomised (N)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Autoinflation method</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Age (years) and whether unilateral or bilateral (if stated)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Outcomes assessed by study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Final follow‐up</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0001" title="ArickD , SilmanS . Nonsurgical home treatment of middle ear effusion and associated hearing loss in children. Part I: clinical trial. Ear, Nose, &amp; Throat Journal2005;84(9):567-8, 570-4, 576 passim. [CENTRAL: CN-00552768] [EMBASE: 41864684] [PMID: 16261757]">Arick 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94</p> <p>174 ears</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Modified Politzer device, used twice daily for 7 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 11</p> <p>Minimum 2‐month history of middle ear effusion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015253-list-0025"> <li> <p>Proportion children with hearing returned to normal</p> </li> <li> <p>Mean (SD) final hearing thresholds (dB) per ear assessed</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0002" title="BanigoA , HuntA , RourkeT , WhitesideO , AldrenC . Does the Earpopper(®) device improve hearing outcomes in children with persistent otitis media with effusion? A randomised single-blinded controlled trial. Clinical Otolaryngology2016;41(1):59-65. [CENTRAL: CN-01078433] [EMBASE: 607683212] [PMID: 26095773]">Banigo 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EarPopper device, used twice daily for 7 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 11</p> <p>3‐month history of persistent OME</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015253-list-0026"> <li> <p>Mean (SD) final hearing thresholds (dB), air conduction at 7 weeks</p> </li> <li> <p>Mean (SD) change in hearing thresholds (dB) from baseline, air conduction thresholds</p> </li> <li> <p>Presence/persistence of OME</p> </li> <li> <p>Adverse events: narrative summary</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0003" title="Bidarian-MoniriA , RamosMJ , EjnellH . Autoinflation for treatment of persistent otitis media with effusion in children: a cross-over study with a 12-month follow-up. International Journal of Pediatric Otorhinolaryngology2014;78(8):1298-305. [CENTRAL: CN-00994829] [EMBASE: 2014464001] [PMID: 24882460]">Bidarian‐Moniri 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>New autoinflation device consisting of an inflatable facemask, a T‐shaped junction tube connecting at one end to the facemask, another end to a balloon and the third end to a handheld pump covered by a teddy bear to improve compliance </p> <p>Used twice daily for 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 to 8</p> <p>All bilateral</p> <p>Persistent OME with a duration of at least 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015253-list-0027"> <li> <p>Proportion of ears with hearing returned to normal: hearing thresholds &gt; 20 dB</p> </li> <li> <p>Mean (SD) change in hearing thresholds (dB) from baseline (best ear): pure tone air conduction thresholds </p> </li> <li> <p>Presence/persistence of OME</p> </li> <li> <p>Adverse events: narrative summary</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks</p> <p>(Additional data at 1‐year follow‐up, but not relevant for this review)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0004" title="BlanshardJ , MawA , BawdenR . The treatment of otitis media with effusion in children by autoinflation. In: 2nd European Congress of Oto-Rhino-Laryngology and Cervico-facial Surgery. 1992:31-7. [CENTRAL: CN-01165327] BlanshardJD , MawAR , BawdenR . Conservative treatment of otitis-media with effusion by autoinflation of the middle-ear. Clinical Otolaryngology1993;18(3):188-92. [CENTRAL: CN-02472342] ">Blanshard 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Otovent device, used 3 times daily for 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 to 10</p> <p>Bilateral</p> <p>Confirmation of type B or C2 tympanograms on 2 occasions separated by ≥ 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015253-list-0028"> <li> <p>Mean (SD) change in hearing thresholds (dB) from baseline: pure tone audiometry</p> </li> <li> <p>Presence/persistence of OME</p> </li> <li> <p>Episodes of acute otitis media</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0005" title="BrookerDS , McNeiceA . Autoinflation in the treatment of glue ear in children. Clinical Otolaryngology and Allied Sciences1992;17(4):289-90. [CENTRAL: CN-00262418] [PMID: 1526044]">Brooker 1992</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> <p>78 ears</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Device comprised of a toy balloon attached to a carnival blower mouthpiece; used 3 times daily for 3 weeks </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&lt; 10 years</p> <p>Unilateral or bilateral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015253-list-0029"> <li> <p>Presence/persistence of OME</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0006" title="ChanKH , BluestoneCD . Lack of efficacy of middle-ear inflation: treatment of otitis media with effusion in children. Otolaryngology--Head and Neck Surgery1989;100(4):317-23. [CENTRAL: CN-00060254] [PMID: 2498820]">Chan 1989</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Modified Valsalva techniques ‐ a disposable anaesthesia mask attached to a floating ball‐type flowmeter. Child instructed to exhale through the nose through the mask (with mouth closed), as the pressure increased the ball in the flowmeter was propelled upwards. Used 3 times daily for 2 weeks. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 to 18</p> <p>Unilateral or bilateral</p> <p>Aimed to include those that had persistence for ≥ 3 months (although this was not everyone) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015253-list-0030"> <li> <p>Presence/persistence of OME</p> </li> <li> <p>Adverse events: narrative summary</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0007" title="ErcanI , CakirBC , KayaogluS , TurgutS . Long term effect of autoinflation in the treatment of otitis media with effusion. Elektronik Kulak Buran Bogaz ve Bas Boyun Cerrahisi Dergisi [Electronic Journal of Otolalryngology - Head and Neck Surgery]2005;4(4):166-70. [CENTRAL: CN-00849154] ">Ercan 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60</p> <p>93 ears</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Otovent, used 3 times daily for 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unilateral and bilateral</p> <p>Chronic OME for 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015253-list-0031"> <li> <p>Presence/persistence of OME</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0008" title="ScaddingG , RajputK , ParikhA , HilssS , Jansz JA , DarbyYC , et al. Double blind, placebo-controlled study of Flixonase with and without Otovent in the treatment of otitis media with effusion. In: 8th International Congress of Paediatric Otorhinolaryngology (ESPO); 2002 Sep 11-14; Oxford, UK. 2002:92-3. [ABSTRACT NUMBER: 21.04] [CENTRAL: CN-00431597] ScaddingGK , DarbyYC , JanszAJ , RichardsD , TateH , HillsS , et al. Double-blind, placebo controlled randomised trial of medical therapy in otitis media with effusion. Advances in Life Sciences and Health2014;1(2):1-11. [CENTRAL: CN-01043521] ">Scadding 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Otovent, used 3 times daily for 4 to 5 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 8</p> <p>With ≥ 3 months of glue ear or &gt; 2 episodes in the past 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015253-list-0032"> <li> <p>Presence/persistence of OME</p> </li> <li> <p>Adverse effects: narrative summary</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 years</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0009" title="StangerupS , TosM . Autoinflation in the treatment of Eustachian tube dysfunction, secretory otitis media and its sequelae. In: Mogi G (editor), editors(s). Recent Advances in Otitis Media. Amsterdam/New York: Kugler Publications, 1994:759-63. [CENTRAL: CN-01214464] StangerupSE , Sederberg-OlsenJ , BalleV . Autoinflation as a treatment of secretory otitis media. A randomized controlled study. Archives of Otolaryngology--Head &amp; Neck Surgery1992;118(2):149-52. [CENTRAL: CN-00082084] [PMID: 1540344]">Stangerup 1992</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tube designed by the author, with a balloon on the end, inserted in one nostril and blown up whilst occluding the other. Used 3 times daily for 2 to 4 weeks. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 to 10</p> <p>Unilateral and bilateral</p> <p>Secretory OM for ≥ 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015253-list-0033"> <li> <p>Presence/persistence of OME</p> </li> <li> <p>Episodes of acute otitis media</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0010" title="ISRCTN55208702. An open randomised study of autoinflation in 4-11 year old school children with otitis media with effusion (OME) in primary care [Study of autoinflation in 4-11 year old school children with glue ear]. https://www.isrctn.com/ISRCTN55208702 (first received 16 June 2011). [CENTRAL: CN-01012774] WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. [CENTRAL: CN-01098789] [EMBASE: 606141685] [PMID: 26377389]WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , KellyS , et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ: Canadian Medical Association Journal2015;187(13):961-9. [CENTRAL: CN-01078404] [PMID: 26216608]">Williamson 2015a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>320</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Otovent, used 3 times daily for between 1 and 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 11</p> <p>Unilateral and bilateral</p> <p>Parental concern with report of ≥ 1 relevant symptom/concern associated with OME in previous 3 months </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015253-list-0034"> <li> <p>Disease‐specific quality of life: OMQ‐14</p> </li> <li> <p>Presence/persistence of OME</p> </li> <li> <p>Receptive language: mean (SD) at endpoint</p> <ul id="CD015253-list-0035"> <li> <p>Auditory disability and speech reception tests and hearing tests</p> </li> </ul> </li> <li> <p>Other adverse effects</p> <ul id="CD015253-list-0036"> <li> <p>Nosebleeds</p> </li> <li> <p>URTI</p> </li> <li> <p>Unspecified RTI</p> </li> <li> <p>Lower RTI</p> </li> <li> <p>Otalgia</p> </li> <li> <p>Headache</p> </li> <li> <p>Hay fever</p> </li> <li> <p>Serious adverse event: hospitalisation</p> </li> </ul> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0011" title="WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. ">Williamson 2015b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Otovent, used 3 times daily for between 1 and 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 11</p> <p>Unilateral and bilateral</p> <p>Parental concern with report of ≥ 1 relevant symptom/concern associated with OME in previous 3 months </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD015253-list-0037"> <li> <p>Presence/persistence of OME</p> </li> <li> <p>Adverse events: narrative summary</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p>OME: otitis media with effusion; RTI: respiratory tract infection; SD: standard deviation; URTI: upper respiratory tract infection </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Key characteristics of studies and participants</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/full#CD015253-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD015253-tbl-0004"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Compliance with autoinflation</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Treatment requirements</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Compliance monitoring and definition</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Age</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Compliance</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0001" title="ArickD , SilmanS . Nonsurgical home treatment of middle ear effusion and associated hearing loss in children. Part I: clinical trial. Ear, Nose, &amp; Throat Journal2005;84(9):567-8, 570-4, 576 passim. [CENTRAL: CN-00552768] [EMBASE: 41864684] [PMID: 16261757]">Arick 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Twice a day, alternating nostrils with each treatment for 7 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Daily log to track compliance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 11 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Complete compliance in 46 of 47 experimental patients (97.9%), moderate compliance in remaining patient </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0002" title="BanigoA , HuntA , RourkeT , WhitesideO , AldrenC . Does the Earpopper(®) device improve hearing outcomes in children with persistent otitis media with effusion? A randomised single-blinded controlled trial. Clinical Otolaryngology2016;41(1):59-65. [CENTRAL: CN-01078433] [EMBASE: 607683212] [PMID: 26095773]">Banigo 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Use twice a day and on each occasion to be used twice in each nostril for 7 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diary card, no definition</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment</p> <p>Mean 5.94 years (range 4.36 to 8.19)</p> <p>Control</p> <p>Mean 5.55 (range 3.96 to 7.79)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94% on average</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0003" title="Bidarian-MoniriA , RamosMJ , EjnellH . Autoinflation for treatment of persistent otitis media with effusion in children: a cross-over study with a 12-month follow-up. International Journal of Pediatric Otorhinolaryngology2014;78(8):1298-305. [CENTRAL: CN-00994829] [EMBASE: 2014464001] [PMID: 24882460]">Bidarian‐Moniri 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Use the device twice a day to perform 20 inflations at each session (approximately 5 to 10 minutes) for 4 weeks </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diary and full compliance was defined as using the device twice a day to perform 20 inflations at each session (approximately 5 to 10 minutes) during a period of 4 weeks </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment: 68 months</p> <p>Control: 53 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All children from 2 years and 9 months of age were able to use the device after demonstration by a doctor or nurse. In one case, the compliance was not satisfactory to complete the 4‐week treatment. The overall compliance for the total treatment time was satisfactory. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0004" title="BlanshardJ , MawA , BawdenR . The treatment of otitis media with effusion in children by autoinflation. In: 2nd European Congress of Oto-Rhino-Laryngology and Cervico-facial Surgery. 1992:31-7. [CENTRAL: CN-01165327] BlanshardJD , MawAR , BawdenR . Conservative treatment of otitis-media with effusion by autoinflation of the middle-ear. Clinical Otolaryngology1993;18(3):188-92. [CENTRAL: CN-02472342] ">Blanshard 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One nostril 3 times a day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Compliance was measured as the number of times the device was used as a percentage of the maximum possible </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment</p> <p>HC (high compliance) n = 19</p> <p>Mean 62.7 months (SD 17.5)</p> <p>LC (low compliance) n = 23</p> <p>Mean 52.8 months (SD 8.9)</p> <p>Control n = 41</p> <p>Mean 59.9 months (SD 18.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Of 42 children in the treatment group, 19 (45%) used it as prescribed (&gt; 70%), 18 (43%) used it irregularly and 5 (12%) were unable to use it at all. Treatment group was divided into those with a high compliance (HC) of greater than 70%, (n = 19) and those with a low compliance (LC) of &lt; 70% (n = 23). In the LC group compliance deteriorated from 45% to 29% over the course of the treatment. </p> <p>See table 1 in <a href="./references#CD015253-bbs2-0004" title="BlanshardJ , MawA , BawdenR . The treatment of otitis media with effusion in children by autoinflation. In: 2nd European Congress of Oto-Rhino-Laryngology and Cervico-facial Surgery. 1992:31-7. [CENTRAL: CN-01165327] BlanshardJD , MawAR , BawdenR . Conservative treatment of otitis-media with effusion by autoinflation of the middle-ear. Clinical Otolaryngology1993;18(3):188-92. [CENTRAL: CN-02472342] ">Blanshard 1993</a> for further information </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0005" title="BrookerDS , McNeiceA . Autoinflation in the treatment of glue ear in children. Clinical Otolaryngology and Allied Sciences1992;17(4):289-90. [CENTRAL: CN-00262418] [PMID: 1526044]">Brooker 1992</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inflate balloon nasally 3 times a day for 3 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information on compliance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age 3 to 10 years, mean 5.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information on compliance</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0006" title="ChanKH , BluestoneCD . Lack of efficacy of middle-ear inflation: treatment of otitis media with effusion in children. Otolaryngology--Head and Neck Surgery1989;100(4):317-23. [CENTRAL: CN-00060254] [PMID: 2498820]">Chan 1989</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 times daily for 2 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants stratified according to their ability of tubal opening during autoinflation</p> <p>Parents asked to record number of exercise cycles completed each day and to hand in a score card at the end of the 2‐week study as a method to monitor patient compliance </p> <p>Ability to autoinflate</p> <p>Autoinflation</p> <p>No 4 (21.1)</p> <p>Yes 15 (78.9)</p> <p>Control</p> <p>No 5 (22.7)</p> <p>Yes 17 (77.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age between 3 and 18 years of age</p> <p>Autoinflation</p> <p>3 to 6 years: 14 (73.6)</p> <p>7 to 11 years: 4 (21.1)</p> <p>&gt; 12 years: 1 (5.3)</p> <p>Control</p> <p>3 to 6 years: 13 (59.1)</p> <p>7 to 11 years: 7 (31.8)</p> <p>&gt; 12 years: 2 (9.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No further details on compliance</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0007" title="ErcanI , CakirBC , KayaogluS , TurgutS . Long term effect of autoinflation in the treatment of otitis media with effusion. Elektronik Kulak Buran Bogaz ve Bas Boyun Cerrahisi Dergisi [Electronic Journal of Otolalryngology - Head and Neck Surgery]2005;4(4):166-70. [CENTRAL: CN-00849154] ">Ercan 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Autoinflation 3 times a day for 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean age 6.2 years (range 4 to 10 years)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>“The compliance of the children to the autoinflation was satisfactory and the autoinflation was somehow amusing for the children” </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0008" title="ScaddingG , RajputK , ParikhA , HilssS , Jansz JA , DarbyYC , et al. Double blind, placebo-controlled study of Flixonase with and without Otovent in the treatment of otitis media with effusion. In: 8th International Congress of Paediatric Otorhinolaryngology (ESPO); 2002 Sep 11-14; Oxford, UK. 2002:92-3. [ABSTRACT NUMBER: 21.04] [CENTRAL: CN-00431597] ScaddingGK , DarbyYC , JanszAJ , RichardsD , TateH , HillsS , et al. Double-blind, placebo controlled randomised trial of medical therapy in otitis media with effusion. Advances in Life Sciences and Health2014;1(2):1-11. [CENTRAL: CN-01043521] ">Scadding 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Otovent 3 times daily for approximately 4 to 5 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Compliance assessed by questioning child and parent/guardian and by number of bottles used. Those who reported spray use on at least 3 days a week remained in the study. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aged between 4 and 8 years</p> <p>Treatment 5.7 (SD 1.3)</p> <p>Placebo</p> <p>5.7 years (SD 1.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Those who reported spray use on at least 3 days a week remained in the study</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0009" title="StangerupS , TosM . Autoinflation in the treatment of Eustachian tube dysfunction, secretory otitis media and its sequelae. In: Mogi G (editor), editors(s). Recent Advances in Otitis Media. Amsterdam/New York: Kugler Publications, 1994:759-63. [CENTRAL: CN-01214464] StangerupSE , Sederberg-OlsenJ , BalleV . Autoinflation as a treatment of secretory otitis media. A randomized controlled study. Archives of Otolaryngology--Head &amp; Neck Surgery1992;118(2):149-52. [CENTRAL: CN-00082084] [PMID: 1540344]">Stangerup 1992</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 times a day for 2 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>At second visit the use of the nose balloon was scored: 0 not used, 1 used a few times, 2 used as prescribed </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aged 3 to 10 years “some children younger than 3 years of age had difficulty performing autoinflation” </p> <p>Median age 5.3 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 children had not performed autoinflation, 10 only once, 33 had followed instructions</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0010" title="ISRCTN55208702. An open randomised study of autoinflation in 4-11 year old school children with otitis media with effusion (OME) in primary care [Study of autoinflation in 4-11 year old school children with glue ear]. https://www.isrctn.com/ISRCTN55208702 (first received 16 June 2011). [CENTRAL: CN-01012774] WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. [CENTRAL: CN-01098789] [EMBASE: 606141685] [PMID: 26377389]WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , KellyS , et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ: Canadian Medical Association Journal2015;187(13):961-9. [CENTRAL: CN-01078404] [PMID: 26216608]">Williamson 2015a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Otovent 3 times per day for 1 to 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weekly diary of compliance, sticker book</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Autoinflation group: mean 5.4 years (SD 1.24)</p> <p>Control group: mean 5.4 years (SD 1.04)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89% (116/130) used ‘most’ or ‘all of the time’ in the first month</p> <p>80% in months 2 and 3 (68/85, 805)</p> <p>See table 22 in <a href="./references#CD015253-bbs2-0010" title="ISRCTN55208702. An open randomised study of autoinflation in 4-11 year old school children with otitis media with effusion (OME) in primary care [Study of autoinflation in 4-11 year old school children with glue ear]. https://www.isrctn.com/ISRCTN55208702 (first received 16 June 2011). [CENTRAL: CN-01012774] WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. [CENTRAL: CN-01098789] [EMBASE: 606141685] [PMID: 26377389]WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , KellyS , et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ: Canadian Medical Association Journal2015;187(13):961-9. [CENTRAL: CN-01078404] [PMID: 26216608]">Williamson 2015a</a> for more information </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD015253-bbs2-0011" title="WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. ">Williamson 2015b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Otovent 3 times per day for 1 to 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Recorded using a daily sticker reward chart</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Age:</p> <p>Autoinflation group:</p> <p>4 to 5 years: 3</p> <p>5 to 6 years: 4</p> <p>6 to 10 years: 0</p> <p>7 to 11 years: 2</p> <p>Control group:</p> <p>4 to 5 years: 2</p> <p>5 to 6 years: 8</p> <p>6 to 10 years: 0</p> <p>7 to 11 years: 0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Compliance described as “excellent” and pilot study answered major unknown issue about “whether or not children were able to perform the technique and achieve sufficient compliance over 1 month in a primary care setting” </p> <p>See table 4 in <a href="./references#CD015253-bbs2-0010" title="ISRCTN55208702. An open randomised study of autoinflation in 4-11 year old school children with otitis media with effusion (OME) in primary care [Study of autoinflation in 4-11 year old school children with glue ear]. https://www.isrctn.com/ISRCTN55208702 (first received 16 June 2011). [CENTRAL: CN-01012774] WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , BreenM , et al. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care. Health Technology Assessment (Winchester, England)2015;19(72):1-150. [CENTRAL: CN-01098789] [EMBASE: 606141685] [PMID: 26377389]WilliamsonI , VennikJ , HarndenA , VoyseyM , PereraR , KellyS , et al. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial. CMAJ: Canadian Medical Association Journal2015;187(13):961-9. [CENTRAL: CN-01078404] [PMID: 26216608]">Williamson 2015a</a> for more information </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>SD: standard deviation</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Compliance with autoinflation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/full#CD015253-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD015253-tbl-0005"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Sensitivity analyses</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Outcome</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Main analysis result</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Sensitivity analysis</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Sensitivity analysis result</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.5.1 Hearing threshold (short‐term, &gt; 6 weeks to ≤ 3 months): 0.5 kHz</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐9.13 (‐15.14 to ‐3.13)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fixed‐effect model</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐10.17 (‐13.63 to ‐6.71)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.5.2 Hearing threshold (short‐term, &gt; 6 weeks to ≤ 3 months): 1 kHz</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐10.34 (‐17.85 to ‐2.83)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fixed‐effect model</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐11.77 (‐15.73 to ‐7.82)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.5.3 Hearing threshold (short‐term, &gt; 6 weeks to ≤ 3 months): 2 kHz</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐9.04 (‐14.84 to ‐3.25)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fixed‐effect model</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐9.85 (‐13.61 to ‐6.10)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.5.4 Hearing threshold (short‐term, &gt; 6 weeks to ≤ 3 months): 4 kHz</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐12.88 (‐17.01 to ‐8.75)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fixed‐effect model</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐12.88 (‐17.01 to ‐8.75)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.7 Persistence of OME (very short‐term, &lt; 6 weeks)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.86 (0.72 to 1.04)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fixed‐effect model</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.83 (0.76 to 0.92)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.7 Persistence of OME (very short‐term, &lt; 6 weeks)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.86 (0.72 to 1.04)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excluding studies at high risk using the trustworthiness tool</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.94 (0.81 to 1.09)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.8 Persistence of OME (short‐term, &gt; 6 weeks to ≤ 3 months)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.88 (0.80 to 0.97)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fixed‐effect model</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.86 (0.77 to 0.97)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.8 Persistence of OME (short‐term, &gt; 6 weeks to ≤ 3 months)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.88 (0.80 to 0.97)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excluding studies at high risk using the trustworthiness tool</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.88 (0.74 to 1.04)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.9 Episodes of acute otitis media (short‐term, &gt; 6 weeks to ≤ 3 months)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.82 (0.49 to 1.36)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Fixed‐effect model</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.85 (0.51 to 1.41)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.9 Episodes of acute otitis media (short‐term, &gt; 6 weeks to ≤ 3 months)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.82 (0.49 to 1.36)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excluding studies at high risk using the trustworthiness tool</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.25 (0.34 to 4.57)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>MD: mean difference; OME: otitis media with effusion; RR: risk ratio</p> <p>Numbers in brackets represent 95% confidence intervals.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Sensitivity analyses</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/full#CD015253-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD015253-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Autoinflation versus watchful waiting/no treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Proportion of children whose hearing is normal (very short‐term, &lt; 6 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Proportion of children whose hearing is normal (short‐term, &gt; 6 weeks to ≤ 3 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.67 [1.73, 4.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Hearing threshold (very short‐term, &lt; 6 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.00 [‐10.10, 0.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Hearing threshold (short‐term, &gt; 6 weeks to ≤ 3 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 0.5 kHz</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.13 [‐15.14, ‐3.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.2 1.0 kHz</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐10.34 [‐17.85, ‐2.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.3 2.0 kHz</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.04 [‐14.84, ‐3.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.4 4.0 kHz</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐12.88 [‐17.01, ‐8.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Disease‐specific quality of life (short‐term, &gt; 6 weeks to ≤ 3 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.42 [‐0.62, ‐0.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Adverse events ‐ pain and distress caused by the procedure (otalgia) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.1 Otalgia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>320</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.50 [0.74, 16.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Persistence of OME (very short‐term, &lt; 6 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>688</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.72, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.1 Per ear data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>670</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.69, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.2 Per child data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.72, 1.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 Persistence of OME (short‐term, &gt; 6 weeks to ≤ 3 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>483</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.80, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.1 Per ear data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>466</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.79, 0.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.2 Per child data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.61, 2.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 Episodes of acute otitis media (short‐term, &gt; 6 weeks to ≤ 3 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>403</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.49, 1.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 Sensitivity analysis: Proportion of children whose hearing is normal (very short‐term, &lt; 6 weeks). Per ear data (ICC of 1, complete correlation between ears) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.11 Sensitivity analysis: Proportion of children whose hearing is normal (very short‐term, &lt; 6 weeks). Per ear data (ICC of 0, no correlation between ears) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.12 Sensitivity analysis: Hearing threshold (short‐term, &gt; 6 weeks to ≤ 3 months). Right ear data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.1 0.5 kHz</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.13 [‐15.35, ‐2.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.2 1.0 kHz</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐10.91 [‐20.07, ‐1.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.3 2.0 kHz</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.59 [‐17.74, ‐1.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.4 4.0 kHz</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐13.37 [‐20.66, ‐6.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.13 Sensitivity analysis: Hearing threshold (short‐term, &gt; 6 weeks to ≤ 3 months). Left ear data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.1 0.5 kHz</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>115</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.97 [‐14.88, ‐3.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.2 1.0 kHz</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>115</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.64 [‐15.50, ‐3.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.3 2.0 kHz</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>115</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.06 [‐12.16, ‐3.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.4 4.0 kHz</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>115</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐10.92 [‐15.42, ‐6.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.14 Sensitivity analysis: Persistence of OME (very short‐term, &lt; 6 weeks). Per ear data (ICC of 0) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>862</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.68, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.15 Sensitivity analysis: Persistence of OME (very short‐term, &lt; 6 weeks). Per ear data (ICC of 1) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>551</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.70, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.16 Sensitivity analysis: Persistence of OME (very short‐term, &lt; 6 weeks). Per child data, where available <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>621</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.68, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.16.1 Per ear data, adjusted for correlation for those with bilateral disease</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.55, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.16.2 Per child data: persistence in any affected ear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.88, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.16.3 Per child data: persistence in all affected ears</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>281</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.68, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.17 Sensitivity analysis: Persistence of OME (short‐term, &gt; 6 weeks to ≤ 3 months). Per ear data (ICC of 0) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>617</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.82, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.17.1 Per ear data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>600</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.82, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.17.2 Per child data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.61, 2.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.18 Sensitivity analysis: Persistence of OME (short‐term, &gt; 6 weeks to ≤ 3 months). Per ear data (ICC of 1) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>402</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.81, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.18.1 Per ear data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.80, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.18.2 Per child data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.61, 2.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.19 Sensitivity analysis: Persistence of OME (short‐term, &gt; 6 weeks to ≤ 3 months). Per child data, where available <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>441</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.78, 0.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.19.1 Per ear data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>179</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.68, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.19.2 Per child data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>262</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.66, 1.02]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Autoinflation versus watchful waiting/no treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD015253.pub2/references#CD015253-tbl-0006">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD015253.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD015253-note-0009">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD015253-note-0020">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD015253-note-0015">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD015253-note-0017">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD015253-note-0014">Hrvatski</a> </li> <li class="section-language"> <a class="" href="hu#CD015253-note-0019">Magyar</a> </li> <li class="section-language"> <a class="" href="id#CD015253-note-0016">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="ms#CD015253-note-0013">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD015253-note-0018">Polski</a> </li> <li class="section-language"> <a class="" href="pt#CD015253-note-0012">Português</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD015253-note-0010">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD015253-note-0011">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD015253\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD015253\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD015253\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD015253\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD015253\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD015253\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD015253\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD015253\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD015253\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD015253\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD015253\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD015253\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD015253\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD015253\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD015253\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD015253\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD015253\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD015253\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=xNbeAU8n&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD015253.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD015253.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD015253.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD015253.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD015253.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740716863469"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD015253.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740716863473"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD015253.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918da9e55cf91be3',t:'MTc0MDcxNjg2My4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 